{"id": "177_356_1_226", "text": "Physical interaction between the transactivation domain (TAD) of the mixed-lineage leukemia protein (MLL) and the KIX domain of the cyclic-AMP response element binding protein (CREB) binding protein (CBP) is necessary for MLL-mediated transcriptional activation", "text_with_entity_marker": "Physical interaction between the transactivation domain (TAD) of the [E1]mixed-lineage leukemia protein (MLL)[/E1] and the KIX domain of the [E2]cyclic-AMP response element binding protein (CREB) binding protein (CBP)[/E2] is necessary for MLL-mediated transcriptional activation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "mixed-lineage leukemia protein (MLL)", "entity_1_idx": [[69, 105]], "entity_1_idx_in_text_with_entity_marker": [73, 109], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "cyclic-AMP response element binding protein (CREB) binding protein (CBP)", "entity_2_idx": [[132, 204]], "entity_2_idx_in_text_with_entity_marker": [145, 217], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "120_241_1_165", "text": "Physical interaction between coat morphogenetic proteins SpoVID and CotE is necessary for spore encasement in Bacillus subtilis.", "text_with_entity_marker": "Physical interaction between coat morphogenetic proteins [E1]SpoVID[/E1] and [E2]CotE[/E2] is necessary for spore encasement in Bacillus subtilis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SpoVID", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CotE", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "120_242_8_166", "text": "Here, we show by yeast two-hybrid and pulldown assays that SpoVID also interacts directly with the outer coat morphogenetic protein, CotE", "text_with_entity_marker": "Here, we show by yeast two-hybrid and pulldown assays that [E1]SpoVID[/E1] also interacts directly with the outer coat morphogenetic protein, [E2]CotE[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SpoVID", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CotE", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "120_242_7_167", "text": "It was previously demonstrated that SpoVID directly interacts with SpoIVA and the inner coat morphogenetic protein, SafA", "text_with_entity_marker": "It was previously demonstrated that [E1]SpoVID[/E1] directly interacts with [E2]SpoIVA[/E2] and the inner coat morphogenetic protein, SafA", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SpoVID", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SpoIVA", "entity_2_idx": [[67, 73]], "entity_2_idx_in_text_with_entity_marker": [80, 86], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "120_242_7_168", "text": "It was previously demonstrated that SpoVID directly interacts with SpoIVA and the inner coat morphogenetic protein, SafA", "text_with_entity_marker": "It was previously demonstrated that [E1]SpoVID[/E1] directly interacts with SpoIVA and the inner coat morphogenetic protein, [E2]SafA[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SpoVID", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SafA", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "6_13_1_16", "text": "Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins.", "text_with_entity_marker": "Threonine 391 phosphorylation of the human [E1]prolactin receptor[/E1] mediates a novel interaction with [E2]14-3-3[/E2] proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "prolactin receptor", "entity_1_idx": [[43, 61]], "entity_1_idx_in_text_with_entity_marker": [47, 65], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "14-3-3", "entity_2_idx": [[96, 102]], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "6_14_3_17", "text": "Here we describe a novel interaction between the PrlR and the phosphoserine/phosphothreonine-binding 14-3-3 proteins", "text_with_entity_marker": "Here we describe a novel interaction between the [E1]PrlR[/E1] and the phosphoserine/phosphothreonine-binding [E2]14-3-3[/E2] proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PrlR", "entity_1_idx": [[49, 53]], "entity_1_idx_in_text_with_entity_marker": [53, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "14-3-3", "entity_2_idx": [[101, 107]], "entity_2_idx_in_text_with_entity_marker": [114, 120], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "314_630_1_425", "text": "Abi-1 is an adaptor protein for Abelson kinase (c-Abl), and Abi-1 promotes the Abl-mediated phosphorylation of Mammalian Enabled (Mena) by binding both c-Abl and Mena", "text_with_entity_marker": "[E1]Abi-1[/E1] is an adaptor protein for [E2]Abelson kinase (c-Abl)[/E2], and Abi-1 promotes the Abl-mediated phosphorylation of Mammalian Enabled (Mena) by binding both c-Abl and Mena", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Abi-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Abelson kinase (c-Abl)", "entity_2_idx": [[32, 54]], "entity_2_idx_in_text_with_entity_marker": [45, 67], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "290_582_9_401", "text": "These findings support the concepts that CrkII binding activity is regulated by tyrosine kinases and phosphatases, and that tyrosine phosphorylation of CrkII can downmodulate cell migration mediated by the focal adhesion kinase/p130cas pathway.", "text_with_entity_marker": "These findings support the concepts that CrkII binding activity is regulated by [E1]tyrosine kinases and phosphatases[/E1][E2]CrkII[/E2] binding activity is regulated by tyrosine kinases and phosphatases, and that tyrosine phosphorylation of CrkII can downmodulate cell migration mediated by the focal adhesion kinase/p130cas pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tyrosine kinases and phosphatases", "entity_1_idx": [[80, 113]], "entity_1_idx_in_text_with_entity_marker": [84, 117], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CrkII", "entity_2_idx": [[41, 46]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "8_18_3_18", "text": "Instead, a serine, histidine, and two aspartic acids are important for signal peptidase activity by the Sec11p subunit of the yeast signal peptidase complex", "text_with_entity_marker": "Instead, a serine, histidine, and two aspartic acids are important for [E1]signal peptidase[/E1] activity by the [E2]Sec11p[/E2] subunit of the yeast signal peptidase complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "signal peptidase", "entity_1_idx": [[71, 87]], "entity_1_idx_in_text_with_entity_marker": [75, 91], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Sec11p", "entity_2_idx": [[104, 110]], "entity_2_idx_in_text_with_entity_marker": [117, 123], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "153_307_1_207", "text": "Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK.", "text_with_entity_marker": "Direct association of [E1]pp125FAK[/E1] with [E2]paxillin[/E2], the focal adhesion-targeting mechanism of pp125FAK.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "pp125FAK", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[36, 44]], "entity_2_idx_in_text_with_entity_marker": [49, 57], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "153_308_6_208", "text": "These findings strongly suggest that pp125FAK is localized to focal adhesions by the direct association with paxillin.", "text_with_entity_marker": "These findings strongly suggest that pp125FAK is localized to focal adhesions by the direct association with [E1]paxillin[/E1][E2]pp125FAK[/E2] is localized to focal adhesions by the direct association with paxillin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "pp125FAK", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [130, 138], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "27_56_6_50", "text": "Stability assays on selected mutants performed both in vitro on purified PscE-PscG complexes and in vivo on P", "text_with_entity_marker": "Stability assays on selected mutants performed both in vitro on purified [E1]PscE[/E1]-[E2]PscG[/E2] complexes and in vivo on P", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PscE", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PscG", "entity_2_idx": [[78, 82]], "entity_2_idx_in_text_with_entity_marker": [91, 95], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "27_56_3_51", "text": "Two proteins, PscG and PscE, stabilize PscF within the bacterial cell before its export and polymerization", "text_with_entity_marker": "Two proteins, PscG and [E1]PscE[/E1], stabilize [E2]PscF[/E2] within the bacterial cell before its export and polymerization", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PscE", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PscF", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "27_56_3_52", "text": "Two proteins, PscG and PscE, stabilize PscF within the bacterial cell before its export and polymerization", "text_with_entity_marker": "Two proteins, [E1]PscG[/E1] and PscE, stabilize [E2]PscF[/E2] within the bacterial cell before its export and polymerization", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PscG", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PscF", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "46_94_3_71", "text": "Here we have identified and characterized a novel mitochondrial outer membrane protein, OMP25, with a single PDZ domain that specifically binds to a unique motif in the C-terminus of synaptojanin 2A", "text_with_entity_marker": "Here we have identified and characterized a novel mitochondrial outer membrane protein, [E1]OMP25[/E1], with a single PDZ domain that specifically binds to a unique motif in the C-terminus of [E2]synaptojanin 2A[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "OMP25", "entity_1_idx": [[88, 93]], "entity_1_idx_in_text_with_entity_marker": [92, 97], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "synaptojanin 2A", "entity_2_idx": [[183, 198]], "entity_2_idx_in_text_with_entity_marker": [196, 211], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "182_365_1_236", "text": "Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.", "text_with_entity_marker": "Inhibition of human pancreatic ribonuclease by the [E1]human ribonuclease inhibitor protein[/E1][E2]human pancreatic ribonuclease[/E2] by the human ribonuclease inhibitor protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "human ribonuclease inhibitor protein", "entity_1_idx": [[51, 87]], "entity_1_idx_in_text_with_entity_marker": [55, 91], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "human pancreatic ribonuclease", "entity_2_idx": [[14, 43]], "entity_2_idx_in_text_with_entity_marker": [100, 129], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "182_366_2_237", "text": "Here, we report on structural and energetic aspects of the interaction between human RI (hRI) and human pancreatic ribonuclease (RNase 1)", "text_with_entity_marker": "Here, we report on structural and energetic aspects of the interaction between [E1]human RI (hRI)[/E1] and human [E2]pancreatic ribonuclease (RNase 1)[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "human RI (hRI)", "entity_1_idx": [[79, 93]], "entity_1_idx_in_text_with_entity_marker": [83, 97], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "pancreatic ribonuclease (RNase 1)", "entity_2_idx": [[104, 137]], "entity_2_idx_in_text_with_entity_marker": [117, 150], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "303_608_5_418", "text": "Here, we demonstrate that the short SAS-5 C-terminal domain (residues 390-404) specifically binds to a narrow central region (residues 275-288) of the SAS-6 coiled coil", "text_with_entity_marker": "Here, we demonstrate that the short [E1]SAS-5[/E1] C-terminal domain (residues 390-404) specifically binds to a narrow central region (residues 275-288) of the [E2]SAS-6[/E2] coiled coil", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SAS-5", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SAS-6", "entity_2_idx": [[151, 156]], "entity_2_idx_in_text_with_entity_marker": [164, 169], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "151_304_1_205", "text": "We have identified a new Dictyostelium p21-activated protein kinase, PAKc, that we demonstrate to be required for proper chemotaxis", "text_with_entity_marker": "We have identified a new Dictyostelium [E1]p21[/E1]-activated protein kinase, [E2]PAKc[/E2], that we demonstrate to be required for proper chemotaxis", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PAKc", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "328_658_2_444", "text": "We report that MeCP2 interacts with ATRX, a SWI2/SNF2 DNA helicase/ATPase that is mutated in ATRX syndrome (alpha-thalassemia/mental retardation, X-linked)", "text_with_entity_marker": "We report that [E1]MeCP2[/E1] interacts with [E2]ATRX[/E2], a SWI2/SNF2 DNA helicase/ATPase that is mutated in ATRX syndrome (alpha-thalassemia/mental retardation, X-linked)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MeCP2", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ATRX", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [49, 53], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "266_534_7_355", "text": "DJ-1 competes with pro-caspase-8 to bind to FADD at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8", "text_with_entity_marker": "[E1]DJ-1[/E1] competes with pro-caspase-8 to bind to [E2]FADD[/E2] at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DJ-1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "266_534_7_356", "text": "DJ-1 competes with pro-caspase-8 to bind to FADD at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8", "text_with_entity_marker": "DJ-1 competes with [E1]pro-caspase-8[/E1] to bind to [E2]FADD[/E2] at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pro-caspase-8", "entity_1_idx": [[19, 32]], "entity_1_idx_in_text_with_entity_marker": [23, 36], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "39_80_1_64", "text": "In bacteria, the actin-like FtsA protein interacts with the tubulin-like FtsZ protein, helping to assemble the cytokinetic Z ring, anchor it to the cytoplasmic membrane and recruit other essential divisome proteins", "text_with_entity_marker": "In bacteria, the actin-like [E1]FtsA[/E1] protein interacts with the tubulin-like [E2]FtsZ[/E2] protein, helping to assemble the cytokinetic Z ring, anchor it to the cytoplasmic membrane and recruit other essential divisome proteins", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "FtsA", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "FtsZ", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "284_570_8_392", "text": "These findings reveal that NHERF can directly bind to the PDGFR and potentiate PDGFR activity, thus elucidating both a novel mechanism by which PDGFR activity can be regulated and a new cellular role for the PDZ domain-containing adapter protein NHERF.", "text_with_entity_marker": "These findings reveal that [E1]NHERF[/E1] can directly bind to the [E2]PDGFR[/E2] and potentiate PDGFR activity, thus elucidating both a novel mechanism by which PDGFR activity can be regulated and a new cellular role for the PDZ domain-containing adapter protein NHERF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NHERF", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PDGFR", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "256_513_1_340", "text": "Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor.", "text_with_entity_marker": "Phosphorylation of PTP1B at Ser(50) by [E1]Akt[/E1][E2]PTP1B[/E2] at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Akt", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PTP1B", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "256_514_14_341", "text": "We conclude that PTP1B is a novel substrate for Akt and that phosphorylation of PTP1B by Akt at Ser(50) may negatively modulate its phosphatase activity creating a positive feedback mechanism for insulin signaling.", "text_with_entity_marker": "We conclude that PTP1B is a novel substrate for [E1]Akt[/E1][E2]PTP1B[/E2] is a novel substrate for Akt and that phosphorylation of PTP1B by Akt at Ser(50) may negatively modulate its phosphatase activity creating a positive feedback mechanism for insulin signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Akt", "entity_1_idx": [[48, 51]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PTP1B", "entity_2_idx": [[17, 22]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "229_459_1_300", "text": "RAD51-associated protein 1 (RAD51AP1) interacts with the meiotic recombinase DMC1 through a conserved motif.", "text_with_entity_marker": "[E1]RAD51-associated protein 1 (RAD51AP1)[/E1] interacts with the meiotic recombinase [E2]DMC1[/E2] through a conserved motif.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51-associated protein 1 (RAD51AP1)", "entity_1_idx": [[0, 37]], "entity_1_idx_in_text_with_entity_marker": [4, 41], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DMC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "229_460_3_301", "text": "We have recently shown that RAD51AP1 also partners with the meiotic recombinase DMC1, displaying isoform-specific interactions with DMC1", "text_with_entity_marker": "We have recently shown that [E1]RAD51AP1[/E1] also partners with the meiotic recombinase [E2]DMC1[/E2], displaying isoform-specific interactions with DMC1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51AP1", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DMC1", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "247_496_1_328", "text": "The kinase interaction (KI) domain of kinase-associated protein phosphatase (KAPP) interacts with the phosphorylated form of an Arabidopsis thaliana receptor-like protein kinase (RLK)", "text_with_entity_marker": "The kinase interaction (KI) domain of [E1]kinase-associated protein phosphatase (KAPP)[/E1] interacts with the phosphorylated form of an Arabidopsis thaliana [E2]receptor-like protein kinase (RLK)[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "kinase-associated protein phosphatase (KAPP)", "entity_1_idx": [[38, 82]], "entity_1_idx_in_text_with_entity_marker": [42, 86], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "receptor-like protein kinase (RLK)", "entity_2_idx": [[149, 183]], "entity_2_idx_in_text_with_entity_marker": [162, 196], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "74_149_1_103", "text": "The negative regulator Opi1 of phospholipid biosynthesis in yeast contacts the pleiotropic repressor Sin3 and the transcriptional activator Ino2.", "text_with_entity_marker": "The negative regulator [E1]Opi1[/E1] of phospholipid biosynthesis in yeast contacts the pleiotropic repressor [E2]Sin3[/E2] and the transcriptional activator Ino2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Opi1", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Sin3", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "74_149_1_104", "text": "The negative regulator Opi1 of phospholipid biosynthesis in yeast contacts the pleiotropic repressor Sin3 and the transcriptional activator Ino2.", "text_with_entity_marker": "The negative regulator [E1]Opi1[/E1] of phospholipid biosynthesis in yeast contacts the pleiotropic repressor Sin3 and the transcriptional activator [E2]Ino2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Opi1", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Ino2", "entity_2_idx": [[140, 144]], "entity_2_idx_in_text_with_entity_marker": [153, 157], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "74_150_4_105", "text": "Using in vivo as well as in vitro interaction assays, we show binding of the pleiotropic repressor Sin3 to the pathway-specific regulator Opi1", "text_with_entity_marker": "Using in vivo as well as in vitro interaction assays, we show binding of the pleiotropic repressor [E1]Sin3[/E1] to the pathway-specific regulator [E2]Opi1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Sin3", "entity_1_idx": [[99, 103]], "entity_1_idx_in_text_with_entity_marker": [103, 107], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Opi1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "218_437_1_286", "text": "LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.", "text_with_entity_marker": "[E1]LRRK2[/E1] directly phosphorylates [E2]Akt1[/E2] as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LRRK2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Akt1", "entity_2_idx": [[30, 34]], "entity_2_idx_in_text_with_entity_marker": [43, 47], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "218_438_2_287", "text": "Here, using in vitro kinase assay with recombinant proteins, we demonstrated for the first time that LRRK2 directly phosphorylates Akt1, a central molecule involved in signal transduction for cell survival and prevention of apoptosis", "text_with_entity_marker": "Here, using in vitro kinase assay with recombinant proteins, we demonstrated for the first time that [E1]LRRK2[/E1] directly phosphorylates [E2]Akt1[/E2], a central molecule involved in signal transduction for cell survival and prevention of apoptosis", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LRRK2", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Akt1", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "1_3_1_2", "text": "p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200.", "text_with_entity_marker": "[E1]p53[/E1] inhibits autophagy by interacting with the human ortholog of yeast Atg17, [E2]RB1CC1/FIP200[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RB1CC1/FIP200", "entity_2_idx": [[78, 91]], "entity_2_idx_in_text_with_entity_marker": [91, 104], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "1_4_6_3", "text": "In conclusion, p53 regulates autophagy through a direct molecular interaction with RB1CC1/FIP200, a protein that is essential for the very apical step of autophagy initiation.", "text_with_entity_marker": "In conclusion, [E1]p53[/E1] regulates autophagy through a direct molecular interaction with [E2]RB1CC1/FIP200[/E2], a protein that is essential for the very apical step of autophagy initiation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p53", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RB1CC1/FIP200", "entity_2_idx": [[83, 96]], "entity_2_idx_in_text_with_entity_marker": [96, 109], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "107_215_1_140", "text": "Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.", "text_with_entity_marker": "[E1]Beta-catenin[/E1] binds to the activation function 2 region of the [E2]androgen receptor[/E2] and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "androgen receptor", "entity_2_idx": [[62, 79]], "entity_2_idx_in_text_with_entity_marker": [75, 92], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "107_216_4_141", "text": "Using mammalian two-hybrid binding assays, analysis of reporter gene transcription, and coimmunoprecipitation, we now show that beta-catenin binds to the androgen receptor ligand-binding domain (LBD) and modulates the transcriptional effects of TIF2 and the androgen receptor N-terminal domain (NTD)", "text_with_entity_marker": "Using mammalian two-hybrid binding assays, analysis of reporter gene transcription, and coimmunoprecipitation, we now show that [E1]beta-catenin[/E1] binds to the [E2]androgen receptor[/E2] ligand-binding domain (LBD) and modulates the transcriptional effects of TIF2 and the androgen receptor N-terminal domain (NTD)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[128, 140]], "entity_1_idx_in_text_with_entity_marker": [132, 144], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "androgen receptor", "entity_2_idx": [[154, 171]], "entity_2_idx_in_text_with_entity_marker": [167, 184], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "4_9_1_13", "text": "Binding of paxillin to alpha4 integrins modifies integrin-dependent biological responses.", "text_with_entity_marker": "Binding of [E1]paxillin[/E1] to [E2]alpha4 integrin[/E2]s modifies integrin-dependent biological responses.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "alpha4 integrin", "entity_2_idx": [[23, 38]], "entity_2_idx_in_text_with_entity_marker": [36, 51], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "4_10_4_14", "text": "Paxillin physically associated with alpha4 integrins in Jurkat T cells at high stoichiometry, and joining the alpha4 tail to alphaIIb resulted in a complex of integrin alphaIIbbeta3 with paxillin", "text_with_entity_marker": "Paxillin physically associated with alpha4 integrins in Jurkat T cells at high stoichiometry, and joining the alpha4 tail to alphaIIb resulted in a complex of integrin alphaIIbbeta3 with [E1]paxillin[/E1][E2]alpha4 integrin[/E2]s in Jurkat T cells at high stoichiometry, and joining the alpha4 tail to alphaIIb resulted in a complex of integrin alphaIIbbeta3 with paxillin", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[187, 195]], "entity_1_idx_in_text_with_entity_marker": [191, 199], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "alpha4 integrin", "entity_2_idx": [[36, 51]], "entity_2_idx_in_text_with_entity_marker": [208, 223], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "0_2_5_1", "text": "The functional binding analysis demonstrated that KIS interacts with beta-tubulin in plant", "text_with_entity_marker": "The functional binding analysis demonstrated that [E1]KIS[/E1] interacts with [E2]beta-tubulin[/E2] in plant", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "KIS", "entity_1_idx": [[50, 53]], "entity_1_idx_in_text_with_entity_marker": [54, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "beta-tubulin", "entity_2_idx": [[69, 81]], "entity_2_idx_in_text_with_entity_marker": [82, 94], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1787_AIMed.d207.s1787.p3", "text": "MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.", "text_with_entity_marker": "MyoD prevents [E1]cyclinA[/E1]/[E2]cdk2[/E2] containing E2F complexes formation in terminally differentiated myocytes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclinA", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1791_AIMed.d207.s1791.p8", "text": "An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "text_with_entity_marker": "An E2F complex containing mainly [E1]E2F4[/E1] and [E2]pRb2[/E2]/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E2F4", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[42, 46]], "entity_2_idx_in_text_with_entity_marker": [55, 59], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1791_AIMed.d207.s1791.p9", "text": "An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "text_with_entity_marker": "An E2F complex containing mainly [E1]E2F4[/E1] and pRb2/[E2]p130[/E2] (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E2F4", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[47, 51]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1791_AIMed.d207.s1791.p30", "text": "An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the cyclinA/cdk2 containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "text_with_entity_marker": "An E2F complex containing mainly E2F4 and pRb2/p130 (E2F-G0/G1 complex) appears when DNA synthesis arrests, replacing the [E1]cyclinA[/E1]/[E2]cdk2[/E2] containing E2F complex of proliferating myoblasts (E2F-G1/S complex).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclinA", "entity_1_idx": [[122, 129]], "entity_1_idx_in_text_with_entity_marker": [126, 133], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[130, 134]], "entity_2_idx_in_text_with_entity_marker": [143, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1794_AIMed.d207.s1794.p0", "text": "Thus, during myogenic differentiation, formation of E2F4 and pRb2/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.", "text_with_entity_marker": "Thus, during myogenic differentiation, formation of [E1]E2F4[/E1] and [E2]pRb2[/E2]/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2F4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pRb2", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1794_AIMed.d207.s1794.p1", "text": "Thus, during myogenic differentiation, formation of E2F4 and pRb2/p130 containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.", "text_with_entity_marker": "Thus, during myogenic differentiation, formation of [E1]E2F4[/E1] and pRb2/[E2]p130[/E2] containing complexes is an early event, but not enough on its own to prevent the reactivation of DNA synthesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2F4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p130", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d207.s1795_AIMed.d207.s1795.p30", "text": "Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of cyclinA/cdk2 to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.", "text_with_entity_marker": "Using a subclone of C3H10T1/2 mouse fibroblasts stably expressing Estrogen Receptor-MyoD (ER-MyoD) chimerae, we found that estrogen directed MyoD activation prevents the reassociation of [E1]cyclinA[/E1]/[E2]cdk2[/E2] to the E2F4 containing complex following serum stimulation and this correlates with suppression of E2F activity and the inability of cells to re-enter the cell cycle.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclinA", "entity_1_idx": [[187, 194]], "entity_1_idx_in_text_with_entity_marker": [191, 198], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1737_AIMed.d202.s1737.p2", "text": "Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta.", "text_with_entity_marker": "Crystal structure of the [E1]type-I interleukin-1 receptor[/E1] complexed with [E2]interleukin-1beta[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "type-I interleukin-1 receptor", "entity_1_idx": [[25, 54]], "entity_1_idx_in_text_with_entity_marker": [29, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-1beta", "entity_2_idx": [[70, 87]], "entity_2_idx_in_text_with_entity_marker": [83, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1741_AIMed.d202.s1741.p1", "text": "The binding of IL-1alpha or IL-1beta to IL1R is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.", "text_with_entity_marker": "The binding of [E1]IL-1alpha[/E1] or IL-1beta to [E2]IL1R[/E2] is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1alpha", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1R", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1741_AIMed.d202.s1741.p3", "text": "The binding of IL-1alpha or IL-1beta to IL1R is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.", "text_with_entity_marker": "The binding of IL-1alpha or [E1]IL-1beta[/E1] to [E2]IL1R[/E2] is an early step in IL-1 signal transduction and blocking this interaction may therefore be a useful target for the development of new drugs.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1beta", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1R", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1742_AIMed.d202.s1742.p0", "text": "Here we report the three-dimensional structure of IL-1beta bound to the extracellular domain of IL1R (s-IL1R) at 2.5 A resolution.", "text_with_entity_marker": "Here we report the three-dimensional structure of [E1]IL-1beta[/E1] bound to the extracellular domain of [E2]IL1R[/E2] (s-IL1R) at 2.5 A resolution.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1beta", "entity_1_idx": [[50, 58]], "entity_1_idx_in_text_with_entity_marker": [54, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1R", "entity_2_idx": [[96, 100]], "entity_2_idx_in_text_with_entity_marker": [109, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1742_AIMed.d202.s1742.p1", "text": "Here we report the three-dimensional structure of IL-1beta bound to the extracellular domain of IL1R (s-IL1R) at 2.5 A resolution.", "text_with_entity_marker": "Here we report the three-dimensional structure of [E1]IL-1beta[/E1] bound to the extracellular domain of IL1R ([E2]s-IL1R[/E2]) at 2.5 A resolution.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1beta", "entity_1_idx": [[50, 58]], "entity_1_idx_in_text_with_entity_marker": [54, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "s-IL1R", "entity_2_idx": [[102, 108]], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1743_AIMed.d202.s1743.p0", "text": "IL-1beta binds to s-IL1R with a 1:1 stoichiometry.", "text_with_entity_marker": "[E1]IL-1beta[/E1] binds to [E2]s-IL1R[/E2] with a 1:1 stoichiometry.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1beta", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "s-IL1R", "entity_2_idx": [[18, 24]], "entity_2_idx_in_text_with_entity_marker": [31, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1744_AIMed.d202.s1744.p0", "text": "The crystal structure shows that s-IL1R consists of three immunoglobulin-like domains which wrap around IL-1beta in a manner distinct from the structures of previously described cytokine-receptor complexes.", "text_with_entity_marker": "The crystal structure shows that [E1]s-IL1R[/E1] consists of three immunoglobulin-like domains which wrap around [E2]IL-1beta[/E2] in a manner distinct from the structures of previously described cytokine-receptor complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "s-IL1R", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1beta", "entity_2_idx": [[104, 112]], "entity_2_idx_in_text_with_entity_marker": [117, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1291_AIMed.d152.s1291.p0", "text": "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.", "text_with_entity_marker": "[E1]TRADD[/E1]-[E2]TRAF2[/E2] and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRAF2", "entity_2_idx": [[6, 11]], "entity_2_idx_in_text_with_entity_marker": [19, 24], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1291_AIMed.d152.s1291.p7", "text": "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.", "text_with_entity_marker": "TRADD-TRAF2 and [E1]TRADD[/E1]-[E2]FADD[/E2] interactions define two distinct TNF receptor 1 signal transduction pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1294_AIMed.d152.s1294.p4", "text": "Here we show that TRADD directly interacts with TRAF2 and FADD, signal transducers that activate NF-kappa B and induce apoptosis, respectively.", "text_with_entity_marker": "Here we show that TRADD directly interacts with [E1]TRAF2[/E1] and FADD, signal transducers that activate [E2]NF-kappa B[/E2] and induce apoptosis, respectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRAF2", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[97, 107]], "entity_2_idx_in_text_with_entity_marker": [110, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1294_AIMed.d152.s1294.p5", "text": "Here we show that TRADD directly interacts with TRAF2 and FADD, signal transducers that activate NF-kappa B and induce apoptosis, respectively.", "text_with_entity_marker": "Here we show that TRADD directly interacts with TRAF2 and [E1]FADD[/E1], signal transducers that activate [E2]NF-kappa B[/E2] and induce apoptosis, respectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[97, 107]], "entity_2_idx_in_text_with_entity_marker": [110, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d201.s1730_AIMed.d201.s1730.p0", "text": "Our finding that HBx directly interacts with RNA polymerase II subunit 5 (RPB5), a common subunit of RNA polymerases, implies that HBx directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).", "text_with_entity_marker": "Our finding that [E1]HBx[/E1] directly interacts with [E2]RNA polymerase II subunit 5[/E2] (RPB5), a common subunit of RNA polymerases, implies that HBx directly modulates the function of RNA polymerase (Cheong, J. H., Yi, M., Lin, Y., and Murakami, S. (1995) EMBO J. 14, 142-150).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HBx", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RNA polymerase II subunit 5", "entity_2_idx": [[45, 72]], "entity_2_idx_in_text_with_entity_marker": [58, 85], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d201.s1735_AIMed.d201.s1735.p1", "text": "Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.", "text_with_entity_marker": "Some [E1]HBx[/E1] substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or [E2]RPB5[/E2] in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HBx", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RPB5", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d201.s1735_AIMed.d201.s1735.p12", "text": "Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that HBx transactivation requires the interactions of both RPB5 and TFIIB.", "text_with_entity_marker": "Some HBx substitution mutants, which had severely impaired transacting activity, exhibited reduced binding affinity with either TFIIB or RPB5 in a mutually exclusive manner, suggesting that [E1]HBx[/E1] transactivation requires the interactions of both [E2]RPB5[/E2] and TFIIB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HBx", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RPB5", "entity_2_idx": [[244, 248]], "entity_2_idx_in_text_with_entity_marker": [257, 261], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d46.s405_AIMed.d46.s405.p0", "text": "The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "text_with_entity_marker": "The binding epitopes of [E1]BMP-2[/E1] for [E2]BMPR-IA[/E2] (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-2", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-IA", "entity_2_idx": [[34, 41]], "entity_2_idx_in_text_with_entity_marker": [47, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d46.s405_AIMed.d46.s405.p1", "text": "The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "text_with_entity_marker": "The binding epitopes of [E1]BMP-2[/E1] for BMPR-IA (type I) and [E2]BMPR-II[/E2] or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-2", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPR-II", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d46.s405_AIMed.d46.s405.p2", "text": "The binding epitopes of BMP-2 for BMPR-IA (type I) and BMPR-II or ActR-II (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "text_with_entity_marker": "The binding epitopes of [E1]BMP-2[/E1] for BMPR-IA (type I) and BMPR-II or [E2]ActR-II[/E2] (type II) were characterized using BMP-2 mutant proteins for analysis of interactions with receptor ectodomains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-2", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ActR-II", "entity_2_idx": [[66, 73]], "entity_2_idx_in_text_with_entity_marker": [79, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s334_AIMed.d39.s334.p1", "text": "Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1.", "text_with_entity_marker": "[E1]Presenilin 1[/E1] suppresses the function of c-Jun homodimers via interaction with [E2]QM[/E2]/Jif-1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Presenilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "QM", "entity_2_idx": [[78, 80]], "entity_2_idx_in_text_with_entity_marker": [91, 93], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s334_AIMed.d39.s334.p2", "text": "Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1.", "text_with_entity_marker": "[E1]Presenilin 1[/E1] suppresses the function of c-Jun homodimers via interaction with QM/[E2]Jif-1[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Presenilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jif-1", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s336_AIMed.d39.s336.p1", "text": "Here we show that QM/Jun-interacting factor (Jif)-1, a negative regulator of c-Jun, is a candidate to mediate the function of PS1 in the cell.", "text_with_entity_marker": "Here we show that [E1]QM[/E1]/Jun-interacting factor (Jif)-1, a negative regulator of [E2]c-Jun[/E2], is a candidate to mediate the function of PS1 in the cell.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "QM", "entity_1_idx": [[18, 20]], "entity_1_idx_in_text_with_entity_marker": [22, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s336_AIMed.d39.s336.p3", "text": "Here we show that QM/Jun-interacting factor (Jif)-1, a negative regulator of c-Jun, is a candidate to mediate the function of PS1 in the cell.", "text_with_entity_marker": "Here we show that QM/[E1]Jun-interacting factor (Jif)-1[/E1], a negative regulator of [E2]c-Jun[/E2], is a candidate to mediate the function of PS1 in the cell.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Jun-interacting factor (Jif)-1", "entity_1_idx": [[21, 51]], "entity_1_idx_in_text_with_entity_marker": [25, 55], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s340_AIMed.d39.s340.p6", "text": "Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.", "text_with_entity_marker": "Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by [E1]c-Jun[/E1]/[E2]c-Jun[/E2] but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[99, 104]], "entity_1_idx_in_text_with_entity_marker": [103, 108], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s340_AIMed.d39.s340.p15", "text": "Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by c-Jun/c-Fos heterodimers, consistent with the reported function of QM/Jif-1.", "text_with_entity_marker": "Chloramphenicol acetyltransferase assays in F9 cells showed that PS1 suppresses transactivation by c-Jun/c-Jun but not by [E1]c-Jun[/E1]/[E2]c-Fos[/E2] heterodimers, consistent with the reported function of QM/Jif-1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Jun", "entity_1_idx": [[122, 127]], "entity_1_idx_in_text_with_entity_marker": [126, 131], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Fos", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p0", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of [E1]hTAFII18[/E1], [E2]hTAFII20[/E2] and hTAFII28: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p1", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of [E1]hTAFII18[/E1], hTAFII20 and [E2]hTAFII28[/E2]: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s867_AIMed.d103.s867.p3", "text": "Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.", "text_with_entity_marker": "Cloning and characterization of hTAFII18, [E1]hTAFII20[/E1] and [E2]hTAFII28[/E2]: three subunits of the human transcription factor TFIID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p0", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that [E1]hTAFII28[/E1] interacts with [E2]hTAFII18[/E2] both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s871_AIMed.d103.s871.p5", "text": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.", "text_with_entity_marker": "We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, [E1]hTAFII28[/E1] also interacts directly with [E2]TBP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[122, 130]], "entity_1_idx_in_text_with_entity_marker": [126, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p1", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that [E1]TBP[/E1] and hTAFII18 bind to distinct domains of [E2]hTAFII28[/E2]. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBP", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p6", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and [E1]hTAFII18[/E1] bind to distinct domains of [E2]hTAFII28[/E2]. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p15", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with [E2]TBP[/E2], but it interacts more strongly with hTAFII28 and hTAFII30.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[117, 120]], "entity_2_idx_in_text_with_entity_marker": [130, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p16", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with TBP, but it interacts more strongly with [E2]hTAFII28[/E2] and hTAFII30.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s872_AIMed.d103.s872.p17", "text": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. hTAFII18 also interacts with TBP, but it interacts more strongly with hTAFII28 and hTAFII30.", "text_with_entity_marker": "Deletion analysis indicates that TBP and hTAFII18 bind to distinct domains of hTAFII28. [E1]hTAFII18[/E1] also interacts with TBP, but it interacts more strongly with hTAFII28 and [E2]hTAFII30[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII18", "entity_1_idx": [[88, 96]], "entity_1_idx_in_text_with_entity_marker": [92, 100], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[171, 179]], "entity_2_idx_in_text_with_entity_marker": [184, 192], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s873_AIMed.d103.s873.p1", "text": "The binding of hTAFII28 and hTAFII30 requires distinct domains of hTAFII18.", "text_with_entity_marker": "The binding of [E1]hTAFII28[/E1] and hTAFII30 requires distinct domains of [E2]hTAFII18[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s873_AIMed.d103.s873.p2", "text": "The binding of hTAFII28 and hTAFII30 requires distinct domains of hTAFII18.", "text_with_entity_marker": "The binding of hTAFII28 and [E1]hTAFII30[/E1] requires distinct domains of [E2]hTAFII18[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII30", "entity_1_idx": [[28, 36]], "entity_1_idx_in_text_with_entity_marker": [32, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p0", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, [E1]hTAFII20[/E1] interacts directly with [E2]TBP[/E2]; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TBP", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p7", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between [E1]hTAFII20[/E1] and [E2]hTAFII28[/E2] or hTAFII30 were detected.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII28", "entity_2_idx": [[145, 153]], "entity_2_idx_in_text_with_entity_marker": [158, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s874_AIMed.d103.s874.p8", "text": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between hTAFII20 and hTAFII28 or hTAFII30 were detected.", "text_with_entity_marker": "As observed with the homologous Drosophila proteins, hTAFII20 interacts directly with TBP; however, additional interactions between [E1]hTAFII20[/E1] and hTAFII28 or [E2]hTAFII30[/E2] were detected.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hTAFII20", "entity_1_idx": [[132, 140]], "entity_1_idx_in_text_with_entity_marker": [136, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII30", "entity_2_idx": [[157, 165]], "entity_2_idx_in_text_with_entity_marker": [170, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d170.s1438_AIMed.d170.s1438.p24", "text": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.", "text_with_entity_marker": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins ([E1]p47-phox[/E1], p67-phox, and p21rac) that translocate to membrane and bind to [E2]cytochrome b558[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p47-phox", "entity_1_idx": [[144, 152]], "entity_1_idx_in_text_with_entity_marker": [148, 156], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cytochrome b558", "entity_2_idx": [[217, 232]], "entity_2_idx_in_text_with_entity_marker": [230, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d170.s1438_AIMed.d170.s1438.p26", "text": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.", "text_with_entity_marker": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, [E1]p67-phox[/E1], and p21rac) that translocate to membrane and bind to [E2]cytochrome b558[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p67-phox", "entity_1_idx": [[154, 162]], "entity_1_idx_in_text_with_entity_marker": [158, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cytochrome b558", "entity_2_idx": [[217, 232]], "entity_2_idx_in_text_with_entity_marker": [230, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d170.s1438_AIMed.d170.s1438.p27", "text": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and p21rac) that translocate to membrane and bind to cytochrome b558.", "text_with_entity_marker": "The phagocyte NADPH oxidase is a complex of membrane cytochrome b558 (comprised of subunits p22-phox and gp91-phox) and three cytosol proteins (p47-phox, p67-phox, and [E1]p21rac[/E1]) that translocate to membrane and bind to [E2]cytochrome b558[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21rac", "entity_1_idx": [[168, 174]], "entity_1_idx_in_text_with_entity_marker": [172, 178], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cytochrome b558", "entity_2_idx": [[217, 232]], "entity_2_idx_in_text_with_entity_marker": [230, 245], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d170.s1439_AIMed.d170.s1439.p2", "text": "This is the first report to demonstrate that two of cytosolic components of cytochrome b558, p47-phox binding to p67-phox each other.", "text_with_entity_marker": "This is the first report to demonstrate that two of cytosolic components of cytochrome b558, [E1]p47-phox[/E1] binding to [E2]p67-phox[/E2] each other.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p47-phox", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p67-phox", "entity_2_idx": [[113, 121]], "entity_2_idx_in_text_with_entity_marker": [126, 134], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1251_AIMed.d148.s1251.p1", "text": "Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein", "text_with_entity_marker": "Two potentially oncogenic cyclins, [E1]cyclin A[/E1] and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the [E2]Rb[/E2] protein", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin A", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[168, 170]], "entity_2_idx_in_text_with_entity_marker": [181, 183], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1251_AIMed.d148.s1251.p2", "text": "Two potentially oncogenic cyclins, cyclin A and cyclin D1, share common properties of subunit configuration, tyrosine phosphorylation and physical association with the Rb protein", "text_with_entity_marker": "Two potentially oncogenic cyclins, cyclin A and [E1]cyclin D1[/E1], share common properties of subunit configuration, tyrosine phosphorylation and physical association with the [E2]Rb[/E2] protein", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[48, 57]], "entity_1_idx_in_text_with_entity_marker": [52, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[168, 170]], "entity_2_idx_in_text_with_entity_marker": [181, 183], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1257_AIMed.d148.s1257.p1", "text": "Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by pp60c-src in vitro.", "text_with_entity_marker": "Moreover, [E1]cyclin D1[/E1] was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by [E2]pp60c-src[/E2] in vitro.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[10, 19]], "entity_1_idx_in_text_with_entity_marker": [14, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp60c-src", "entity_2_idx": [[130, 139]], "entity_2_idx_in_text_with_entity_marker": [143, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1257_AIMed.d148.s1257.p2", "text": "Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like cyclin A, was readily phosphorylated by pp60c-src in vitro.", "text_with_entity_marker": "Moreover, cyclin D1 was found to be phosphorylated on tyrosine residues in vivo and, like [E1]cyclin A[/E1], was readily phosphorylated by [E2]pp60c-src[/E2] in vitro.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin A", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp60c-src", "entity_2_idx": [[130, 139]], "entity_2_idx_in_text_with_entity_marker": [143, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1258_AIMed.d148.s1258.p0", "text": "In synchronized human osteosarcoma cells, cyclin D1 is induced in early G1 and becomes associated with p9Ckshs1, a Cdk-binding subunit.", "text_with_entity_marker": "In synchronized human osteosarcoma cells, [E1]cyclin D1[/E1] is induced in early G1 and becomes associated with [E2]p9Ckshs1[/E2], a Cdk-binding subunit.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p9Ckshs1", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1259_AIMed.d148.s1259.p0", "text": "Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.", "text_with_entity_marker": "Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that [E1]cyclin D1[/E1] is associated with both [E2]p34cdc2[/E2] and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[106, 115]], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p34cdc2", "entity_2_idx": [[140, 147]], "entity_2_idx_in_text_with_entity_marker": [153, 160], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d148.s1259_AIMed.d148.s1259.p1", "text": "Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that cyclin D1 is associated with both p34cdc2 and p33cdk2, and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.", "text_with_entity_marker": "Immunoprecipitation experiments with human osteosarcoma cells and Ewing's sarcoma cells demonstrated that [E1]cyclin D1[/E1] is associated with both p34cdc2 and [E2]p33cdk2[/E2], and that cyclin D1 immune complexes exhibit appreciable histone H1 kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[106, 115]], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p33cdk2", "entity_2_idx": [[152, 159]], "entity_2_idx_in_text_with_entity_marker": [165, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d141.s1192_AIMed.d141.s1192.p17", "text": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "text_with_entity_marker": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by [E1]cyclin A[/E1]-[E2]Cdk2[/E2], cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin A", "entity_1_idx": [[98, 106]], "entity_1_idx_in_text_with_entity_marker": [102, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d141.s1192_AIMed.d141.s1192.p30", "text": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "text_with_entity_marker": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, [E1]cyclin E[/E1]-[E2]Cdk2[/E2], cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[113, 121]], "entity_1_idx_in_text_with_entity_marker": [117, 125], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d141.s1192_AIMed.d141.s1192.p39", "text": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "text_with_entity_marker": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, [E1]cyclin D1[/E1]-[E2]Cdk4[/E2], and cyclin D2-Cdk4 complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[128, 137]], "entity_1_idx_in_text_with_entity_marker": [132, 141], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdk4", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d141.s1192_AIMed.d141.s1192.p44", "text": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and cyclin D2-Cdk4 complexes.", "text_with_entity_marker": "p21CIP1 is a potent, tight-binding inhibitor of Cdks and can inhibit the phosphorylation of Rb by cyclin A-Cdk2, cyclin E-Cdk2, cyclin D1-Cdk4, and [E1]cyclin D2[/E1]-[E2]Cdk4[/E2] complexes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D2", "entity_1_idx": [[148, 157]], "entity_1_idx_in_text_with_entity_marker": [152, 161], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdk4", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1766_AIMed.d205.s1766.p1", "text": "Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5.", "text_with_entity_marker": "Thymocyte activation induces the association of [E1]phosphatidylinositol 3-kinase[/E1] and pp120 with [E2]CD5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phosphatidylinositol 3-kinase", "entity_1_idx": [[48, 77]], "entity_1_idx_in_text_with_entity_marker": [52, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1766_AIMed.d205.s1766.p2", "text": "Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5.", "text_with_entity_marker": "Thymocyte activation induces the association of phosphatidylinositol 3-kinase and [E1]pp120[/E1] with [E2]CD5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp120", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[93, 96]], "entity_2_idx_in_text_with_entity_marker": [106, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1771_AIMed.d205.s1771.p0", "text": "We investigated whether phosphatidylinositol (PI) 3-kinase, which binds to tyrosine-phosphorylated ITAM, interacts with CD5 following T cell activation.", "text_with_entity_marker": "We investigated whether [E1]phosphatidylinositol (PI) 3-kinase[/E1], which binds to tyrosine-phosphorylated [E2]ITAM[/E2], interacts with CD5 following T cell activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phosphatidylinositol (PI) 3-kinase", "entity_1_idx": [[24, 58]], "entity_1_idx_in_text_with_entity_marker": [28, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ITAM", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1772_AIMed.d205.s1772.p5", "text": "PI 3-kinase activity and the regulatory p85 subunit of PI 3-kinase associated with CD5 in pervanadate-stimulated, but not in unstimulated thymocytes.", "text_with_entity_marker": "PI 3-kinase activity and the regulatory p85 subunit of [E1]PI 3-kinase[/E1] associated with [E2]CD5[/E2] in pervanadate-stimulated, but not in unstimulated thymocytes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[55, 66]], "entity_1_idx_in_text_with_entity_marker": [59, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[83, 86]], "entity_2_idx_in_text_with_entity_marker": [96, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1776_AIMed.d205.s1776.p1", "text": "We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and pp120 to CD5.", "text_with_entity_marker": "We conclude that stimulation of thymocytes with pervanadate induces the recruitment of [E1]PI 3-kinase[/E1] and pp120 to [E2]CD5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[87, 98]], "entity_1_idx_in_text_with_entity_marker": [91, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[112, 115]], "entity_2_idx_in_text_with_entity_marker": [125, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1776_AIMed.d205.s1776.p2", "text": "We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and pp120 to CD5.", "text_with_entity_marker": "We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and [E1]pp120[/E1] to [E2]CD5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp120", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[112, 115]], "entity_2_idx_in_text_with_entity_marker": [125, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s554_AIMed.d65.s554.p0", "text": "Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.", "text_with_entity_marker": "Cross-family dimerization of transcription factors [E1]Fos[/E1]/[E2]Jun[/E2] and ATF/CREB alters DNA binding specificity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fos", "entity_1_idx": [[51, 54]], "entity_1_idx_in_text_with_entity_marker": [55, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jun", "entity_2_idx": [[55, 58]], "entity_2_idx_in_text_with_entity_marker": [68, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d65.s554_AIMed.d65.s554.p5", "text": "Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.", "text_with_entity_marker": "Cross-family dimerization of transcription factors Fos/Jun and [E1]ATF[/E1]/[E2]CREB[/E2] alters DNA binding specificity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATF", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s742_AIMed.d88.s742.p0", "text": "Interaction of the protein nucleobindin with G alpha i2, as revealed by the yeast two-hybrid system.", "text_with_entity_marker": "Interaction of the protein [E1]nucleobindin[/E1] with [E2]G alpha i2[/E2], as revealed by the yeast two-hybrid system.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nucleobindin", "entity_1_idx": [[27, 39]], "entity_1_idx_in_text_with_entity_marker": [31, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[45, 55]], "entity_2_idx_in_text_with_entity_marker": [58, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s749_AIMed.d88.s749.p0", "text": "The specificity of intehraction between G alpha i2 and nucleobindin was confirmed by an in vitro binding assay using recombinant proteins.", "text_with_entity_marker": "The specificity of intehraction between [E1]G alpha i2[/E1] and [E2]nucleobindin[/E2] was confirmed by an in vitro binding assay using recombinant proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "G alpha i2", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "nucleobindin", "entity_2_idx": [[55, 67]], "entity_2_idx_in_text_with_entity_marker": [68, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s606_AIMed.d71.s606.p4", "text": "We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.", "text_with_entity_marker": "We present evidence that mitogen-activated protein-serine (MAP) kinases ([E1]pp54[/E1] and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of [E2]c-jun[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp54", "entity_1_idx": [[73, 77]], "entity_1_idx_in_text_with_entity_marker": [77, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s606_AIMed.d71.s606.p5", "text": "We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and pp42/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of c-jun.", "text_with_entity_marker": "We present evidence that mitogen-activated protein-serine (MAP) kinases (pp54 and [E1]pp42[/E1]/44) specifically phosphorylate these sites and that their phosphorylation positively regulates the transacting activity of [E2]c-jun[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp42", "entity_1_idx": [[82, 86]], "entity_1_idx_in_text_with_entity_marker": [86, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[210, 215]], "entity_2_idx_in_text_with_entity_marker": [223, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1084_AIMed.d127.s1084.p0", "text": "Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.", "text_with_entity_marker": "Interaction of [E1]IL-2R beta[/E1] and gamma c chains with [E2]Jak1[/E2] and Jak3: implications for XSCID and XCID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-2R beta", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jak1", "entity_2_idx": [[50, 54]], "entity_2_idx_in_text_with_entity_marker": [63, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1084_AIMed.d127.s1084.p1", "text": "Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.", "text_with_entity_marker": "Interaction of [E1]IL-2R beta[/E1] and gamma c chains with Jak1 and [E2]Jak3[/E2]: implications for XSCID and XCID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-2R beta", "entity_1_idx": [[15, 25]], "entity_1_idx_in_text_with_entity_marker": [19, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jak3", "entity_2_idx": [[59, 63]], "entity_2_idx_in_text_with_entity_marker": [72, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1088_AIMed.d127.s1088.p1", "text": "Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.", "text_with_entity_marker": "[E1]Jak1[/E1] and Jak3 associated with [E2]IL-2R beta[/E2] and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Jak1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2R beta", "entity_2_idx": [[30, 40]], "entity_2_idx_in_text_with_entity_marker": [43, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1088_AIMed.d127.s1088.p6", "text": "Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.", "text_with_entity_marker": "Jak1 and [E1]Jak3[/E1] associated with [E2]IL-2R beta[/E2] and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Jak3", "entity_1_idx": [[9, 13]], "entity_1_idx_in_text_with_entity_marker": [13, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2R beta", "entity_2_idx": [[30, 40]], "entity_2_idx_in_text_with_entity_marker": [43, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1088_AIMed.d127.s1088.p18", "text": "Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced Jak3-IL-2R beta and increased Jak3-gamma c associations.", "text_with_entity_marker": "Jak1 and Jak3 associated with IL-2R beta and gamma c, respectively; IL-2 induced [E1]Jak3[/E1]-[E2]IL-2R beta[/E2] and increased Jak3-gamma c associations.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Jak3", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2R beta", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d164.s1379_AIMed.d164.s1379.p0", "text": "U2AF65 binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for U2AF35.", "text_with_entity_marker": "[E1]U2AF65[/E1] binds specifically to 3' splice sites, but previous studies failed to demonstrate a function for [E2]U2AF35[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "U2AF65", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2AF35", "entity_2_idx": [[104, 110]], "entity_2_idx_in_text_with_entity_marker": [117, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d164.s1381_AIMed.d164.s1381.p0", "text": "Nuclear extracts deficient in U2AF35 were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant U2AF35.", "text_with_entity_marker": "Nuclear extracts deficient in [E1]U2AF35[/E1] were inactive; however, both constitutive and enhancer-dependent splicing could be restored by the addition of purified recombinant [E2]U2AF35[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "U2AF35", "entity_1_idx": [[30, 36]], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2AF35", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d91.s779_AIMed.d91.s779.p0", "text": "Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) TFIID, termed hTAFII32.", "text_with_entity_marker": "Here we report the cloning, expression, and biochemical characterization of the 32-kDa subunit of human (h) [E1]TFIID[/E1], termed [E2]hTAFII32[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[108, 113]], "entity_1_idx_in_text_with_entity_marker": [112, 117], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII32", "entity_2_idx": [[122, 130]], "entity_2_idx_in_text_with_entity_marker": [135, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d91.s780_AIMed.d91.s780.p0", "text": "We find that hTAFII32 is the human homologue of Drosophila TAFII40.", "text_with_entity_marker": "We find that [E1]hTAFII32[/E1] is the human homologue of Drosophila [E2]TAFII40[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII32", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII40", "entity_2_idx": [[59, 66]], "entity_2_idx_in_text_with_entity_marker": [72, 79], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d91.s782_AIMed.d91.s782.p0", "text": "Moreover, a partial recombinant TFIID complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the VP16 activation domain.", "text_with_entity_marker": "Moreover, a partial recombinant [E1]TFIID[/E1] complex containing [E2]hTAFII32[/E2] was capable of mediating in vitro transcriptional activation by the VP16 activation domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII32", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d91.s782_AIMed.d91.s782.p1", "text": "Moreover, a partial recombinant TFIID complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the VP16 activation domain.", "text_with_entity_marker": "Moreover, a partial recombinant [E1]TFIID[/E1] complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the [E2]VP16[/E2] activation domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "VP16", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d91.s782_AIMed.d91.s782.p2", "text": "Moreover, a partial recombinant TFIID complex containing hTAFII32 was capable of mediating in vitro transcriptional activation by the VP16 activation domain.", "text_with_entity_marker": "Moreover, a partial recombinant TFIID complex containing [E1]hTAFII32[/E1] was capable of mediating in vitro transcriptional activation by the [E2]VP16[/E2] activation domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII32", "entity_1_idx": [[57, 65]], "entity_1_idx_in_text_with_entity_marker": [61, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "VP16", "entity_2_idx": [[134, 138]], "entity_2_idx_in_text_with_entity_marker": [147, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p0", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human [E1]TrkC[/E1] second immunoglobulin-like domain, which does not bind [E2]nerve growth factor[/E2] (NGF), were substituted with those from human TrkA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TrkC", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "nerve growth factor", "entity_2_idx": [[114, 133]], "entity_2_idx_in_text_with_entity_marker": [127, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p1", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human [E1]TrkC[/E1] second immunoglobulin-like domain, which does not bind nerve growth factor ([E2]NGF[/E2]), were substituted with those from human TrkA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TrkC", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NGF", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p2", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human [E1]TrkC[/E1] second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human [E2]TrkA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TrkC", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TrkA", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p3", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind [E1]nerve growth factor[/E1] ([E2]NGF[/E2]), were substituted with those from human TrkA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nerve growth factor", "entity_1_idx": [[114, 133]], "entity_1_idx_in_text_with_entity_marker": [118, 137], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NGF", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p4", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind [E1]nerve growth factor[/E1] (NGF), were substituted with those from human [E2]TrkA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nerve growth factor", "entity_1_idx": [[114, 133]], "entity_1_idx_in_text_with_entity_marker": [118, 137], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TrkA", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d43.s376_AIMed.d43.s376.p5", "text": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor (NGF), were substituted with those from human TrkA.", "text_with_entity_marker": "In this study, a minimum set of residues in the human TrkC second immunoglobulin-like domain, which does not bind nerve growth factor ([E1]NGF[/E1]), were substituted with those from human [E2]TrkA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NGF", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TrkA", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1372_AIMed.d163.s1372.p0", "text": "Enhanced degradation of EGF receptors by a sorting nexin, SNX1.", "text_with_entity_marker": "Enhanced degradation of [E1]EGF[/E1] receptors by a sorting [E2]nexin[/E2], SNX1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EGF", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "nexin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1372_AIMed.d163.s1372.p1", "text": "Enhanced degradation of EGF receptors by a sorting nexin, SNX1.", "text_with_entity_marker": "Enhanced degradation of [E1]EGF[/E1] receptors by a sorting nexin, [E2]SNX1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "EGF", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SNX1", "entity_2_idx": [[58, 62]], "entity_2_idx_in_text_with_entity_marker": [71, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1372_AIMed.d163.s1372.p2", "text": "Enhanced degradation of EGF receptors by a sorting nexin, SNX1.", "text_with_entity_marker": "Enhanced degradation of EGF receptors by a sorting [E1]nexin[/E1], [E2]SNX1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nexin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SNX1", "entity_2_idx": [[58, 62]], "entity_2_idx_in_text_with_entity_marker": [71, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1375_AIMed.d163.s1375.p0", "text": "SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "text_with_entity_marker": "[E1]SNX1[/E1] contains a region of homology to a yeast vacuolar sorting protein, and overexpression of [E2]SNX1[/E2] decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SNX1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SNX1", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1375_AIMed.d163.s1375.p1", "text": "SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "text_with_entity_marker": "[E1]SNX1[/E1] contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of [E2]EGFR[/E2] on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SNX1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1375_AIMed.d163.s1375.p2", "text": "SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of SNX1 decreased the amount of EGFR on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "text_with_entity_marker": "SNX1 contains a region of homology to a yeast vacuolar sorting protein, and overexpression of [E1]SNX1[/E1] decreased the amount of [E2]EGFR[/E2] on the cell surface as a result of enhanced rates of constitutive and ligand-induced degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SNX1", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d163.s1376_AIMed.d163.s1376.p0", "text": "Thus, SNX1 is likely to play a role in sorting EGFR to lysosomes.", "text_with_entity_marker": "Thus, [E1]SNX1[/E1] is likely to play a role in sorting [E2]EGFR[/E2] to lysosomes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SNX1", "entity_1_idx": [[6, 10]], "entity_1_idx_in_text_with_entity_marker": [10, 14], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGFR", "entity_2_idx": [[47, 51]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s335_AIMed.d39.s335.p0", "text": "Presenilin 1 (PS1) is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.", "text_with_entity_marker": "[E1]Presenilin 1[/E1] ([E2]PS1[/E2]) is the causative gene for an autosomal dominant familial Alzheimer's disease (AD) mapped to chromosome 14.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Presenilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[14, 17]], "entity_2_idx_in_text_with_entity_marker": [27, 30], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s339_AIMed.d39.s339.p0", "text": "Immunoelectronmicroscopic analysis showed that QM/Jif-1 and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "text_with_entity_marker": "Immunoelectronmicroscopic analysis showed that [E1]QM[/E1]/[E2]Jif-1[/E2] and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "QM", "entity_1_idx": [[47, 49]], "entity_1_idx_in_text_with_entity_marker": [51, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jif-1", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s339_AIMed.d39.s339.p1", "text": "Immunoelectronmicroscopic analysis showed that QM/Jif-1 and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "text_with_entity_marker": "Immunoelectronmicroscopic analysis showed that [E1]QM[/E1]/Jif-1 and [E2]PS1[/E2] are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "QM", "entity_1_idx": [[47, 49]], "entity_1_idx_in_text_with_entity_marker": [51, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s339_AIMed.d39.s339.p2", "text": "Immunoelectronmicroscopic analysis showed that QM/Jif-1 and PS1 are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "text_with_entity_marker": "Immunoelectronmicroscopic analysis showed that QM/[E1]Jif-1[/E1] and [E2]PS1[/E2] are colocalized at the endoplasmic reticulum, and the nuclear matrix in human brain neurons.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jif-1", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s342_AIMed.d39.s342.p0", "text": "PS1 suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.", "text_with_entity_marker": "[E1]PS1[/E1] suppressed [E2]c-jun[/E2]-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[15, 20]], "entity_2_idx_in_text_with_entity_marker": [28, 33], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s342_AIMed.d39.s342.p1", "text": "PS1 suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.", "text_with_entity_marker": "[E1]PS1[/E1] suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in [E2]PS1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[159, 162]], "entity_2_idx_in_text_with_entity_marker": [172, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s342_AIMed.d39.s342.p2", "text": "PS1 suppressed c-jun-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in PS1.", "text_with_entity_marker": "PS1 suppressed [E1]c-jun[/E1]-associated apoptosis by retinoic acid in F9 embryonic carcinoma cells, whereas this suppression of apoptosis is attenuated by mutation in [E2]PS1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "c-jun", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[159, 162]], "entity_2_idx_in_text_with_entity_marker": [172, 175], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p0", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of [E1]PS1[/E1] via [E2]QM[/E2]/Jif-1 influences c-jun-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "QM", "entity_2_idx": [[44, 46]], "entity_2_idx_in_text_with_entity_marker": [57, 59], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p1", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of [E1]PS1[/E1] via QM/[E2]Jif-1[/E2] influences c-jun-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jif-1", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p2", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of [E1]PS1[/E1] via QM/Jif-1 influences [E2]c-jun[/E2]-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p3", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of PS1 via [E1]QM[/E1]/[E2]Jif-1[/E2] influences c-jun-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "QM", "entity_1_idx": [[44, 46]], "entity_1_idx_in_text_with_entity_marker": [48, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jif-1", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p4", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of PS1 via [E1]QM[/E1]/Jif-1 influences [E2]c-jun[/E2]-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "QM", "entity_1_idx": [[44, 46]], "entity_1_idx_in_text_with_entity_marker": [48, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d39.s343_AIMed.d39.s343.p5", "text": "Collectively, the novel function of PS1 via QM/Jif-1 influences c-jun-mediated transcription and apoptosis.", "text_with_entity_marker": "Collectively, the novel function of PS1 via QM/[E1]Jif-1[/E1] influences [E2]c-jun[/E2]-mediated transcription and apoptosis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jif-1", "entity_1_idx": [[47, 52]], "entity_1_idx_in_text_with_entity_marker": [51, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d77.s652_AIMed.d77.s652.p0", "text": "Desmoplakin (DPI), a desmosomal component lacking a transmembrane domain, has been implicated in this interaction, although most studies have been conducted with cells that contain few or no desmosomes, and efforts to demonstrate direct interactions between desmoplakin and intermediate filaments have not been successful.", "text_with_entity_marker": "[E1]Desmoplakin[/E1] ([E2]DPI[/E2]), a desmosomal component lacking a transmembrane domain, has been implicated in this interaction, although most studies have been conducted with cells that contain few or no desmosomes, and efforts to demonstrate direct interactions between desmoplakin and intermediate filaments have not been successful.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Desmoplakin", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "DPI", "entity_2_idx": [[13, 16]], "entity_2_idx_in_text_with_entity_marker": [26, 29], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d35.s292_AIMed.d35.s292.p0", "text": "Most familial early-onset Alzheimer's disease cases are caused by mutations in the presenilin 1 (PS1) gene.", "text_with_entity_marker": "Most familial early-onset Alzheimer's disease cases are caused by mutations in the [E1]presenilin 1[/E1] ([E2]PS1[/E2]) gene.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "presenilin 1", "entity_1_idx": [[83, 95]], "entity_1_idx_in_text_with_entity_marker": [87, 99], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[97, 100]], "entity_2_idx_in_text_with_entity_marker": [110, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d35.s294_AIMed.d35.s294.p0", "text": "Although numerous studies revealed predominant localization of PS1 to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of PS1 to the cell surface.", "text_with_entity_marker": "Although numerous studies revealed predominant localization of [E1]PS1[/E1] to endoplasmic reticulum and Golgi, there are conflicting reports on the localization of [E2]PS1[/E2] to the cell surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS1", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d151.s1286_AIMed.d151.s1286.p0", "text": "We now report the isolation and expression of cDNAs encoding PTF gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.", "text_with_entity_marker": "We now report the isolation and expression of cDNAs encoding [E1]PTF[/E1] gamma and [E2]PTF[/E2] delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PTF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PTF", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d151.s1286_AIMed.d151.s1286.p1", "text": "We now report the isolation and expression of cDNAs encoding PTF gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.", "text_with_entity_marker": "We now report the isolation and expression of cDNAs encoding [E1]PTF[/E1] gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native [E2]PTF[/E2] complex in HeLa extracts.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PTF", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PTF", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d151.s1286_AIMed.d151.s1286.p2", "text": "We now report the isolation and expression of cDNAs encoding PTF gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.", "text_with_entity_marker": "We now report the isolation and expression of cDNAs encoding PTF gamma and [E1]PTF[/E1] delta, as well as functional studies with cognate antibodies that recognize the native [E2]PTF[/E2] complex in HeLa extracts.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PTF", "entity_1_idx": [[75, 78]], "entity_1_idx_in_text_with_entity_marker": [79, 82], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PTF", "entity_2_idx": [[166, 169]], "entity_2_idx_in_text_with_entity_marker": [179, 182], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s321_AIMed.d38.s321.p0", "text": "Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "text_with_entity_marker": "Previously, we mapped the novel CC chemokine [E1]myeloid progenitor inhibitory factor 2[/E1] ([E2]MPIF-2[/E2])/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myeloid progenitor inhibitory factor 2", "entity_1_idx": [[45, 83]], "entity_1_idx_in_text_with_entity_marker": [49, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MPIF-2", "entity_2_idx": [[85, 91]], "entity_2_idx_in_text_with_entity_marker": [98, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s321_AIMed.d38.s321.p1", "text": "Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "text_with_entity_marker": "Previously, we mapped the novel CC chemokine [E1]myeloid progenitor inhibitory factor 2[/E1] (MPIF-2)/[E2]eotaxin-2[/E2] to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myeloid progenitor inhibitory factor 2", "entity_1_idx": [[45, 83]], "entity_1_idx_in_text_with_entity_marker": [49, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-2", "entity_2_idx": [[93, 102]], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s321_AIMed.d38.s321.p2", "text": "Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 (MPIF-2)/eotaxin-2 to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "text_with_entity_marker": "Previously, we mapped the novel CC chemokine myeloid progenitor inhibitory factor 2 ([E1]MPIF-2[/E1])/[E2]eotaxin-2[/E2] to chromosome 7q11.23 (Nomiyama, H., Osborne, L. R., Imai, T., Kusuda, J., Miura, R., Tsui, L.-C., and Yoshie, O. (1998) Genomics 49, 339-340).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[85, 91]], "entity_1_idx_in_text_with_entity_marker": [89, 95], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-2", "entity_2_idx": [[93, 102]], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p0", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for [E1]MPIF-2[/E1]/[E2]eotaxin-2[/E2] (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-2", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p1", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for [E1]MPIF-2[/E1]/eotaxin-2 ([E2]SCYA24[/E2]) and have identified a novel CC chemokine termed eotaxin-3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA24", "entity_2_idx": [[102, 108]], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p2", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for [E1]MPIF-2[/E1]/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed [E2]eotaxin-3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[84, 90]], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[158, 167]], "entity_2_idx_in_text_with_entity_marker": [171, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p3", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/[E1]eotaxin-2[/E1] ([E2]SCYA24[/E2]) and have identified a novel CC chemokine termed eotaxin-3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-2", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA24", "entity_2_idx": [[102, 108]], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p4", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/[E1]eotaxin-2[/E1] (SCYA24) and have identified a novel CC chemokine termed [E2]eotaxin-3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-2", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[158, 167]], "entity_2_idx_in_text_with_entity_marker": [171, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s323_AIMed.d38.s323.p5", "text": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 (SCYA24) and have identified a novel CC chemokine termed eotaxin-3.", "text_with_entity_marker": "Prompted by this hypothesis, we analyzed the genomic region containing the gene for MPIF-2/eotaxin-2 ([E1]SCYA24[/E1]) and have identified a novel CC chemokine termed [E2]eotaxin-3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SCYA24", "entity_1_idx": [[102, 108]], "entity_1_idx_in_text_with_entity_marker": [106, 112], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[158, 167]], "entity_2_idx_in_text_with_entity_marker": [171, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p0", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for [E1]MPIF-2[/E1]/[E2]eotaxin-2[/E2] (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-2", "entity_2_idx": [[21, 30]], "entity_2_idx_in_text_with_entity_marker": [34, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p1", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for [E1]MPIF-2[/E1]/eotaxin-2 ([E2]SCYA24[/E2]) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA24", "entity_2_idx": [[32, 38]], "entity_2_idx_in_text_with_entity_marker": [45, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p2", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for [E1]MPIF-2[/E1]/eotaxin-2 (SCYA24) and [E2]eotaxin-3[/E2] (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[44, 53]], "entity_2_idx_in_text_with_entity_marker": [57, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p3", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for [E1]MPIF-2[/E1]/eotaxin-2 (SCYA24) and eotaxin-3 ([E2]SCYA26[/E2]) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MPIF-2", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA26", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p4", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/[E1]eotaxin-2[/E1] ([E2]SCYA24[/E2]) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-2", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA24", "entity_2_idx": [[32, 38]], "entity_2_idx_in_text_with_entity_marker": [45, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p5", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/[E1]eotaxin-2[/E1] (SCYA24) and [E2]eotaxin-3[/E2] (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-2", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[44, 53]], "entity_2_idx_in_text_with_entity_marker": [57, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p6", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/[E1]eotaxin-2[/E1] (SCYA24) and eotaxin-3 ([E2]SCYA26[/E2]) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-2", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA26", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p7", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/eotaxin-2 ([E1]SCYA24[/E1]) and [E2]eotaxin-3[/E2] (SCYA26) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SCYA24", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "eotaxin-3", "entity_2_idx": [[44, 53]], "entity_2_idx_in_text_with_entity_marker": [57, 66], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p8", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/eotaxin-2 ([E1]SCYA24[/E1]) and eotaxin-3 ([E2]SCYA26[/E2]) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SCYA24", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA26", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s324_AIMed.d38.s324.p9", "text": "The genes for MPIF-2/eotaxin-2 (SCYA24) and eotaxin-3 (SCYA26) are localized within a region of approximately 40 kilobases.", "text_with_entity_marker": "The genes for MPIF-2/eotaxin-2 (SCYA24) and [E1]eotaxin-3[/E1] ([E2]SCYA26[/E2]) are localized within a region of approximately 40 kilobases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-3", "entity_1_idx": [[44, 53]], "entity_1_idx_in_text_with_entity_marker": [48, 57], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SCYA26", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s327_AIMed.d38.s327.p0", "text": "Eotaxin-3 induced transient calcium mobilization specifically in CC chemokine receptor 3 (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.", "text_with_entity_marker": "[E1]Eotaxin-3[/E1] induced transient calcium mobilization specifically in [E2]CC chemokine receptor 3[/E2] (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Eotaxin-3", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CC chemokine receptor 3", "entity_2_idx": [[65, 88]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s327_AIMed.d38.s327.p1", "text": "Eotaxin-3 induced transient calcium mobilization specifically in CC chemokine receptor 3 (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.", "text_with_entity_marker": "[E1]Eotaxin-3[/E1] induced transient calcium mobilization specifically in CC chemokine receptor 3 ([E2]CCR3[/E2])-expressing L1.2 cells with an EC(50) of 3 nM.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Eotaxin-3", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s327_AIMed.d38.s327.p2", "text": "Eotaxin-3 induced transient calcium mobilization specifically in CC chemokine receptor 3 (CCR3)-expressing L1.2 cells with an EC(50) of 3 nM.", "text_with_entity_marker": "Eotaxin-3 induced transient calcium mobilization specifically in [E1]CC chemokine receptor 3[/E1] ([E2]CCR3[/E2])-expressing L1.2 cells with an EC(50) of 3 nM.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC chemokine receptor 3", "entity_1_idx": [[65, 88]], "entity_1_idx_in_text_with_entity_marker": [69, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d38.s332_AIMed.d38.s332.p0", "text": "Identification of eotaxin-3 will further promote our understanding of the control of eosinophil trafficking and other CCR3-mediated biological phenomena.", "text_with_entity_marker": "Identification of [E1]eotaxin-3[/E1] will further promote our understanding of the control of eosinophil trafficking and other [E2]CCR3[/E2]-mediated biological phenomena.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "eotaxin-3", "entity_1_idx": [[18, 27]], "entity_1_idx_in_text_with_entity_marker": [22, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR3", "entity_2_idx": [[118, 122]], "entity_2_idx_in_text_with_entity_marker": [131, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d74.s630_AIMed.d74.s630.p0", "text": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, erythropoietin and interleukin-2 (beta-chain) and also to the prolactin receptor.", "text_with_entity_marker": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for [E1]interleukin-6[/E1], [E2]erythropoietin[/E2] and interleukin-2 (beta-chain) and also to the prolactin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin-6", "entity_1_idx": [[250, 263]], "entity_1_idx_in_text_with_entity_marker": [254, 267], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "erythropoietin", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d74.s630_AIMed.d74.s630.p1", "text": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, erythropoietin and interleukin-2 (beta-chain) and also to the prolactin receptor.", "text_with_entity_marker": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for [E1]interleukin-6[/E1], erythropoietin and [E2]interleukin-2[/E2] (beta-chain) and also to the prolactin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin-6", "entity_1_idx": [[250, 263]], "entity_1_idx_in_text_with_entity_marker": [254, 267], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-2", "entity_2_idx": [[284, 297]], "entity_2_idx_in_text_with_entity_marker": [297, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d74.s630_AIMed.d74.s630.p2", "text": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, erythropoietin and interleukin-2 (beta-chain) and also to the prolactin receptor.", "text_with_entity_marker": "It does not contain a tyrosine kinase domain nor show homology with members of the immunoglobulin super gene family, but does show some significant sequence homologies with receptors for several other haemopoietic growth factors, including those for interleukin-6, [E1]erythropoietin[/E1] and [E2]interleukin-2[/E2] (beta-chain) and also to the prolactin receptor.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "erythropoietin", "entity_1_idx": [[265, 279]], "entity_1_idx_in_text_with_entity_marker": [269, 283], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-2", "entity_2_idx": [[284, 297]], "entity_2_idx_in_text_with_entity_marker": [297, 310], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1638_AIMed.d192.s1638.p0", "text": "Lipopolysaccharide-activated ICE-deficient (ICE-/-) Kupffer cells synthesized the IGIF precursor but failed to process it into the active form.", "text_with_entity_marker": "Lipopolysaccharide-activated [E1]ICE[/E1]-deficient (ICE-/-) Kupffer cells synthesized the [E2]IGIF[/E2] precursor but failed to process it into the active form.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ICE", "entity_1_idx": [[29, 32]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGIF", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1639_AIMed.d192.s1639.p0", "text": "Interferon-gamma and IGIF were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "text_with_entity_marker": "[E1]Interferon-gamma[/E1] and [E2]IGIF[/E2] were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interferon-gamma", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGIF", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1639_AIMed.d192.s1639.p1", "text": "Interferon-gamma and IGIF were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "text_with_entity_marker": "[E1]Interferon-gamma[/E1] and IGIF were diminished in the sera of [E2]ICE[/E2]-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interferon-gamma", "entity_1_idx": [[0, 16]], "entity_1_idx_in_text_with_entity_marker": [4, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ICE", "entity_2_idx": [[57, 60]], "entity_2_idx_in_text_with_entity_marker": [70, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d192.s1639_AIMed.d192.s1639.p2", "text": "Interferon-gamma and IGIF were diminished in the sera of ICE-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "text_with_entity_marker": "Interferon-gamma and [E1]IGIF[/E1] were diminished in the sera of [E2]ICE[/E2]-/- mice exposed to Propionibacterium acnes and lipopolysaccharide.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IGIF", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ICE", "entity_2_idx": [[57, 60]], "entity_2_idx_in_text_with_entity_marker": [70, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d127.s1090_AIMed.d127.s1090.p0", "text": "Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal Jak3 activation, suggesting that mutations of Jak3 may result in an XSCID-like phenotype.", "text_with_entity_marker": "Thus, gamma c mutations in at least some XSCID and XCID patients prevent normal [E1]Jak3[/E1] activation, suggesting that mutations of [E2]Jak3[/E2] may result in an XSCID-like phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jak3", "entity_1_idx": [[80, 84]], "entity_1_idx_in_text_with_entity_marker": [84, 88], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jak3", "entity_2_idx": [[126, 130]], "entity_2_idx_in_text_with_entity_marker": [139, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1695_AIMed.d199.s1695.p0", "text": "Stimulation of fibroblast growth factor receptor 3 (FGFR3) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.", "text_with_entity_marker": "Stimulation of [E1]fibroblast growth factor receptor 3[/E1] ([E2]FGFR3[/E2]) results in a variety of functional effects, including regulation of epithelial cell growth and differentiation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibroblast growth factor receptor 3", "entity_1_idx": [[15, 50]], "entity_1_idx_in_text_with_entity_marker": [19, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p0", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which [E1]FGFR3[/E1] regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E2]FGFR3[/E2] IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[190, 195]], "entity_2_idx_in_text_with_entity_marker": [203, 208], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p1", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which [E1]FGFR3[/E1] regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E2]FGFR3 IIIb[/E2] and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3 IIIb", "entity_2_idx": [[190, 200]], "entity_2_idx_in_text_with_entity_marker": [203, 213], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p2", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which [E1]FGFR3[/E1] regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and [E2]FGFR3[/E2] IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p3", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which [E1]FGFR3[/E1] regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and [E2]FGFR3 IIIc[/E2], that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3 IIIc", "entity_2_idx": [[205, 215]], "entity_2_idx_in_text_with_entity_marker": [218, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p4", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which [E1]FGFR3[/E1] regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the [E2]FGFR3[/E2] gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p5", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1-E2]FGFR3[/E1] IIIb[/E2] and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [197, 202], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3[/E1] IIIb", "entity_2_idx": [[190, 200]], "entity_2_idx_in_text_with_entity_marker": [197, 212], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p6", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3[/E1] IIIb and [E2]FGFR3[/E2] IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p7", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3[/E1] IIIb and [E2]FGFR3 IIIc[/E2], that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3 IIIc", "entity_2_idx": [[205, 215]], "entity_2_idx_in_text_with_entity_marker": [218, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p8", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3[/E1] IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the [E2]FGFR3[/E2] gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p9", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3 IIIb[/E1] and [E2]FGFR3[/E2] IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3 IIIb", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p10", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3 IIIb[/E1] and [E2]FGFR3 IIIc[/E2], that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3 IIIb", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3 IIIc", "entity_2_idx": [[205, 215]], "entity_2_idx_in_text_with_entity_marker": [218, 228], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p11", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, [E1]FGFR3 IIIb[/E1] and FGFR3 IIIc, that result from alternative splicing of exon III of the [E2]FGFR3[/E2] gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3 IIIb", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p12", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and [E1-E2]FGFR3[/E1] IIIc[/E2], that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [212, 217], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3[/E1] IIIc", "entity_2_idx": [[205, 215]], "entity_2_idx_in_text_with_entity_marker": [212, 227], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p13", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and [E1]FGFR3[/E1] IIIc, that result from alternative splicing of exon III of the [E2]FGFR3[/E2] gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1696_AIMed.d199.s1696.p14", "text": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and FGFR3 IIIc, that result from alternative splicing of exon III of the FGFR3 gene encoding the ligand binding domain.", "text_with_entity_marker": "In order to characterize the signaling pathway through which FGFR3 regulates cell growth, L6 cells lacking any endogenous FGFR were stably transfected with the two different human isoforms, FGFR3 IIIb and [E1]FGFR3 IIIc[/E1], that result from alternative splicing of exon III of the [E2]FGFR3[/E2] gene encoding the ligand binding domain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3 IIIc", "entity_1_idx": [[205, 215]], "entity_1_idx_in_text_with_entity_marker": [209, 219], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[274, 279]], "entity_2_idx_in_text_with_entity_marker": [287, 292], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1698_AIMed.d199.s1698.p0", "text": "Activation of FGFR3 upon ligand binding resulted in activation of mitogen-activated protein kinase pathway.", "text_with_entity_marker": "Activation of [E1]FGFR3[/E1] upon ligand binding resulted in activation of [E2]mitogen-activated protein kinase[/E2] pathway.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "mitogen-activated protein kinase", "entity_2_idx": [[66, 98]], "entity_2_idx_in_text_with_entity_marker": [79, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1705_AIMed.d199.s1705.p0", "text": "Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of FGFR3, suggesting that the 66-kDa protein may play an important role in FGFR3-specific signaling.", "text_with_entity_marker": "Tyrosine phophorylation of the 66-kDa protein was dependent on ligand activation of [E1]FGFR3[/E1], suggesting that the 66-kDa protein may play an important role in [E2]FGFR3[/E2]-specific signaling.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FGFR3", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1708_AIMed.d199.s1708.p0", "text": "Furthermore, activated FGFR3 was not able to induce dissociation of GRB2.", "text_with_entity_marker": "Furthermore, activated [E1]FGFR3[/E1] was not able to induce dissociation of [E2]GRB2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GRB2", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1709_AIMed.d199.s1709.p0", "text": "Sos complex following Sos phosphorylation.", "text_with_entity_marker": "[E1]Sos[/E1] complex following [E2]Sos[/E2] phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Sos", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos", "entity_2_idx": [[22, 25]], "entity_2_idx_in_text_with_entity_marker": [35, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1715_AIMed.d199.s1715.p0", "text": "Finally, activated FGFR3 was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of c-Src.", "text_with_entity_marker": "Finally, activated [E1]FGFR3[/E1] was also found to result in phosphorylation of [E2]phospholipase C-gamma[/E2] but reduced phosphorylation of c-Src.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phospholipase C-gamma", "entity_2_idx": [[72, 93]], "entity_2_idx_in_text_with_entity_marker": [85, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1715_AIMed.d199.s1715.p1", "text": "Finally, activated FGFR3 was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of c-Src.", "text_with_entity_marker": "Finally, activated [E1]FGFR3[/E1] was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of [E2]c-Src[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FGFR3", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Src", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d199.s1715_AIMed.d199.s1715.p2", "text": "Finally, activated FGFR3 was also found to result in phosphorylation of phospholipase C-gamma but reduced phosphorylation of c-Src.", "text_with_entity_marker": "Finally, activated FGFR3 was also found to result in phosphorylation of [E1]phospholipase C-gamma[/E1] but reduced phosphorylation of [E2]c-Src[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase C-gamma", "entity_1_idx": [[72, 93]], "entity_1_idx_in_text_with_entity_marker": [76, 97], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Src", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d134.s1141_AIMed.d134.s1141.p0", "text": "A protein ligand for the ECK receptor protein-tyrosine kinase has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.", "text_with_entity_marker": "A protein ligand for the [E1-E2]ECK[/E1] receptor protein-tyrosine kinase[/E2] has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ECK", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ECK[/E1] receptor protein-tyrosine kinase", "entity_2_idx": [[25, 61]], "entity_2_idx_in_text_with_entity_marker": [32, 73], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d134.s1141_AIMed.d134.s1141.p1", "text": "A protein ligand for the ECK receptor protein-tyrosine kinase has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.", "text_with_entity_marker": "A protein ligand for the [E1]ECK[/E1] receptor protein-tyrosine kinase has been isolated by using the extracellular domain ([E2]ECK[/E2]-X) of the receptor as an affinity reagent.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ECK", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ECK", "entity_2_idx": [[115, 118]], "entity_2_idx_in_text_with_entity_marker": [128, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d134.s1141_AIMed.d134.s1141.p2", "text": "A protein ligand for the ECK receptor protein-tyrosine kinase has been isolated by using the extracellular domain (ECK-X) of the receptor as an affinity reagent.", "text_with_entity_marker": "A protein ligand for the [E1]ECK receptor protein-tyrosine kinase[/E1] has been isolated by using the extracellular domain ([E2]ECK[/E2]-X) of the receptor as an affinity reagent.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ECK receptor protein-tyrosine kinase", "entity_1_idx": [[25, 61]], "entity_1_idx_in_text_with_entity_marker": [29, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ECK", "entity_2_idx": [[115, 118]], "entity_2_idx_in_text_with_entity_marker": [128, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d134.s1143_AIMed.d134.s1143.p0", "text": "Subsequently, supernatants from selected cell lines were fractionated directly by receptor affinity chromatography, resulting in the single-step purification of B61, a protein previously identified as the product of an early response gene induced by tumour necrosis factor-alpha.", "text_with_entity_marker": "Subsequently, supernatants from selected cell lines were fractionated directly by receptor affinity chromatography, resulting in the single-step purification of [E1]B61[/E1], a protein previously identified as the product of an early response gene induced by [E2]tumour necrosis factor-alpha[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "B61", "entity_1_idx": [[161, 164]], "entity_1_idx_in_text_with_entity_marker": [165, 168], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tumour necrosis factor-alpha", "entity_2_idx": [[250, 278]], "entity_2_idx_in_text_with_entity_marker": [263, 291], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d134.s1145_AIMed.d134.s1145.p0", "text": "ECK is a member of a large orphan receptor protein-tyrosine kinase family headed by EPH, and we suggest that ligands for other members of this family will be related to B61, and can be isolated in the same way.", "text_with_entity_marker": "[E1]ECK[/E1] is a member of a large orphan receptor protein-tyrosine kinase family headed by EPH, and we suggest that ligands for other members of this family will be related to [E2]B61[/E2], and can be isolated in the same way.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ECK", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B61", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1316_AIMed.d155.s1316.p0", "text": "The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in TFIID-promoter complexes.", "text_with_entity_marker": "The general transcription factor [E1]TFIID[/E1] nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced [E2]TFIID[/E2] recruitment or conformational changes in TFIID-promoter complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1316_AIMed.d155.s1316.p1", "text": "The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in TFIID-promoter complexes.", "text_with_entity_marker": "The general transcription factor [E1]TFIID[/E1] nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in [E2]TFIID[/E2]-promoter complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[317, 322]], "entity_2_idx_in_text_with_entity_marker": [330, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1316_AIMed.d155.s1316.p2", "text": "The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced TFIID recruitment or conformational changes in TFIID-promoter complexes.", "text_with_entity_marker": "The general transcription factor TFIID nucleates initiation complex formation through direct core promoter binding, commits promoters within chromatin to transcription, and mediates the action of transcriptional activators, a phenomenon that may correlate with enhanced [E1]TFIID[/E1] recruitment or conformational changes in [E2]TFIID[/E2]-promoter complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[317, 322]], "entity_2_idx_in_text_with_entity_marker": [330, 335], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p0", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human [E1]TFIID[/E1] subunits [E2]hTAF80[/E2], hTAF31 and hTAF20/15.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF80", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p1", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human [E1]TFIID[/E1] subunits hTAF80, [E2]hTAF31[/E2] and hTAF20/15.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF31", "entity_2_idx": [[124, 130]], "entity_2_idx_in_text_with_entity_marker": [137, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p2", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human [E1]TFIID[/E1] subunits hTAF80, hTAF31 and [E2]hTAF20/15[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF20/15", "entity_2_idx": [[135, 144]], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p3", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits [E1]hTAF80[/E1], [E2]hTAF31[/E2] and hTAF20/15.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAF80", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF31", "entity_2_idx": [[124, 130]], "entity_2_idx_in_text_with_entity_marker": [137, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p4", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits [E1]hTAF80[/E1], hTAF31 and [E2]hTAF20/15[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAF80", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF20/15", "entity_2_idx": [[135, 144]], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1318_AIMed.d155.s1318.p5", "text": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, hTAF31 and hTAF20/15.", "text_with_entity_marker": "Here we present biochemical evidence for the structural relevance of histone homologies in the human TFIID subunits hTAF80, [E1]hTAF31[/E1] and [E2]hTAF20/15[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAF31", "entity_1_idx": [[124, 130]], "entity_1_idx_in_text_with_entity_marker": [128, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAF20/15", "entity_2_idx": [[135, 144]], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d155.s1319_AIMed.d155.s1319.p0", "text": "Together with analyses of native TFIID complexes and accompanying crystallographic studies, the results suggest that there is a histone octamer-like TAF complex within TFIID.", "text_with_entity_marker": "Together with analyses of native [E1]TFIID[/E1] complexes and accompanying crystallographic studies, the results suggest that there is a histone octamer-like TAF complex within [E2]TFIID[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d37.s314_AIMed.d37.s314.p0", "text": "All CC-chemokines currently available were tested for their ability to compete with [(125)I]-MIP-1beta binding on a stable cell line expressing recombinant CCR5, and/or to induce a functional response in these cells.", "text_with_entity_marker": "All CC-chemokines currently available were tested for their ability to compete with [(125)I]-[E1]MIP-1beta[/E1] binding on a stable cell line expressing recombinant [E2]CCR5[/E2], and/or to induce a functional response in these cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MIP-1beta", "entity_1_idx": [[93, 102]], "entity_1_idx_in_text_with_entity_marker": [97, 106], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1829_AIMed.d211.s1829.p0", "text": "Through their interaction with the ErbB family of receptors (ErbB2, ErbB3 and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.", "text_with_entity_marker": "Through their interaction with the ErbB family of receptors ([E1]ErbB2[/E1], [E2]ErbB3[/E2] and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ErbB2", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB3", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1829_AIMed.d211.s1829.p1", "text": "Through their interaction with the ErbB family of receptors (ErbB2, ErbB3 and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.", "text_with_entity_marker": "Through their interaction with the ErbB family of receptors ([E1]ErbB2[/E1], ErbB3 and [E2]ErbB4[/E2]), neuregulins help to regulate cell growth and differentiation in many tissues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ErbB2", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB4", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1829_AIMed.d211.s1829.p2", "text": "Through their interaction with the ErbB family of receptors (ErbB2, ErbB3 and ErbB4), neuregulins help to regulate cell growth and differentiation in many tissues.", "text_with_entity_marker": "Through their interaction with the ErbB family of receptors (ErbB2, [E1]ErbB3[/E1] and [E2]ErbB4[/E2]), neuregulins help to regulate cell growth and differentiation in many tissues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ErbB3", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB4", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1831_AIMed.d211.s1831.p0", "text": "The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(EGF)-like domain gives rise to two isoforms (alpha and beta).", "text_with_entity_marker": "The encoded product of the [E1]neuregulin-2[/E1] gene has a motif structure similar to that of neuregulins and an alternative splicing site in the [E2]epidermal growth factor[/E2](EGF)-like domain gives rise to two isoforms (alpha and beta).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuregulin-2", "entity_1_idx": [[27, 39]], "entity_1_idx_in_text_with_entity_marker": [31, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor", "entity_2_idx": [[138, 161]], "entity_2_idx_in_text_with_entity_marker": [151, 174], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1831_AIMed.d211.s1831.p1", "text": "The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(EGF)-like domain gives rise to two isoforms (alpha and beta).", "text_with_entity_marker": "The encoded product of the [E1]neuregulin-2[/E1] gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor([E2]EGF[/E2])-like domain gives rise to two isoforms (alpha and beta).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuregulin-2", "entity_1_idx": [[27, 39]], "entity_1_idx_in_text_with_entity_marker": [31, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1831_AIMed.d211.s1831.p2", "text": "The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the epidermal growth factor(EGF)-like domain gives rise to two isoforms (alpha and beta).", "text_with_entity_marker": "The encoded product of the neuregulin-2 gene has a motif structure similar to that of neuregulins and an alternative splicing site in the [E1]epidermal growth factor[/E1]([E2]EGF[/E2])-like domain gives rise to two isoforms (alpha and beta).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "epidermal growth factor", "entity_1_idx": [[138, 161]], "entity_1_idx_in_text_with_entity_marker": [142, 165], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EGF", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1217_AIMed.d144.s1217.p0", "text": "The retinoblastoma protein (p110RB) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.", "text_with_entity_marker": "The [E1]retinoblastoma protein[/E1] ([E2]p110RB[/E2]) interacts with many cellular proteins in complexes potentially important for its growth-suppressing function.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "retinoblastoma protein", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p110RB", "entity_2_idx": [[28, 34]], "entity_2_idx_in_text_with_entity_marker": [41, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1219_AIMed.d144.s1219.p0", "text": "One clone encodes a novel type 1 protein phosphatase catalytic subunit (PP-1 alpha 2), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.", "text_with_entity_marker": "One clone encodes a novel [E1]type 1 protein phosphatase[/E1] catalytic subunit ([E2]PP-1 alpha 2[/E2]), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "type 1 protein phosphatase", "entity_1_idx": [[26, 52]], "entity_1_idx_in_text_with_entity_marker": [30, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PP-1 alpha 2", "entity_2_idx": [[72, 84]], "entity_2_idx_in_text_with_entity_marker": [85, 97], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1219_AIMed.d144.s1219.p1", "text": "One clone encodes a novel type 1 protein phosphatase catalytic subunit (PP-1 alpha 2), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.", "text_with_entity_marker": "One clone encodes a novel [E1]type 1 protein phosphatase[/E1] catalytic subunit (PP-1 alpha 2), which differs from the originally defined [E2]PP-1 alpha[/E2] by an amino-terminal 11-amino-acid insert.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "type 1 protein phosphatase", "entity_1_idx": [[26, 52]], "entity_1_idx_in_text_with_entity_marker": [30, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PP-1 alpha", "entity_2_idx": [[129, 139]], "entity_2_idx_in_text_with_entity_marker": [142, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1219_AIMed.d144.s1219.p2", "text": "One clone encodes a novel type 1 protein phosphatase catalytic subunit (PP-1 alpha 2), which differs from the originally defined PP-1 alpha by an amino-terminal 11-amino-acid insert.", "text_with_entity_marker": "One clone encodes a novel type 1 protein phosphatase catalytic subunit ([E1]PP-1 alpha 2[/E1]), which differs from the originally defined [E2]PP-1 alpha[/E2] by an amino-terminal 11-amino-acid insert.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PP-1 alpha 2", "entity_1_idx": [[72, 84]], "entity_1_idx_in_text_with_entity_marker": [76, 88], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PP-1 alpha", "entity_2_idx": [[129, 139]], "entity_2_idx_in_text_with_entity_marker": [142, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s0_BioInfer.d288.s0.p0", "text": "Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.", "text_with_entity_marker": "Immunofluorescence experiments showed that, like [E1]Abp1p[/E1], cofilin is associated with the membrane [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s0_BioInfer.d288.s0.p2", "text": "Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.", "text_with_entity_marker": "Immunofluorescence experiments showed that, like Abp1p, [E1]cofilin[/E1] is associated with the membrane [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s2_BioInfer.d288.s2.p0", "text": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.", "text_with_entity_marker": "The NH2-terminal 16kD of [E1]Abp1p[/E1], a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s2_BioInfer.d288.s2.p1", "text": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.", "text_with_entity_marker": "The NH2-terminal 16kD of [E1]Abp1p[/E1], a 65-kD yeast protein identified by its ability to bind to [E2]actin[/E2] filaments, is 23% identical to yeast cofilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s3_BioInfer.d288.s3.p0", "text": "We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian actin binding protein cofilin.", "text_with_entity_marker": "We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian [E1]actin binding protein[/E1] [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[89, 110]], "entity_1_idx_in_text_with_entity_marker": [93, 114], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s0_BioInfer.d320.s0.p1", "text": "In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "text_with_entity_marker": "In brush cells, villin and [E1]fimbrin[/E1] are not only present in the [E2]actin[/E2] filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s0_BioInfer.d320.s0.p2", "text": "In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "text_with_entity_marker": "In brush cells, [E1]villin[/E1] and fimbrin are not only present in the [E2]actin[/E2] filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s1_BioInfer.d320.s1.p0", "text": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.", "text_with_entity_marker": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against [E1]villin[/E1] and fimbrin, two proteins that crosslink [E2]actin[/E2] filaments to form bundles.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[161, 167]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d320.s1_BioInfer.d320.s1.p2", "text": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.", "text_with_entity_marker": "In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and [E1]fimbrin[/E1], two proteins that crosslink [E2]actin[/E2] filaments to form bundles.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[209, 214]], "entity_2_idx_in_text_with_entity_marker": [222, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d571.s0_BioInfer.d571.s0.p1", "text": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "text_with_entity_marker": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two [E1]actin[/E1]-associated proteins of the adherens junctions, such as [E2]vinculin[/E2] and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d571.s0_BioInfer.d571.s0.p2", "text": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "text_with_entity_marker": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two [E1]actin[/E1]-associated proteins of the adherens junctions, such as vinculin and [E2]talin[/E2], and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[183, 188]], "entity_2_idx_in_text_with_entity_marker": [196, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d755.s0_BioInfer.d755.s0.p2", "text": "Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.", "text_with_entity_marker": "Thus, [E1]mHip1R[/E1] contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like [E2]actin[/E2]-binding domain at the COOH terminus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "mHip1R", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d755.s0_BioInfer.d755.s0.p5", "text": "Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.", "text_with_entity_marker": "Thus, [E1]mHip1R[/E1] contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a [E2]talin[/E2]-like actin-binding domain at the COOH terminus.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "mHip1R", "entity_1_idx": [[6, 12]], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s0_BioInfer.d263.s0.p0", "text": "High levels of profilin suppress the lethality caused by overproduction of actin in yeast cells.", "text_with_entity_marker": "High levels of [E1]profilin[/E1] suppress the lethality caused by overproduction of [E2]actin[/E2] in yeast cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s1_BioInfer.d263.s1.p1", "text": "In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.", "text_with_entity_marker": "In contrast, overexpression of the [E1]profilin[/E1] gene, PFY1, encoding an [E2]actin-binding protein[/E2], leads to no very obvious phenotype.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[68, 89]], "entity_2_idx_in_text_with_entity_marker": [81, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s2_BioInfer.d263.s2.p0", "text": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.", "text_with_entity_marker": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much [E1]actin[/E1] in a [E2]profilin[/E2] concentration-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d263.s2_BioInfer.d263.s2.p1", "text": "Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.", "text_with_entity_marker": "Interestingly, [E1]profilin[/E1] overproduction can compensate for the deleterious effects of too much [E2]actin[/E2] in a profilin concentration-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d394.s0_BioInfer.d394.s0.p1", "text": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "text_with_entity_marker": "It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G [E1]actin[/E1] from [E2]profilin[/E2] or promoting the cross-linking of actin or its anchorage to the plasma membrane.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p3", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E1]SIR[/E1] genes, SIR1 and [E2]SIR4[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR4", "entity_2_idx": [[204, 208]], "entity_2_idx_in_text_with_entity_marker": [217, 221], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p6", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E1]SIR[/E1] genes, [E2]SIR1[/E2] and SIR4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d508.s0_BioInfer.d508.s0.p0", "text": "Recently we reported that the isolated 23 kDa N-terminal fragment of myosin heavy chain, which contains the 'consensus' ATP binding site, binds to actin in an ATP-sensitive manner (Muhlrad, A. (1989) Biochemistry 28, 4002).", "text_with_entity_marker": "Recently we reported that the isolated 23 kDa N-terminal fragment of [E1]myosin heavy chain[/E1], which contains the 'consensus' ATP binding site, binds to [E2]actin[/E2] in an ATP-sensitive manner (Muhlrad, A. (1989) Biochemistry 28, 4002).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[69, 87]], "entity_1_idx_in_text_with_entity_marker": [73, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d305.s0_BioInfer.d305.s0.p0", "text": "In 50 mM KCl, high concentrations of Acanthamoeba profilin inhibit the elongation rate of muscle actin filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.", "text_with_entity_marker": "In 50 mM KCl, high concentrations of Acanthamoeba [E1]profilin[/E1] inhibit the elongation rate of [E2]muscle actin[/E2] filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[50, 58]], "entity_1_idx_in_text_with_entity_marker": [54, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s0_BioInfer.d471.s0.p0", "text": "Other than monomeric actin, no major profilin ligands are detected in crude extracts.", "text_with_entity_marker": "Other than monomeric [E1]actin[/E1], no major [E2]profilin[/E2] ligands are detected in crude extracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s1_BioInfer.d471.s1.p0", "text": "Our results show that the major pool of polymerizable actin monomers is complexed with profilin and spread throughout the cytoplasm.", "text_with_entity_marker": "Our results show that the major pool of polymerizable [E1]actin[/E1] monomers is complexed with [E2]profilin[/E2] and spread throughout the cytoplasm.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[87, 95]], "entity_2_idx_in_text_with_entity_marker": [100, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s2_BioInfer.d471.s2.p0", "text": "Selective monoclonal antibodies confirm that most of the profilin is bound to actin: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.", "text_with_entity_marker": "Selective monoclonal antibodies confirm that most of the [E1]profilin[/E1] is bound to [E2]actin[/E2]: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[57, 65]], "entity_1_idx_in_text_with_entity_marker": [61, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p0", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: actin, membrane PIP(2), [E2]Arp2[/E2]/3 complex and polyproline sequences.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[180, 184]], "entity_2_idx_in_text_with_entity_marker": [193, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p3", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: [E2]actin[/E2], membrane PIP(2), Arp2/3 complex and polyproline sequences.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d471.s3_BioInfer.d471.s3.p4", "text": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.", "text_with_entity_marker": "We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much [E1]profilin[/E1] is bound to its known ligands: actin, membrane PIP(2), [E2]Arp[/E2]2/3 complex and polyproline sequences.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[116, 124]], "entity_1_idx_in_text_with_entity_marker": [120, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[180, 183], [185, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s0_BioInfer.d290.s0.p1", "text": "Immunofluorescence studies with these antibodies showed profilin I to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric actin also was present, as shown by labeling with fluorescent DNase.", "text_with_entity_marker": "Immunofluorescence studies with these antibodies showed [E1]profilin I[/E1] to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric [E2]actin[/E2] also was present, as shown by labeling with fluorescent DNase.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[56, 66]], "entity_1_idx_in_text_with_entity_marker": [60, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[228, 233]], "entity_2_idx_in_text_with_entity_marker": [241, 246], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p1", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E1]profilin I[/E1] functions predominantly as an [E2]actin[/E2] monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[190, 200]], "entity_1_idx_in_text_with_entity_marker": [194, 204], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p4", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) [E2]profilin I[/E2] functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[190, 200]], "entity_2_idx_in_text_with_entity_marker": [203, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p5", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) [E2]profilin II[/E2] regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[266, 277]], "entity_2_idx_in_text_with_entity_marker": [279, 290], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d290.s1_BioInfer.d290.s1.p6", "text": "The differential localization of the three actin monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) actobindin inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "text_with_entity_marker": "The differential localization of the three [E1]actin[/E1] monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) profilin I functions predominantly as an actin monomer-binding protein; (2) profilin II regulates, or is regulated by, PIP2; and (3) [E2]actobindin[/E2] inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[43, 48]], "entity_1_idx_in_text_with_entity_marker": [47, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[323, 333]], "entity_2_idx_in_text_with_entity_marker": [336, 346], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p0", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the [E1]nuclear receptor coactivator[/E1] [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "nuclear receptor coactivator", "entity_1_idx": [[205, 233]], "entity_1_idx_in_text_with_entity_marker": [209, 237], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p3", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator [E2]p160/SRC-1[/E2]-interacting domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p160/SRC-1", "entity_2_idx": [[234, 244]], "entity_2_idx_in_text_with_entity_marker": [247, 257], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p12", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, C/ATF was found to interact with three domains of [E1]CBP[/E1] including [E2]CREB[/E2] binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[63, 66]], "entity_1_idx_in_text_with_entity_marker": [67, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d80.s0_BioInfer.d80.s0.p14", "text": "As expected, C/ATF was found to interact with three domains of CBP including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "text_with_entity_marker": "As expected, [E1]C/ATF[/E1] was found to interact with three domains of [E2]CBP[/E2] including CREB binding domain or kinase-inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the nuclear receptor coactivator p160/SRC-1-interacting domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "C/ATF", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p11", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with [E2]LEF-1[/E2] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p15", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E1]beta-catenin[/E1], cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[251, 263]], "entity_1_idx_in_text_with_entity_marker": [255, 267], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p23", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E1]beta-catenin[/E1], [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[251, 263]], "entity_1_idx_in_text_with_entity_marker": [255, 267], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p26", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E2]vinculin[/E2]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p29", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with LEF-1 and [E2]vinculin[/E2]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p32", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and [E2]beta-catenin[/E2] differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[46, 58]], "entity_2_idx_in_text_with_entity_marker": [59, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p3", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the [E1]alpha-catenin[/E1]-binding region of [E2]beta-catenin[/E2] linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[28, 41]], "entity_1_idx_in_text_with_entity_marker": [32, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[60, 72]], "entity_2_idx_in_text_with_entity_marker": [73, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d9.s0_BioInfer.d9.s0.p5", "text": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.", "text_with_entity_marker": "A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since [E1]beta-catenin[/E1] binding disrupts the [E2]alpha-catenin[/E2] dimer.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[179, 191]], "entity_1_idx_in_text_with_entity_marker": [183, 195], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[213, 226]], "entity_2_idx_in_text_with_entity_marker": [226, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p1", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilin and [E2]gelsolin[/E2] bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p3", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s0_BioInfer.d14.s0.p5", "text": "Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "text_with_entity_marker": "[E1]Actin-binding proteins[/E1] such as [E2]profilin[/E2] and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Actin-binding proteins", "entity_1_idx": [[0, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 26], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[31, 39]], "entity_2_idx_in_text_with_entity_marker": [44, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p4", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as [E1]tau[/E1] or actin do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tau", "entity_1_idx": [[93, 96]], "entity_1_idx_in_text_with_entity_marker": [97, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d14.s2_BioInfer.d14.s2.p5", "text": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.", "text_with_entity_marker": "This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or [E1]actin[/E1] do not affect [E2]PI 3-kinase[/E2] activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s0_BioInfer.d382.s0.p2", "text": "In this study, we demonstrate that profilin isoforms expressed in a single cell can have different effects on actin in living cells and that the poly-L-proline binding function of profilin may have important consequences for the regulation of actin cytoskeletal dynamics in plant cells.", "text_with_entity_marker": "In this study, we demonstrate that profilin isoforms expressed in a single cell can have different effects on actin in living cells and that the poly-L-proline binding function of [E1]profilin[/E1] may have important consequences for the regulation of [E2]actin[/E2] cytoskeletal dynamics in plant cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[180, 188]], "entity_1_idx_in_text_with_entity_marker": [184, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[243, 248]], "entity_2_idx_in_text_with_entity_marker": [256, 261], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s0_BioInfer.d382.s0.p3", "text": "In this study, we demonstrate that profilin isoforms expressed in a single cell can have different effects on actin in living cells and that the poly-L-proline binding function of profilin may have important consequences for the regulation of actin cytoskeletal dynamics in plant cells.", "text_with_entity_marker": "In this study, we demonstrate that [E1]profilin[/E1] isoforms expressed in a single cell can have different effects on [E2]actin[/E2] in living cells and that the poly-L-proline binding function of profilin may have important consequences for the regulation of actin cytoskeletal dynamics in plant cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s1_BioInfer.d382.s1.p0", "text": "Recently, we characterized several profilin isoforms from maize pollen for their ability to alter cytoarchitecture when microinjected into living plant cells and for their association with poly-L-proline and monomeric actin from maize pollen.", "text_with_entity_marker": "Recently, we characterized several [E1]profilin[/E1] isoforms from maize pollen for their ability to alter cytoarchitecture when microinjected into living plant cells and for their association with poly-L-proline and monomeric [E2]actin[/E2] from maize pollen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[218, 223]], "entity_2_idx_in_text_with_entity_marker": [231, 236], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s2_BioInfer.d382.s2.p0", "text": "The affinity of ZmPRO4 for monomeric actin, which was measured by two independent methods, is similar to that of the three profilin isoforms previously identified in pollen.", "text_with_entity_marker": "The affinity of [E1]ZmPRO4[/E1] for monomeric [E2]actin[/E2], which was measured by two independent methods, is similar to that of the three profilin isoforms previously identified in pollen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ZmPRO4", "entity_1_idx": [[16, 22]], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s2_BioInfer.d382.s2.p2", "text": "The affinity of ZmPRO4 for monomeric actin, which was measured by two independent methods, is similar to that of the three profilin isoforms previously identified in pollen.", "text_with_entity_marker": "The affinity of ZmPRO4 for monomeric [E1]actin[/E1], which was measured by two independent methods, is similar to that of the three [E2]profilin[/E2] isoforms previously identified in pollen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[123, 131]], "entity_2_idx_in_text_with_entity_marker": [136, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s3_BioInfer.d382.s3.p0", "text": "When ZmPRO4 was microinjected into plant cells, the effect on actin-dependent nuclear position was significantly more rapid than that of another pollen profilin isoform, ZmPRO1.", "text_with_entity_marker": "When ZmPRO4 was microinjected into plant cells, the effect on [E1]actin[/E1]-dependent nuclear position was significantly more rapid than that of another pollen profilin isoform, [E2]ZmPRO1[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO1", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s3_BioInfer.d382.s3.p2", "text": "When ZmPRO4 was microinjected into plant cells, the effect on actin-dependent nuclear position was significantly more rapid than that of another pollen profilin isoform, ZmPRO1.", "text_with_entity_marker": "When ZmPRO4 was microinjected into plant cells, the effect on actin-dependent nuclear position was significantly more rapid than that of another pollen [E1]profilin[/E1] isoform, [E2]ZmPRO1[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[152, 160]], "entity_1_idx_in_text_with_entity_marker": [156, 164], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO1", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d382.s3_BioInfer.d382.s3.p3", "text": "When ZmPRO4 was microinjected into plant cells, the effect on actin-dependent nuclear position was significantly more rapid than that of another pollen profilin isoform, ZmPRO1.", "text_with_entity_marker": "When [E1]ZmPRO4[/E1] was microinjected into plant cells, the effect on [E2]actin[/E2]-dependent nuclear position was significantly more rapid than that of another pollen profilin isoform, ZmPRO1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ZmPRO4", "entity_1_idx": [[5, 11]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p0", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the [E1]UL5[/E1] and [E2]UL52[/E2] subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p1", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the UL5 and [E1]UL52[/E1] subunits retains both enzymic activities, and the [E2]UL8[/E2] protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p2", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the [E1]UL5[/E1] and UL52 subunits retains both enzymic activities, and the [E2]UL8[/E2] protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p0", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded [E2]UL5[/E2], UL8, and UL52 proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p1", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, [E2]UL8[/E2], and UL52 proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p2", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p4", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with [E2]actin depolymerizing factor[/E2], cofilin, and profilin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[167, 194]], "entity_2_idx_in_text_with_entity_marker": [180, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p5", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with [E1]actin depolymerizing factor[/E1], [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[167, 194]], "entity_1_idx_in_text_with_entity_marker": [171, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p6", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with [E1]actin depolymerizing factor[/E1], cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[167, 194]], "entity_1_idx_in_text_with_entity_marker": [171, 198], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p7", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with actin depolymerizing factor, [E2]cofilin[/E2], and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p8", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this [E1]actin[/E1] may travel as a complex with actin depolymerizing factor, cofilin, and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[132, 137]], "entity_1_idx_in_text_with_entity_marker": [136, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s1_BioInfer.d214.s1.p9", "text": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.", "text_with_entity_marker": "Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, [E1]cofilin[/E1], and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[196, 203]], "entity_1_idx_in_text_with_entity_marker": [200, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[209, 217]], "entity_2_idx_in_text_with_entity_marker": [222, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p0", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, actin depolymerizing factor, cofilin, and [E2]profilin[/E2], in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[118, 126]], "entity_2_idx_in_text_with_entity_marker": [131, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p3", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, [E2]actin depolymerizing factor[/E2], cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[76, 103]], "entity_2_idx_in_text_with_entity_marker": [89, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d214.s2_BioInfer.d214.s2.p4", "text": "We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "text_with_entity_marker": "We examined the axonal transport of [E1]actin[/E1] and its monomer binding proteins, actin depolymerizing factor, [E2]cofilin[/E2], and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[105, 112]], "entity_2_idx_in_text_with_entity_marker": [118, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s3_BioInfer.d35.s3.p2", "text": "Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.", "text_with_entity_marker": "Here, we report that [E1]Aip1p[/E1] also interacts with the ubiquitous actin depolymerizing factor [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p1", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a cofilin-associated protein that enhances the filament disassembly activity of [E2]cofilin[/E2] and restricts cofilin localization to cortical actin patches.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[106, 113]], "entity_2_idx_in_text_with_entity_marker": [119, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p4", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p5", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts [E1]cofilin[/E1] localization to cortical [E2]actin[/E2] patches.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[128, 135]], "entity_1_idx_in_text_with_entity_marker": [132, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s4_BioInfer.d35.s4.p8", "text": "We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "text_with_entity_marker": "We conclude that [E1]Aip1p[/E1] is a [E2]cofilin[/E2]-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[28, 35]], "entity_2_idx_in_text_with_entity_marker": [41, 48], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d724.s0_BioInfer.d724.s0.p0", "text": "The structure of an actin-crosslinking domain from human fimbrin.", "text_with_entity_marker": "The structure of an [E1]actin[/E1]-crosslinking domain from human [E2]fimbrin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[57, 64]], "entity_2_idx_in_text_with_entity_marker": [70, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s0_BioInfer.d274.s0.p1", "text": "However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "text_with_entity_marker": "However, similar to [E1]utrophin[/E1], [E2]alpha-syntrophin[/E2] is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-syntrophin", "entity_2_idx": [[30, 46]], "entity_2_idx_in_text_with_entity_marker": [43, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p0", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to syntrophin triplet, [E2]dystrophin[/E2], and utrophin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[66, 76]], "entity_2_idx_in_text_with_entity_marker": [79, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p1", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to [E2]syntrophin triplet[/E2], dystrophin, and utrophin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntrophin triplet", "entity_2_idx": [[46, 64]], "entity_2_idx_in_text_with_entity_marker": [59, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d274.s1_BioInfer.d274.s1.p2", "text": "Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.", "text_with_entity_marker": "Identification of [E1]alpha-syntrophin[/E1] binding to syntrophin triplet, dystrophin, and [E2]utrophin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-syntrophin", "entity_1_idx": [[18, 34]], "entity_1_idx_in_text_with_entity_marker": [22, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[82, 90]], "entity_2_idx_in_text_with_entity_marker": [95, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p0", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The [E1]actin[/E1] cytoskeleton-associated protein [E2]talin[/E2] binds to integrins, vinculin, and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p4", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to [E2]integrins[/E2], vinculin, and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[57, 66]], "entity_2_idx_in_text_with_entity_marker": [70, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p5", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to integrins, [E2]vinculin[/E2], and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d563.s0_BioInfer.d563.s0.p6", "text": "The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.", "text_with_entity_marker": "The actin cytoskeleton-associated protein [E1]talin[/E1] binds to integrins, vinculin, and [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[82, 87]], "entity_2_idx_in_text_with_entity_marker": [95, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d556.s0_BioInfer.d556.s0.p0", "text": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.", "text_with_entity_marker": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor [E1]p57KIP2[/E1] requires binding to [E2]proliferating cell nuclear antigen[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p57KIP2", "entity_1_idx": [[76, 83]], "entity_1_idx_in_text_with_entity_marker": [80, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proliferating cell nuclear antigen", "entity_2_idx": [[104, 138]], "entity_2_idx_in_text_with_entity_marker": [117, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d556.s0_BioInfer.d556.s0.p2", "text": "Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.", "text_with_entity_marker": "Suppression of cell transformation by the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p57KIP2[/E2] requires binding to proliferating cell nuclear antigen.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[42, 75]], "entity_1_idx_in_text_with_entity_marker": [46, 79], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p57KIP2", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p5", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to [E1]cyclin D3[/E1]/[E2]CDK4[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D3", "entity_1_idx": [[298, 307]], "entity_1_idx_in_text_with_entity_marker": [302, 311], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p8", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/CDK2 (but not to cyclin D3/[E2]CDK4[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK4", "entity_2_idx": [[308, 312]], "entity_2_idx_in_text_with_entity_marker": [321, 325], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p10", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27[/E2], enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[127, 160]], "entity_1_idx_in_text_with_entity_marker": [131, 164], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[161, 164]], "entity_2_idx_in_text_with_entity_marker": [174, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p18", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to [E1]cyclin E[/E1]/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[272, 280]], "entity_1_idx_in_text_with_entity_marker": [276, 284], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p23", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/[E2]CDK2[/E2] (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDK2", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p34", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to [E2]cyclin E[/E2]/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin E", "entity_2_idx": [[272, 280]], "entity_2_idx_in_text_with_entity_marker": [285, 293], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p36", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with [E1]cyclin E[/E1]/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[199, 207]], "entity_1_idx_in_text_with_entity_marker": [203, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p37", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with cyclin E/[E2]CDK2[/E2] complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[208, 212]], "entity_2_idx_in_text_with_entity_marker": [221, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p41", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of [E1]kinase[/E1] activity associated to cyclin E/CDK2 (but not to [E2]cyclin D3[/E2]/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "kinase", "entity_1_idx": [[242, 248]], "entity_1_idx_in_text_with_entity_marker": [246, 252], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cyclin D3", "entity_2_idx": [[298, 307]], "entity_2_idx_in_text_with_entity_marker": [311, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d239.s0_BioInfer.d239.s0.p42", "text": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "text_with_entity_marker": "Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of [E1]p27[/E1] with [E2]cyclin E[/E2]/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[199, 207]], "entity_2_idx_in_text_with_entity_marker": [212, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d389.s0_BioInfer.d389.s0.p0", "text": "Involvement of profilin in the actin-based motility of L. monocytogenes in cells and in cell-free extracts.", "text_with_entity_marker": "Involvement of [E1]profilin[/E1] in the [E2]actin[/E2]-based motility of L. monocytogenes in cells and in cell-free extracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[31, 36]], "entity_2_idx_in_text_with_entity_marker": [44, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d20.s0_BioInfer.d20.s0.p0", "text": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "text_with_entity_marker": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein [E1]CREB-binding-protein[/E1], CBP, which bridges the CRE/[E2]CREB[/E2] complex to components of the basal transcriptional apparatus.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB-binding-protein", "entity_1_idx": [[134, 154]], "entity_1_idx_in_text_with_entity_marker": [138, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[183, 187]], "entity_2_idx_in_text_with_entity_marker": [196, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d20.s0_BioInfer.d20.s0.p1", "text": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "text_with_entity_marker": "Active, Ser133-phosphorylated [E1]CREB[/E1] effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein [E2]CREB-binding-protein[/E2], CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB-binding-protein", "entity_2_idx": [[134, 154]], "entity_2_idx_in_text_with_entity_marker": [147, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d20.s0_BioInfer.d20.s0.p4", "text": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "text_with_entity_marker": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, [E1]CBP[/E1], which bridges the CRE/[E2]CREB[/E2] complex to components of the basal transcriptional apparatus.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[156, 159]], "entity_1_idx_in_text_with_entity_marker": [160, 163], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB", "entity_2_idx": [[183, 187]], "entity_2_idx_in_text_with_entity_marker": [196, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d20.s0_BioInfer.d20.s0.p5", "text": "Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "text_with_entity_marker": "Active, Ser133-phosphorylated [E1]CREB[/E1] effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, [E2]CBP[/E2], which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d554.s0_BioInfer.d554.s0.p4", "text": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.", "text_with_entity_marker": "Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of [E1]profilin[/E1] to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[206, 211]], "entity_2_idx_in_text_with_entity_marker": [219, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p2", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse [E2]Rep-3[/E2] gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "Rep-3", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p5", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other [E2]mutS[/E2] homologues that are involved in replication repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[147, 151]], "entity_2_idx_in_text_with_entity_marker": [160, 164], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p7", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic [E2]mutS[/E2] homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "mutS", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d104.s0_BioInfer.d104.s0.p9", "text": "MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.", "text_with_entity_marker": "[E1]MSH3[/E1] appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene [E2]MSH2[/E2] and other mutS homologues that are involved in replication repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH3", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d310.s0_BioInfer.d310.s0.p0", "text": "In addition, interactions with components of the phosphatidylinositol cycle and the RAS pathway in yeast implicate profilin as an important link through which the actin cytoskeleton is able to communicate with major signaling pathways.", "text_with_entity_marker": "In addition, interactions with components of the phosphatidylinositol cycle and the [E1]RAS[/E1] pathway in yeast implicate [E2]profilin[/E2] as an important link through which the actin cytoskeleton is able to communicate with major signaling pathways.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RAS", "entity_1_idx": [[84, 87]], "entity_1_idx_in_text_with_entity_marker": [88, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[115, 123]], "entity_2_idx_in_text_with_entity_marker": [128, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d310.s0_BioInfer.d310.s0.p2", "text": "In addition, interactions with components of the phosphatidylinositol cycle and the RAS pathway in yeast implicate profilin as an important link through which the actin cytoskeleton is able to communicate with major signaling pathways.", "text_with_entity_marker": "In addition, interactions with components of the phosphatidylinositol cycle and the RAS pathway in yeast implicate [E1]profilin[/E1] as an important link through which the [E2]actin[/E2] cytoskeleton is able to communicate with major signaling pathways.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d310.s1_BioInfer.d310.s1.p0", "text": "So far, three ligands for profilin have been well-characterized in vitro: actin monomers, membrane polyphosphoinositides and poly-L-proline.", "text_with_entity_marker": "So far, three ligands for [E1]profilin[/E1] have been well-characterized in vitro: [E2]actin[/E2] monomers, membrane polyphosphoinositides and poly-L-proline.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d136.s0_BioInfer.d136.s0.p0", "text": "Characterization of a mutant profilin with reduced actin-binding capacity: effects in vitro and in vivo.", "text_with_entity_marker": "Characterization of a mutant [E1]profilin[/E1] with reduced [E2]actin[/E2]-binding capacity: effects in vitro and in vivo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[29, 37]], "entity_1_idx_in_text_with_entity_marker": [33, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d628.s0_BioInfer.d628.s0.p1", "text": "The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.", "text_with_entity_marker": "The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] p27([E2]kip1[/E2]) but a striking inhibition of the expression of cyclin D1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[118, 151]], "entity_1_idx_in_text_with_entity_marker": [122, 155], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "kip1", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d628.s0_BioInfer.d628.s0.p2", "text": "The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.", "text_with_entity_marker": "The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27[/E2](kip1) but a striking inhibition of the expression of cyclin D1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[118, 151]], "entity_1_idx_in_text_with_entity_marker": [122, 155], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[152, 155]], "entity_2_idx_in_text_with_entity_marker": [165, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d754.s0_BioInfer.d754.s0.p0", "text": "Thus, it is likely that the both cofilin isoforms are involved in the regulation of actin assembly during myofibrillogenesis.", "text_with_entity_marker": "Thus, it is likely that the both [E1]cofilin[/E1] isoforms are involved in the regulation of [E2]actin[/E2] assembly during myofibrillogenesis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d595.s0_BioInfer.d595.s0.p0", "text": "The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "text_with_entity_marker": "The common denominator is impaired [E1]beta-catenin[/E1] association with either [E2]E-cadherin[/E2] (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[72, 82]], "entity_2_idx_in_text_with_entity_marker": [85, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d595.s0_BioInfer.d595.s0.p1", "text": "The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).", "text_with_entity_marker": "The common denominator is impaired [E1]beta-catenin[/E1] association with either E-cadherin (PaTuII) or [E2]alpha-catenin[/E2] (BxPc3 and T3M4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[95, 108]], "entity_2_idx_in_text_with_entity_marker": [108, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d98.s0_BioInfer.d98.s0.p0", "text": "Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.", "text_with_entity_marker": "Binding to human [E1]dipeptidyl peptidase IV[/E1] by [E2]adenosine deaminase[/E2] and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "dipeptidyl peptidase IV", "entity_1_idx": [[17, 40]], "entity_1_idx_in_text_with_entity_marker": [21, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[44, 63]], "entity_2_idx_in_text_with_entity_marker": [57, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p4", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-[E2]cdk2[/E2], cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p5", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by [E2]cyclin E[/E2]-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p7", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, [E1]cyclin A[/E1]-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin A", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p10", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, [E2]cyclin A[/E2]-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin A", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p12", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and [E1]cyclin D[/E1]-[E2]cdk4[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p14", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p17", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p19", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p20", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-[E2]cdk2[/E2], cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d385.s0_BioInfer.d385.s0.p0", "text": "Introduction of high concentrations of profilin (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of actin tail elongation and bacterial migration.", "text_with_entity_marker": "Introduction of high concentrations of [E1]profilin[/E1] (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of [E2]actin[/E2] tail elongation and bacterial migration.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p2", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as [E2]verprolin[/E2]/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p9", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E2]cofilin[/E2]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p15", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase [E2]CDC42Hs[/E2] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p20", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] [E2]CDC42Hs[/E2] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CDC42Hs", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p23", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p26", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E1]CDC42Hs[/E1]-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CDC42Hs", "entity_1_idx": [[162, 169]], "entity_1_idx_in_text_with_entity_marker": [166, 173], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p28", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E1]actin[/E1] structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p31", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E1]actin[/E1] structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[133, 138]], "entity_1_idx_in_text_with_entity_marker": [137, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p0", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the [E1]actin[/E1]-binding site at the C terminal suggests that [E2]talin[/E2] may work as a crosslinker between myosin and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p3", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that [E1]talin[/E1] may work as a crosslinker between [E2]myosin[/E2] and actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[111, 117]], "entity_2_idx_in_text_with_entity_marker": [124, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p4", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that [E1]talin[/E1] may work as a crosslinker between myosin and [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d661.s0_BioInfer.d661.s0.p5", "text": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between myosin and actin.", "text_with_entity_marker": "The position of the actin-binding site at the C terminal suggests that talin may work as a crosslinker between [E1]myosin[/E1] and [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[111, 117]], "entity_1_idx_in_text_with_entity_marker": [115, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p2", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; [E1]MHC-IIB(B2)[/E1] differs from [E2]MHC-IIB(DeltaB2)[/E2] by the insertion of B2 exon cassette near the actin binding region.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MHC-IIB(B2)", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC-IIB(DeltaB2)", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p3", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; [E1]MHC-IIB(B2)[/E1] differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MHC-IIB(B2)", "entity_1_idx": [[98, 109]], "entity_1_idx_in_text_with_entity_marker": [102, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d780.s0_BioInfer.d780.s0.p9", "text": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from MHC-IIB(DeltaB2) by the insertion of B2 exon cassette near the actin binding region.", "text_with_entity_marker": "Two isoforms of nonmuscle myosin heavy chain IIB (MHC-IIB) are generated by alternative splicing; MHC-IIB(B2) differs from [E1]MHC-IIB(DeltaB2)[/E1] by the insertion of B2 exon cassette near the [E2]actin[/E2] binding region.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MHC-IIB(DeltaB2)", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[186, 191]], "entity_2_idx_in_text_with_entity_marker": [199, 204], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p0", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "Villin and [E1]fimbrin[/E1] are two actin-binding proteins that bundle [E2]actin[/E2] filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[11, 18]], "entity_1_idx_in_text_with_entity_marker": [15, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p1", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "[E1]Villin[/E1] and fimbrin are two actin-binding proteins that bundle [E2]actin[/E2] filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Villin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p4", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "Villin and [E1]fimbrin[/E1] are two [E2]actin-binding proteins[/E2] that bundle actin filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[11, 18]], "entity_1_idx_in_text_with_entity_marker": [15, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[27, 49]], "entity_2_idx_in_text_with_entity_marker": [40, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d793.s0_BioInfer.d793.s0.p5", "text": "Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.", "text_with_entity_marker": "[E1]Villin[/E1] and fimbrin are two [E2]actin-binding proteins[/E2] that bundle actin filaments in the intestine and kidney brush border epithelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Villin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[27, 49]], "entity_2_idx_in_text_with_entity_marker": [40, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s2_BioInfer.d169.s2.p9", "text": "Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.", "text_with_entity_marker": "Recombinant plant (birch) profilin was analyzed for its ability to promote [E1]actin[/E1] polymerization from the [E2]actin[/E2]:thymosin beta4 and beta9 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[75, 80]], "entity_1_idx_in_text_with_entity_marker": [79, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p0", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the [E1]profilin[/E1] and [E2]DNase I[/E2] binding sites on actin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p1", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the profilin and [E1]DNase I[/E1] binding sites on [E2]actin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DNase I", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d169.s3_BioInfer.d169.s3.p2", "text": "These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.", "text_with_entity_marker": "These data indicated a negative co-operativity between the [E1]profilin[/E1] and DNase I binding sites on [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[59, 67]], "entity_1_idx_in_text_with_entity_marker": [63, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s1_BioInfer.d336.s1.p0", "text": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.", "text_with_entity_marker": "[E1]Myosin heavy chain A[/E1] staining was dimmer and its colocalization with filamentous [E2]actin[/E2] bundles in growth cones was less striking than that of myosin heavy chain B.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myosin heavy chain A", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s1_BioInfer.d336.s1.p1", "text": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.", "text_with_entity_marker": "Myosin heavy chain A staining was dimmer and its colocalization with filamentous [E1]actin[/E1] bundles in growth cones was less striking than that of [E2]myosin heavy chain B[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain B", "entity_2_idx": [[142, 162]], "entity_2_idx_in_text_with_entity_marker": [155, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d529.s0_BioInfer.d529.s0.p1", "text": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.", "text_with_entity_marker": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and [E1]smooth muscle myosin heavy chain[/E1] isoforms: SM1, [E2]SM2[/E2] and SMemb.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[136, 168]], "entity_1_idx_in_text_with_entity_marker": [140, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM2", "entity_2_idx": [[184, 187]], "entity_2_idx_in_text_with_entity_marker": [197, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d529.s0_BioInfer.d529.s0.p12", "text": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.", "text_with_entity_marker": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and [E1]smooth muscle myosin heavy chain[/E1] isoforms: [E2]SM1[/E2], SM2 and SMemb.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[136, 168]], "entity_1_idx_in_text_with_entity_marker": [140, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SM1", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d529.s0_BioInfer.d529.s0.p14", "text": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.", "text_with_entity_marker": "Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and [E1]smooth muscle myosin heavy chain[/E1] isoforms: SM1, SM2 and [E2]SMemb[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[136, 168]], "entity_1_idx_in_text_with_entity_marker": [140, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMemb", "entity_2_idx": [[192, 197]], "entity_2_idx_in_text_with_entity_marker": [205, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p3", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an [E1]E-cadherin[/E1] mAb, which is known to co-precipitate the [E2]catenins[/E2], demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[81, 89]], "entity_2_idx_in_text_with_entity_marker": [94, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d300.s0_BioInfer.d300.s0.p11", "text": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "text_with_entity_marker": "Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing [E1]E-cadherin[/E1] did not co-precipitate [E2]alpha-catenin[/E2], although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[163, 173]], "entity_1_idx_in_text_with_entity_marker": [167, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d611.s0_BioInfer.d611.s0.p1", "text": "The existence of this pathway helps to explain some of the effects of LIM kinase and cofilin in the control of actin dynamics.", "text_with_entity_marker": "The existence of this pathway helps to explain some of the effects of [E1]LIM kinase[/E1] and cofilin in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LIM kinase", "entity_1_idx": [[70, 80]], "entity_1_idx_in_text_with_entity_marker": [74, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d611.s0_BioInfer.d611.s0.p2", "text": "The existence of this pathway helps to explain some of the effects of LIM kinase and cofilin in the control of actin dynamics.", "text_with_entity_marker": "The existence of this pathway helps to explain some of the effects of LIM kinase and [E1]cofilin[/E1] in the control of [E2]actin[/E2] dynamics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[85, 92]], "entity_1_idx_in_text_with_entity_marker": [89, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d441.s0_BioInfer.d441.s0.p1", "text": "Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: gelsolin and profilin.", "text_with_entity_marker": "Motile areas of leech neurites are rich in microfilaments and two [E1]actin-binding proteins[/E1]: [E2]gelsolin[/E2] and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[66, 88]], "entity_1_idx_in_text_with_entity_marker": [70, 92], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[90, 98]], "entity_2_idx_in_text_with_entity_marker": [103, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d441.s0_BioInfer.d441.s0.p2", "text": "Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: gelsolin and profilin.", "text_with_entity_marker": "Motile areas of leech neurites are rich in microfilaments and two [E1]actin-binding proteins[/E1]: gelsolin and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[66, 88]], "entity_1_idx_in_text_with_entity_marker": [70, 92], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d441.s1_BioInfer.d441.s1.p0", "text": "The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.", "text_with_entity_marker": "The colocalization of gelsolin and [E1]profilin[/E1] in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the [E2]actin[/E2] dynamics that underlie neurite growth.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d441.s1_BioInfer.d441.s1.p1", "text": "The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.", "text_with_entity_marker": "The colocalization of [E1]gelsolin[/E1] and [E2]profilin[/E2] in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[35, 43]], "entity_2_idx_in_text_with_entity_marker": [48, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d441.s1_BioInfer.d441.s1.p2", "text": "The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.", "text_with_entity_marker": "The colocalization of [E1]gelsolin[/E1] and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the [E2]actin[/E2] dynamics that underlie neurite growth.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d50.s0_BioInfer.d50.s0.p0", "text": "mDia binds profilin likely to promote actin polymerization.", "text_with_entity_marker": "[E1]mDia[/E1] binds [E2]profilin[/E2] likely to promote actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "mDia", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[11, 19]], "entity_2_idx_in_text_with_entity_marker": [24, 32], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d50.s0_BioInfer.d50.s0.p1", "text": "mDia binds profilin likely to promote actin polymerization.", "text_with_entity_marker": "[E1]mDia[/E1] binds profilin likely to promote [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "mDia", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d50.s0_BioInfer.d50.s0.p2", "text": "mDia binds profilin likely to promote actin polymerization.", "text_with_entity_marker": "mDia binds [E1]profilin[/E1] likely to promote [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[38, 43]], "entity_2_idx_in_text_with_entity_marker": [51, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p0", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that [E1]verprolin[/E1] establishes and maintains its location independent of the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[120, 129]], "entity_1_idx_in_text_with_entity_marker": [124, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[188, 193]], "entity_2_idx_in_text_with_entity_marker": [201, 206], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s0_BioInfer.d268.s0.p5", "text": "However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "text_with_entity_marker": "However, disassembly of the [E1]actin[/E1] cytoskeleton using Latrunculin-A does not alter [E2]verprolin[/E2]'s location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[82, 91]], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d268.s1_BioInfer.d268.s1.p0", "text": "Using the two-hybrid system, we show that verprolin binds actin.", "text_with_entity_marker": "Using the two-hybrid system, we show that [E1]verprolin[/E1] binds [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p5", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2], but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[43, 55]], "entity_2_idx_in_text_with_entity_marker": [56, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p11", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not [E2]CD44s[/E2], CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44s", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p16", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p20", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p23", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], [E2]alpha-catenin[/E2] and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[25, 38]], "entity_2_idx_in_text_with_entity_marker": [38, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p25", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, [E2]CD44v5[/E2], CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v5", "entity_2_idx": [[72, 78]], "entity_2_idx_in_text_with_entity_marker": [85, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p27", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p4", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for [E1]beta-catenin[/E1], the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[245, 257]], "entity_1_idx_in_text_with_entity_marker": [249, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p8", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p9", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s0_BioInfer.d27.s0.p0", "text": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "ADP-ribosylation of [E1]actin[/E1] at Arg 177 by Clostridium perfringens [E2]iota toxin[/E2] increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "iota toxin", "entity_2_idx": [[64, 74]], "entity_2_idx_in_text_with_entity_marker": [77, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s0_BioInfer.d27.s0.p2", "text": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "ADP-ribosylation of actin at Arg 177 by Clostridium perfringens [E1]iota toxin[/E1] increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the [E2]profilin[/E2]-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "iota toxin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d27.s1_BioInfer.d27.s1.p2", "text": "In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "text_with_entity_marker": "In contrast, ADP-ribosylation of [E1]actin[/E1] at Arg95/Arg372 induced by turkey [E2]erythrocyte transferase[/E2] decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "erythrocyte transferase", "entity_2_idx": [[73, 96]], "entity_2_idx_in_text_with_entity_marker": [86, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d435.s0_BioInfer.d435.s0.p0", "text": "Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "text_with_entity_marker": "Moreover, talin, but not [E1]vinculin[/E1] or tubulin, appears to co-localize with [E2]actin[/E2] microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d435.s0_BioInfer.d435.s0.p1", "text": "Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "text_with_entity_marker": "Moreover, talin, but not vinculin or [E1]tubulin[/E1], appears to co-localize with [E2]actin[/E2] microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tubulin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d435.s0_BioInfer.d435.s0.p2", "text": "Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "text_with_entity_marker": "Moreover, [E1]talin[/E1], but not vinculin or tubulin, appears to co-localize with [E2]actin[/E2] microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p0", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to [E2]integrins[/E2] to form a link to the actin cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[39, 48]], "entity_2_idx_in_text_with_entity_marker": [52, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p2", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of talin thus binds to [E1]integrins[/E1] to form a link to the [E2]actin[/E2] cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[39, 48]], "entity_1_idx_in_text_with_entity_marker": [43, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p3", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate [E2]integrin[/E2] function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p4", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to integrins to form a link to the [E2]actin[/E2] cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d160.s0_BioInfer.d160.s0.p0", "text": "Cytoplasmic staining included stress fibers that colocalized with actin, probably as a consequence of the myosin heavy chain component of the fusion protein.", "text_with_entity_marker": "Cytoplasmic staining included stress fibers that colocalized with [E1]actin[/E1], probably as a consequence of the [E2]myosin heavy chain[/E2] component of the fusion protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[106, 124]], "entity_2_idx_in_text_with_entity_marker": [119, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p2", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) [E1]phosphoprotein[/E1] (P) with nucleocapsid (N) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[61, 75]], "entity_1_idx_in_text_with_entity_marker": [65, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d631.s0_BioInfer.d631.s0.p3", "text": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "text_with_entity_marker": "The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein ([E1]P[/E1]) with nucleocapsid (N) and [E2]large polymerase[/E2] (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "P", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large polymerase", "entity_2_idx": [[106, 122], [127, 135]], "entity_2_idx_in_text_with_entity_marker": [119, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p0", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the UL5, [E2]UL8[/E2], and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[119, 122]], "entity_2_idx_in_text_with_entity_marker": [132, 135], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p1", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the [E2]UL5[/E2], UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d260.s0_BioInfer.d260.s0.p2", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of three polypeptides encoded by the UL5, UL8, and [E2]UL52[/E2] genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d12.s0_BioInfer.d12.s0.p0", "text": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.", "text_with_entity_marker": "A core activity associated with the N terminus of the yeast RAD52 protein is revealed by [E1]RAD51[/E1] overexpression suppression of C-terminal [E2]rad52[/E2] truncation alleles.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[89, 94]], "entity_1_idx_in_text_with_entity_marker": [93, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rad52", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d455.s0_BioInfer.d455.s0.p1", "text": "Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.", "text_with_entity_marker": "Notably, the two pro-apoptotic adapter proteins TRADD and [E1]FADD[/E1] are also involved in the activation of [E2]A-SMase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d455.s0_BioInfer.d455.s0.p2", "text": "Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.", "text_with_entity_marker": "Notably, the two pro-apoptotic adapter proteins [E1]TRADD[/E1] and FADD are also involved in the activation of [E2]A-SMase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p1", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant [E2]BCK1-20[/E2] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "BCK1-20", "entity_2_idx": [[59, 66]], "entity_2_idx_in_text_with_entity_marker": [72, 79], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p10", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p13", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of [E1]BCK1[/E1] ([E2]MEKK[/E2]) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BCK1", "entity_1_idx": [[31, 35]], "entity_1_idx_in_text_with_entity_marker": [35, 39], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEKK", "entity_2_idx": [[37, 41]], "entity_2_idx_in_text_with_entity_marker": [50, 54], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p25", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p29", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of [E1]MKK1[/E1] ([E2]MEK[/E2]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MKK1", "entity_1_idx": [[100, 104]], "entity_1_idx_in_text_with_entity_marker": [104, 108], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEK", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p39", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a [E2]glc7-10[/E2] dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p51", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E1]HCS77[/E1]/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HCS77", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p74", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/[E1]WSC1[/E1]/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WSC1", "entity_1_idx": [[276, 280]], "entity_1_idx_in_text_with_entity_marker": [280, 284], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p84", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and [E1]MID2[/E1] also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MID2", "entity_1_idx": [[290, 294]], "entity_1_idx_in_text_with_entity_marker": [294, 298], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p93", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E1]RHO2[/E1], HCS77/WSC1/SLG1 and MID2 also suppressed [E2]glc7-10[/E2] effectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RHO2", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glc7-10", "entity_2_idx": [[311, 318]], "entity_2_idx_in_text_with_entity_marker": [324, 331], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d751.s0_BioInfer.d751.s0.p1", "text": "Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "text_with_entity_marker": "Thus, [E1]actin[/E1] was found in association with [E2]fimbrin[/E2] in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[42, 49]], "entity_2_idx_in_text_with_entity_marker": [55, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p10", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein (P), H, nucleocapsid ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p11", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein (P), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p12", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] ([E2]F[/E2]), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[128, 129]], "entity_2_idx_in_text_with_entity_marker": [141, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p13", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), phosphoprotein (P), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p14", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion ([E1]F[/E1]), [E2]phosphoprotein[/E2] (P), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[128, 129]], "entity_1_idx_in_text_with_entity_marker": [132, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[132, 146], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [145, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p15", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein ([E1]P[/E1]), H, [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[148, 149]], "entity_1_idx_in_text_with_entity_marker": [152, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p16", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, [E1]nucleocapsid[/E1] ([E2]N[/E2]) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[155, 167], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [159, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[169, 170]], "entity_2_idx_in_text_with_entity_marker": [182, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p17", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p18", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, [E2]nucleocapsid[/E2] (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[155, 167], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [168, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p19", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, [E1]nucleocapsid[/E1] (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[155, 167], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [159, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d209.s0_BioInfer.d209.s0.p0", "text": "Finally it was shown that the two isoforms of actin can be separated from each other in the absence of profilin also by chromatography on hydroxyapatite.", "text_with_entity_marker": "Finally it was shown that the two isoforms of [E1]actin[/E1] can be separated from each other in the absence of [E2]profilin[/E2] also by chromatography on hydroxyapatite.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p10", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, [E1]calcium vector protein[/E1], [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calcium vector protein", "entity_1_idx": [[166, 188]], "entity_1_idx_in_text_with_entity_marker": [170, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p11", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], [E2]calmodulin[/E2], calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p12", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p13", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, [E1]myosin light chain kinase[/E1], [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain kinase", "entity_1_idx": [[97, 122]], "entity_1_idx_in_text_with_entity_marker": [101, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p14", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p15", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p16", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E2]myosin heavy chain[/E2], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p17", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p18", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p19", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, [E1]myosin heavy chain[/E1], calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p60", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E1]calponin[/E1], calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p61", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E1]muscle LIM[/E1] protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle LIM", "entity_1_idx": [[207, 217]], "entity_1_idx_in_text_with_entity_marker": [211, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p62", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E1]creatine kinase[/E1], [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "creatine kinase", "entity_1_idx": [[190, 205]], "entity_1_idx_in_text_with_entity_marker": [194, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p63", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E1]calponin[/E1], calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p64", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, [E1]calponin[/E1], calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[156, 164]], "entity_1_idx_in_text_with_entity_marker": [160, 168], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p65", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E1]creatine kinase[/E1], muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "creatine kinase", "entity_1_idx": [[190, 205]], "entity_1_idx_in_text_with_entity_marker": [194, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p40", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], [E2]profilins[/E2] Ia/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins", "entity_2_idx": [[67, 76], [86, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p41", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p42", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], [E2]profilins I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [80, 91], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p43", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p44", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, [E1]actin I[/E1], profilins Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin I", "entity_1_idx": [[58, 65]], "entity_1_idx_in_text_with_entity_marker": [62, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p45", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p46", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1-E2]profilins[/E1] I[/E2]a/b and II, myosins IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [74, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilins[/E1] I", "entity_2_idx": [[67, 78], [80, 81]], "entity_2_idx_in_text_with_entity_marker": [74, 90], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p47", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, [E2]myosins IB[/E2], IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins IB", "entity_2_idx": [[90, 100]], "entity_2_idx_in_text_with_entity_marker": [103, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p48", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins[/E1] Ia/b and II, myosins IB, IC and II, and [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins", "entity_1_idx": [[67, 76], [86, 88]], "entity_1_idx_in_text_with_entity_marker": [71, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calmodulin", "entity_2_idx": [[117, 127]], "entity_2_idx_in_text_with_entity_marker": [130, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d616.s0_BioInfer.d616.s0.p49", "text": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.", "text_with_entity_marker": "The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, [E1]profilins I[/E1]a/b and II, [E2]myosins[/E2] IB, IC and II, and calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilins I", "entity_1_idx": [[67, 78], [80, 81]], "entity_1_idx_in_text_with_entity_marker": [71, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosins", "entity_2_idx": [[90, 97], [109, 111]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p80", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p81", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, [E2]MEC1[/E2], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[51, 55]], "entity_2_idx_in_text_with_entity_marker": [64, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p82", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p83", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p84", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p85", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 [E2]MEC3[/E2], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p86", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p87", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p88", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p89", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p0", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in [E1]sgs1[/E1] [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sgs1", "entity_1_idx": [[112, 116]], "entity_1_idx_in_text_with_entity_marker": [116, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p1", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and RAD57, suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p2", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and [E1]RAD57[/E1], suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD57", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p3", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and RAD57, suggesting that the cell cycle defect in [E2]sgs1[/E2] srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sgs1", "entity_2_idx": [[112, 116]], "entity_2_idx_in_text_with_entity_marker": [125, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p4", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and RAD57, suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p5", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, RAD52, and [E1]RAD57[/E1], suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD57", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p6", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 [E2]srs2[/E2] mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[117, 121]], "entity_2_idx_in_text_with_entity_marker": [130, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p7", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in RAD51, [E1]RAD52[/E1], and [E2]RAD57[/E2], suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p8", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], [E2]RAD52[/E2], and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d737.s0_BioInfer.d737.s0.p9", "text": "This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "text_with_entity_marker": "This arrest can be suppressed by mutations in [E1]RAD51[/E1], RAD52, and [E2]RAD57[/E2], suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p0", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:18S RNA and [E1]fast myosin heavy chain[/E1] mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fast myosin heavy chain", "entity_1_idx": [[34, 57]], "entity_1_idx_in_text_with_entity_marker": [38, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p1", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:18S RNA and [E2]fast myosin heavy chain[/E2] mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fast myosin heavy chain", "entity_2_idx": [[34, 57]], "entity_2_idx_in_text_with_entity_marker": [47, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p2", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:[E1]18S RNA[/E1] and [E2]fast myosin heavy chain[/E2] mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "18S RNA", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fast myosin heavy chain", "entity_2_idx": [[34, 57]], "entity_2_idx_in_text_with_entity_marker": [47, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p3", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:18S RNA and fast myosin heavy chain mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p4", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios actin mRNA:[E1]18S RNA[/E1] and fast myosin heavy chain mRNA:[E2]18S RNA[/E2] were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "18S RNA", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d679.s0_BioInfer.d679.s0.p5", "text": "The ratios actin mRNA:18S RNA and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "text_with_entity_marker": "The ratios [E1]actin[/E1] mRNA:[E2]18S RNA[/E2] and fast myosin heavy chain mRNA:18S RNA were unaffected by clenbuterol.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[11, 16]], "entity_1_idx_in_text_with_entity_marker": [15, 20], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "18S RNA", "entity_2_idx": [[22, 29]], "entity_2_idx_in_text_with_entity_marker": [35, 42], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d24.s0_BioInfer.d24.s0.p0", "text": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).", "text_with_entity_marker": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of [E1]actin-binding protein[/E1], talin, and [E2]pp60src[/E2] in response to A23187 (1 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding protein", "entity_1_idx": [[88, 109]], "entity_1_idx_in_text_with_entity_marker": [92, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pp60src", "entity_2_idx": [[122, 129]], "entity_2_idx_in_text_with_entity_marker": [135, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d24.s0_BioInfer.d24.s0.p1", "text": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).", "text_with_entity_marker": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, [E1]talin[/E1], and [E2]pp60src[/E2] in response to A23187 (1 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pp60src", "entity_2_idx": [[122, 129]], "entity_2_idx_in_text_with_entity_marker": [135, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d24.s0_BioInfer.d24.s0.p2", "text": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).", "text_with_entity_marker": "Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of [E1]actin-binding protein[/E1], [E2]talin[/E2], and pp60src in response to A23187 (1 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding protein", "entity_1_idx": [[88, 109]], "entity_1_idx_in_text_with_entity_marker": [92, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p0", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2], display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[40, 52]], "entity_2_idx_in_text_with_entity_marker": [53, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p1", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both alpha-catenin and [E1]beta-catenin[/E1], display unusual expression of [E2]N-cadherin[/E2], and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[40, 52]], "entity_1_idx_in_text_with_entity_marker": [44, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[84, 94]], "entity_2_idx_in_text_with_entity_marker": [97, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d693.s0_BioInfer.d693.s0.p2", "text": "These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.", "text_with_entity_marker": "These cells have both [E1]alpha-catenin[/E1] and beta-catenin, display unusual expression of [E2]N-cadherin[/E2], and have the typical fibroblastic phenotype of transformed cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[22, 35]], "entity_1_idx_in_text_with_entity_marker": [26, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[84, 94]], "entity_2_idx_in_text_with_entity_marker": [97, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p0", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), vimentin (2.5-fold to sevenfold), [E2]tropomyosin[/E2] (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p1", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), [E2]vimentin[/E2] (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p2", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including [E1]actin[/E1] (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[107, 112]], "entity_1_idx_in_text_with_entity_marker": [111, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p3", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), [E1]vimentin[/E1] (2.5-fold to sevenfold), [E2]tropomyosin[/E2] (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p4", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), [E1]tropomyosin[/E1] (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[171, 182]], "entity_1_idx_in_text_with_entity_marker": [175, 186], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d270.s0_BioInfer.d270.s0.p5", "text": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).", "text_with_entity_marker": "However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), [E1]vimentin[/E1] (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and [E2]myosin heavy chain[/E2], far exceeding overall increases in cellular protein content (20-40%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[211, 229]], "entity_2_idx_in_text_with_entity_marker": [224, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p60", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p61", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p62", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p63", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p64", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), [E2]haemagglutinin neuraminidase[/E2] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin neuraminidase", "entity_2_idx": [[183, 211], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [196, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p65", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p66", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p67", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p68", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E2]N[/E2]; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[240, 241]], "entity_2_idx_in_text_with_entity_marker": [253, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p69", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d8.s0_BioInfer.d8.s0.p0", "text": "Accordingly, beta-catenin is also found in these structures, again in the absence of alpha-catenin.", "text_with_entity_marker": "Accordingly, [E1]beta-catenin[/E1] is also found in these structures, again in the absence of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[13, 25]], "entity_1_idx_in_text_with_entity_marker": [17, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p50", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p51", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] ([E2]H[/E2]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[53, 54]], "entity_2_idx_in_text_with_entity_marker": [66, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p52", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p53", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p54", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p55", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p56", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p57", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p58", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p59", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p0", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], alpha actinin, [E2]actin[/E2] and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p1", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], [E2]alpha actinin[/E2], actin and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha actinin", "entity_2_idx": [[75, 88]], "entity_2_idx_in_text_with_entity_marker": [88, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p2", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, [E1]myosin heavy chain[/E1], alpha actinin, actin and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[55, 73]], "entity_1_idx_in_text_with_entity_marker": [59, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p3", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, [E1]alpha actinin[/E1], [E2]actin[/E2] and troponin T suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha actinin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p4", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, [E1]actin[/E1] and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d182.s0_BioInfer.d182.s0.p5", "text": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.", "text_with_entity_marker": "During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, [E1]alpha actinin[/E1], actin and [E2]troponin T[/E2] suffered degradation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha actinin", "entity_1_idx": [[75, 88]], "entity_1_idx_in_text_with_entity_marker": [79, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin T", "entity_2_idx": [[100, 110]], "entity_2_idx_in_text_with_entity_marker": [113, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d670.s0_BioInfer.d670.s0.p0", "text": "The products of the yeast mismatch repair genes MSH2 and MSH3 participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.", "text_with_entity_marker": "The products of the yeast mismatch repair genes [E1]MSH2[/E1] and [E2]MSH3[/E2] participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p20", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p21", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p22", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E1]FAP[/E1], but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FAP", "entity_1_idx": [[296, 299]], "entity_1_idx_in_text_with_entity_marker": [300, 303], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p23", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for [E1]FADD[/E1] and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[287, 291]], "entity_1_idx_in_text_with_entity_marker": [291, 295], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p24", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p25", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p26", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p27", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p28", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, [E1]RIP[/E1], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p29", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, [E1]RIP[/E1], and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p0", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E1]actin[/E1] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble [E2]talin[/E2]-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[504, 509]], "entity_1_idx_in_text_with_entity_marker": [508, 513], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[594, 599]], "entity_2_idx_in_text_with_entity_marker": [607, 612], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p1", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E1]actin[/E1] stress fibers on fibronectin, whereas [E2]vinculin[/E2] (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[504, 509]], "entity_1_idx_in_text_with_entity_marker": [508, 513], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[548, 556]], "entity_2_idx_in_text_with_entity_marker": [561, 569], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p2", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble [E1]vinculin[/E1] or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[453, 461]], "entity_1_idx_in_text_with_entity_marker": [457, 465], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p3", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E1]actin[/E1] stress fibers on [E2]fibronectin[/E2], whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[504, 509]], "entity_1_idx_in_text_with_entity_marker": [508, 513], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fibronectin", "entity_2_idx": [[527, 538]], "entity_2_idx_in_text_with_entity_marker": [540, 551], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p4", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or [E1]laminin[/E1] and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[67, 74]], "entity_1_idx_in_text_with_entity_marker": [71, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p5", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not [E1]fibronectin[/E1] (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[202, 213]], "entity_1_idx_in_text_with_entity_marker": [206, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p6", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on [E1]gelatin[/E1] or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gelatin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p7", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p8", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p9", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E1]paxillin[/E1]-containing focal adhesions or [E2]actin[/E2] stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "paxillin", "entity_1_idx": [[465, 473]], "entity_1_idx_in_text_with_entity_marker": [469, 477], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[504, 509]], "entity_2_idx_in_text_with_entity_marker": [517, 522], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p10", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not [E1]E-cadherin[/E1], p120(cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[22, 32]], "entity_1_idx_in_text_with_entity_marker": [26, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p11", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, [E2]p120[/E2](cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p12", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1]([E2]cas[/E2]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p13", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1](cas) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p14", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, [E1]p120[/E1](cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p120", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p15", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120([E2]cas[/E2]) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cas", "entity_2_idx": [[39, 42]], "entity_2_idx_in_text_with_entity_marker": [52, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p16", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p17", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "[E1]beta-catenin[/E1], but not E-cadherin, p120(cas) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p18", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120([E1]cas[/E1]) or alpha-catenin, becomes stabilized when [E2]proteasome[/E2]-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cas", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "proteasome", "entity_2_idx": [[86, 96]], "entity_2_idx_in_text_with_entity_marker": [99, 109], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d253.s1_BioInfer.d253.s1.p19", "text": "beta-catenin, but not E-cadherin, p120(cas) or alpha-catenin, becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "text_with_entity_marker": "beta-catenin, but not E-cadherin, p120([E1]cas[/E1]) or [E2]alpha-catenin[/E2], becomes stabilized when proteasome-mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cas", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d336.s0_BioInfer.d336.s0.p0", "text": "In growth cones, myosin heavy chain B was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, actin-rich peripheral region.", "text_with_entity_marker": "In growth cones, [E1]myosin heavy chain B[/E1] was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, [E2]actin[/E2]-rich peripheral region.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain B", "entity_1_idx": [[17, 37]], "entity_1_idx_in_text_with_entity_marker": [21, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[143, 148]], "entity_2_idx_in_text_with_entity_marker": [156, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p40", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p41", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p42", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p43", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p44", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein ([E2]P[/E2]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[200, 201]], "entity_2_idx_in_text_with_entity_marker": [213, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p45", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p46", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p47", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p48", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p49", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p0", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1-E2]myosin[/E1] heavy chain[/E2] and light chains, but not actin, in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[71, 77], [94, 106]], "entity_1_idx_in_text_with_entity_marker": [78, 84], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin[/E1] heavy chain", "entity_2_idx": [[71, 89]], "entity_2_idx_in_text_with_entity_marker": [78, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p1", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1]myosin[/E1] heavy chain and light chains, but not [E2]actin[/E2], in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[71, 77], [94, 106]], "entity_1_idx_in_text_with_entity_marker": [75, 81], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s0_BioInfer.d687.s0.p2", "text": "The results indicate increased fractional synthesis and degradation of myosin heavy chain and light chains, but not actin, in the left compared to the right ventricular free wall.", "text_with_entity_marker": "The results indicate increased fractional synthesis and degradation of [E1]myosin heavy chain[/E1] and light chains, but not [E2]actin[/E2], in the left compared to the right ventricular free wall.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[71, 89]], "entity_1_idx_in_text_with_entity_marker": [75, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[116, 121]], "entity_2_idx_in_text_with_entity_marker": [129, 134], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p0", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, [E1]myosin light chain[/E1], phosphorylatable myosin light chain, and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[264, 282]], "entity_1_idx_in_text_with_entity_marker": [268, 286], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p1", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], [E2]myosin light chain[/E2], phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain", "entity_2_idx": [[264, 282]], "entity_2_idx_in_text_with_entity_marker": [277, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p2", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, [E1]myosin light chain[/E1], [E2]phosphorylatable myosin light chain[/E2], and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[264, 282]], "entity_1_idx_in_text_with_entity_marker": [268, 286], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[284, 319]], "entity_2_idx_in_text_with_entity_marker": [297, 332], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p3", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], myosin light chain, phosphorylatable myosin light chain, and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p4", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, [E1]phosphorylatable myosin light chain[/E1], and [E2]actin[/E2] in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphorylatable myosin light chain", "entity_1_idx": [[284, 319]], "entity_1_idx_in_text_with_entity_marker": [288, 323], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[325, 330]], "entity_2_idx_in_text_with_entity_marker": [338, 343], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d687.s1_BioInfer.d687.s1.p5", "text": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, myosin heavy chain, myosin light chain, phosphorylatable myosin light chain, and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "text_with_entity_marker": "To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, [E1]myosin heavy chain[/E1], myosin light chain, [E2]phosphorylatable myosin light chain[/E2], and actin in the right and left ventricular free walls of growing, New Zealand White rabbits.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[244, 262]], "entity_1_idx_in_text_with_entity_marker": [248, 266], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[284, 319]], "entity_2_idx_in_text_with_entity_marker": [297, 332], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d194.s0_BioInfer.d194.s0.p0", "text": "Even though rates of total protein and actin synthesis resembled values measured in vivo, myosin heavy chain fractional rate of synthesis was only 22% of in vivo levels.", "text_with_entity_marker": "Even though rates of total protein and [E1]actin[/E1] synthesis resembled values measured in vivo, [E2]myosin heavy chain[/E2] fractional rate of synthesis was only 22% of in vivo levels.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[90, 108]], "entity_2_idx_in_text_with_entity_marker": [103, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p20", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p21", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p22", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p23", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p24", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p25", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p26", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p27", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p28", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E1]M[/E1]: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[273, 274]], "entity_1_idx_in_text_with_entity_marker": [277, 278], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p29", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p0", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p1", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], UL29, [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p2", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, UL29, [E2]UL30[/E2], UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL30", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p3", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p4", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p5", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, [E1]UL30[/E1], [E2]UL42[/E2], and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL30", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p6", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, [E1]UL8[/E1], [E2]UL29[/E2], UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL29", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p7", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 [E1]UL5[/E1], UL8, [E2]UL29[/E2], UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL29", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p8", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], UL30, UL42, and UL52 gene products along with the AAV [E2]Rep68[/E2] protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rep68", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p9", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, [E1]UL29[/E1], UL30, UL42, and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL29", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p0", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, [E1]myosin light chain 2[/E1], actin, [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 2", "entity_1_idx": [[36, 56]], "entity_1_idx_in_text_with_entity_marker": [40, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p1", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, myosin light chain 2, [E1]actin[/E1], [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p2", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], myosin light chain 2, actin, [E2]troponin-I[/E2] in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "troponin-I", "entity_2_idx": [[65, 75]], "entity_2_idx_in_text_with_entity_marker": [78, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p3", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of myosin heavy chain, [E1]myosin light chain 2[/E1], [E2]actin[/E2], troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 2", "entity_1_idx": [[36, 56]], "entity_1_idx_in_text_with_entity_marker": [40, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p4", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], [E2]myosin light chain 2[/E2], actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain 2", "entity_2_idx": [[36, 56]], "entity_2_idx_in_text_with_entity_marker": [49, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d598.s0_BioInfer.d598.s0.p5", "text": "The contents of myosin heavy chain, myosin light chain 2, actin, troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "text_with_entity_marker": "The contents of [E1]myosin heavy chain[/E1], myosin light chain 2, [E2]actin[/E2], troponin-I in 125-week-old rats decreased compared with those of 12-week-old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[16, 34]], "entity_1_idx_in_text_with_entity_marker": [20, 38], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p0", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ([E1]XRCC1[/E1], XRCC3, [E2]XRCC5[/E2], RAD51, RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC1", "entity_1_idx": [[232, 237]], "entity_1_idx_in_text_with_entity_marker": [236, 241], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XRCC5", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p1", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, [E1]XRCC5[/E1], RAD51, [E2]RAD52[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC5", "entity_1_idx": [[246, 251]], "entity_1_idx_in_text_with_entity_marker": [250, 255], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p2", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, [E1]XRCC3[/E1], [E2]XRCC5[/E2], RAD51, RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC3", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XRCC5", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p3", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, [E1]XRCC5[/E1], [E2]RAD51[/E2], RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC5", "entity_1_idx": [[246, 251]], "entity_1_idx_in_text_with_entity_marker": [250, 255], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[253, 258]], "entity_2_idx_in_text_with_entity_marker": [266, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p4", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ([E1]XRCC1[/E1], XRCC3, XRCC5, RAD51, [E2]RAD52[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC1", "entity_1_idx": [[232, 237]], "entity_1_idx_in_text_with_entity_marker": [236, 241], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p5", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ([E1]XRCC1[/E1], [E2]XRCC3[/E2], XRCC5, RAD51, RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC1", "entity_1_idx": [[232, 237]], "entity_1_idx_in_text_with_entity_marker": [236, 241], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "XRCC3", "entity_2_idx": [[239, 244]], "entity_2_idx_in_text_with_entity_marker": [252, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p6", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ([E1]XRCC1[/E1], XRCC3, XRCC5, [E2]RAD51[/E2], RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC1", "entity_1_idx": [[232, 237]], "entity_1_idx_in_text_with_entity_marker": [236, 241], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[253, 258]], "entity_2_idx_in_text_with_entity_marker": [266, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p7", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, [E1]XRCC3[/E1], XRCC5, RAD51, [E2]RAD52[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC3", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p8", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, [E1]RAD51[/E1], [E2]RAD52[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[253, 258]], "entity_1_idx_in_text_with_entity_marker": [257, 262], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[260, 265]], "entity_2_idx_in_text_with_entity_marker": [273, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d678.s0_BioInfer.d678.s0.p9", "text": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).", "text_with_entity_marker": "The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, [E1]XRCC3[/E1], XRCC5, [E2]RAD51[/E2], RAD52).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "XRCC3", "entity_1_idx": [[239, 244]], "entity_1_idx_in_text_with_entity_marker": [243, 248], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[253, 258]], "entity_2_idx_in_text_with_entity_marker": [266, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p0", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p1", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E1]pan-desmocollin[/E1] and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pan-desmocollin", "entity_1_idx": [[194, 209]], "entity_1_idx_in_text_with_entity_marker": [198, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p2", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p3", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p4", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E1]alpha-catenin[/E1], or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[171, 184]], "entity_1_idx_in_text_with_entity_marker": [175, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p5", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and [E2]pan-desmoglein[/E2] antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmoglein", "entity_2_idx": [[214, 228]], "entity_2_idx_in_text_with_entity_marker": [227, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p6", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p7", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p8", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p9", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to [E1]P-cadherin[/E1], [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[159, 169]], "entity_1_idx_in_text_with_entity_marker": [163, 173], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p0", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein ([E1]P[/E1]) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E2]RNA polymerase[/E2] gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[97, 98]], "entity_1_idx_in_text_with_entity_marker": [101, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RNA polymerase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p1", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E1]RNA polymerase[/E1] gave rise to [E2]CAT[/E2] activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RNA polymerase", "entity_1_idx": [[226, 240]], "entity_1_idx_in_text_with_entity_marker": [230, 244], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CAT", "entity_2_idx": [[254, 257]], "entity_2_idx_in_text_with_entity_marker": [267, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p2", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein ([E1]N[/E1]), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E2]RNA polymerase[/E2] gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RNA polymerase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p3", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), [E1]phosphoprotein[/E1] (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E2]RNA polymerase[/E2] gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[81, 95]], "entity_1_idx_in_text_with_entity_marker": [85, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RNA polymerase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p4", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and [E1]L[/E1] protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E2]RNA polymerase[/E2] gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[104, 105]], "entity_1_idx_in_text_with_entity_marker": [108, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RNA polymerase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p5", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, [E1]nucleocapsid protein[/E1] (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 [E2]RNA polymerase[/E2] gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[55, 75]], "entity_1_idx_in_text_with_entity_marker": [59, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RNA polymerase", "entity_2_idx": [[226, 240]], "entity_2_idx_in_text_with_entity_marker": [239, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p6", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein ([E1]P[/E1]) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to [E2]CAT[/E2] activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[97, 98]], "entity_1_idx_in_text_with_entity_marker": [101, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CAT", "entity_2_idx": [[254, 257]], "entity_2_idx_in_text_with_entity_marker": [267, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p7", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein ([E1]N[/E1]), phosphoprotein ([E2]P[/E2]) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[77, 78]], "entity_1_idx_in_text_with_entity_marker": [81, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[97, 98]], "entity_2_idx_in_text_with_entity_marker": [110, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p8", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), [E1]phosphoprotein[/E1] ([E2]P[/E2]) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[81, 95]], "entity_1_idx_in_text_with_entity_marker": [85, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[97, 98]], "entity_2_idx_in_text_with_entity_marker": [110, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p9", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein ([E1]P[/E1]) and [E2]L[/E2] protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[97, 98]], "entity_1_idx_in_text_with_entity_marker": [101, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[104, 105]], "entity_2_idx_in_text_with_entity_marker": [117, 118], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d697.s0_BioInfer.d697.s0.p0", "text": "These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of RAD51 and RAD52.", "text_with_entity_marker": "These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of [E1]RAD51[/E1] and [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p0", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin ([E1]alpha-SMA[/E1]), [E2]myosin heavy chain[/E2], and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-SMA", "entity_1_idx": [[163, 172]], "entity_1_idx_in_text_with_entity_marker": [167, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p1", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin ([E1]alpha-SMA[/E1]), myosin heavy chain, and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-SMA", "entity_1_idx": [[163, 172]], "entity_1_idx_in_text_with_entity_marker": [167, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p2", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] ([E2]alpha-SMA[/E2]), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-SMA", "entity_2_idx": [[163, 172]], "entity_2_idx_in_text_with_entity_marker": [176, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p3", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), [E1]myosin heavy chain[/E1], and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p4", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] (alpha-SMA), [E2]myosin heavy chain[/E2], and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p5", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] (alpha-SMA), myosin heavy chain, and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p10", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), [E2]V protein[/E2], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V protein", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p11", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p12", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p13", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p14", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p15", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p16", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), [E2]phosphoprotein[/E2] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[71, 85]], "entity_2_idx_in_text_with_entity_marker": [84, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p17", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p18", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p19", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p60", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p61", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E1]HN[/E1]) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[204, 206]], "entity_1_idx_in_text_with_entity_marker": [208, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p62", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p63", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p64", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E1]haemagglutinin-neuraminidase[/E1] (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin-neuraminidase", "entity_1_idx": [[174, 202], [208, 215]], "entity_1_idx_in_text_with_entity_marker": [178, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p65", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p66", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E1]SH[/E1]) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SH", "entity_1_idx": [[161, 163]], "entity_1_idx_in_text_with_entity_marker": [165, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p67", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E1]F[/E1]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[138, 139]], "entity_1_idx_in_text_with_entity_marker": [142, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p68", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E1]large[/E1] ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[220, 225], [230, 237]], "entity_1_idx_in_text_with_entity_marker": [224, 229], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p69", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p0", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which [E1]actin[/E1]-based motility occurred by a mechanism independent of the PRRs, VASP, and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p1", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which [E1]actin[/E1]-based motility occurred by a mechanism independent of the PRRs, [E2]VASP[/E2], and profilin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "VASP", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s0_BioInfer.d638.s0.p2", "text": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.", "text_with_entity_marker": "The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, [E1]VASP[/E1], and [E2]profilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VASP", "entity_1_idx": [[166, 170]], "entity_1_idx_in_text_with_entity_marker": [170, 174], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d275.s0_BioInfer.d275.s0.p0", "text": "However, smooth muscle contents of actin (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and myosin heavy chain (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.", "text_with_entity_marker": "However, smooth muscle contents of [E1]actin[/E1] (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and [E2]myosin heavy chain[/E2] (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[98, 116]], "entity_2_idx_in_text_with_entity_marker": [111, 129], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p50", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p51", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p52", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, smooth muscle myosin heavy chain, [E2]collagen type IV[/E2], laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "collagen type IV", "entity_2_idx": [[201, 217]], "entity_2_idx_in_text_with_entity_marker": [214, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p53", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p54", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E1]collagen type IV[/E1], [E2]laminin[/E2] and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "collagen type IV", "entity_1_idx": [[201, 217]], "entity_1_idx_in_text_with_entity_marker": [205, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p0", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, [E1]tropomyosin[/E1], actin, heat shock protein (HSP)-60, an unidentified protein and [E2]myosin heavy chain[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[47, 58]], "entity_1_idx_in_text_with_entity_marker": [51, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p1", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as [E1]myosin light chain 1[/E1], [E2]tropomyosin[/E2], actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 1", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[47, 58]], "entity_2_idx_in_text_with_entity_marker": [60, 71], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p2", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, [E1]tropomyosin[/E1], [E2]actin[/E2], heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[47, 58]], "entity_1_idx_in_text_with_entity_marker": [51, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p3", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, [E1]tropomyosin[/E1], actin, [E2]heat shock protein[/E2] (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[47, 58]], "entity_1_idx_in_text_with_entity_marker": [51, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock protein", "entity_2_idx": [[67, 85], [91, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p4", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, [E1]tropomyosin[/E1], actin, heat shock protein ([E2]HSP[/E2])-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[47, 58]], "entity_1_idx_in_text_with_entity_marker": [51, 62], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p5", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as [E1]myosin light chain 1[/E1], tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and [E2]myosin heavy chain[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 1", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p6", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, [E1]actin[/E1], heat shock protein (HSP)-60, an unidentified protein and [E2]myosin heavy chain[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p7", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, actin, [E1]heat shock protein[/E1] (HSP)-60, an unidentified protein and [E2]myosin heavy chain[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "heat shock protein", "entity_1_idx": [[67, 85], [91, 94]], "entity_1_idx_in_text_with_entity_marker": [71, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p8", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein ([E1]HSP[/E1])-60, an unidentified protein and [E2]myosin heavy chain[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HSP", "entity_1_idx": [[87, 90]], "entity_1_idx_in_text_with_entity_marker": [91, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[124, 142]], "entity_2_idx_in_text_with_entity_marker": [137, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p9", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as [E1]myosin light chain 1[/E1], tropomyosin, [E2]actin[/E2], heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 1", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p10", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as [E1]myosin light chain 1[/E1], tropomyosin, actin, [E2]heat shock protein[/E2] (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 1", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock protein", "entity_2_idx": [[67, 85], [91, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p11", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as [E1]myosin light chain 1[/E1], tropomyosin, actin, heat shock protein ([E2]HSP[/E2])-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 1", "entity_1_idx": [[25, 45]], "entity_1_idx_in_text_with_entity_marker": [29, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p12", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, [E1]actin[/E1], [E2]heat shock protein[/E2] (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "heat shock protein", "entity_2_idx": [[67, 85], [91, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p13", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, [E1]actin[/E1], heat shock protein ([E2]HSP[/E2])-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d719.s0_BioInfer.d719.s0.p14", "text": "These were identified as myosin light chain 1, tropomyosin, actin, heat shock protein (HSP)-60, an unidentified protein and myosin heavy chain, respectively.", "text_with_entity_marker": "These were identified as myosin light chain 1, tropomyosin, actin, [E1]heat shock protein[/E1] ([E2]HSP[/E2])-60, an unidentified protein and myosin heavy chain, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "heat shock protein", "entity_1_idx": [[67, 85], [91, 94]], "entity_1_idx_in_text_with_entity_marker": [71, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d163.s0_BioInfer.d163.s0.p0", "text": "Data presented here suggest that two of the repressed genes encode the proteins actin and myosin heavy chain.", "text_with_entity_marker": "Data presented here suggest that two of the repressed genes encode the proteins [E1]actin[/E1] and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[90, 108]], "entity_2_idx_in_text_with_entity_marker": [103, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d163.s1_BioInfer.d163.s1.p0", "text": "Selective repression of actin and myosin heavy chain expression during the programmed death of insect skeletal muscle.", "text_with_entity_marker": "Selective repression of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] expression during the programmed death of insect skeletal muscle.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[34, 52]], "entity_2_idx_in_text_with_entity_marker": [47, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d163.s2_BioInfer.d163.s2.p0", "text": "The reduction in actin and myosin heavy chain synthesis presumably plays a role in the rapid dissolution of the muscles.", "text_with_entity_marker": "The reduction in [E1]actin[/E1] and [E2]myosin heavy chain[/E2] synthesis presumably plays a role in the rapid dissolution of the muscles.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[27, 45]], "entity_2_idx_in_text_with_entity_marker": [40, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s0_HPRD50.d29.s0.p0", "text": "Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription", "text_with_entity_marker": "Modification of de novo DNA methyltransferase 3a ([E1]Dnmt3a[/E1]) by [E2]SUMO-1[/E2] modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[50, 56]], "entity_1_idx_in_text_with_entity_marker": [54, 60], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "SUMO-1", "entity_2_idx": [[61, 67]], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p0", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that [E1]Dnmt3a[/E1] interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme [E2]Ubc9[/E2] and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "Ubc9", "entity_2_idx": [[128, 132]], "entity_2_idx_in_text_with_entity_marker": [141, 145], "entity_2_type": "pm0110323", "entity_2_type_id": 105}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p1", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that [E1]Dnmt3a[/E1] interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases [E2]PIAS1[/E2] and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "PIAS1", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "pm0117395", "entity_2_type_id": 106}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p2", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that [E1]Dnmt3a[/E1] interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and [E2]PIASxalpha[/E2], all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "PIASxalpha", "entity_2_idx": [[167, 177]], "entity_2_idx_in_text_with_entity_marker": [180, 190], "entity_2_type": "pm0119764", "entity_2_type_id": 107}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p6", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme [E1]Ubc9[/E1] and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, [E2]SUMO-1[/E2], to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ubc9", "entity_1_idx": [[128, 132]], "entity_1_idx_in_text_with_entity_marker": [132, 136], "entity_1_type": "pm0110323", "entity_1_type_id": 105, "entity_2": "SUMO-1", "entity_2_idx": [[267, 273]], "entity_2_idx_in_text_with_entity_marker": [280, 286], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p8", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases [E1]PIAS1[/E1] and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, [E2]SUMO-1[/E2], to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PIAS1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "pm0117395", "entity_1_type_id": 106, "entity_2": "SUMO-1", "entity_2_idx": [[267, 273]], "entity_2_idx_in_text_with_entity_marker": [280, 286], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s1_HPRD50.d29.s1.p9", "text": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and PIASxalpha, all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, SUMO-1, to its target proteins", "text_with_entity_marker": "Here we show that Dnmt3a interacts with multiple components of the sumoylation machinery, namely the E2 sumo conjugating enzyme Ubc9 and the E3 sumo ligases PIAS1 and [E1]PIASxalpha[/E1], all of which are involved in conjugating the small ubiquitin-like modifier polypeptide, [E2]SUMO-1[/E2], to its target proteins", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PIASxalpha", "entity_1_idx": [[167, 177]], "entity_1_idx_in_text_with_entity_marker": [171, 181], "entity_1_type": "pm0119764", "entity_1_type_id": 107, "entity_2": "SUMO-1", "entity_2_idx": [[267, 273]], "entity_2_idx_in_text_with_entity_marker": [280, 286], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s2_HPRD50.d29.s2.p0", "text": "Dnmt3a is modified by SUMO-1 in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N-terminal regulatory domain", "text_with_entity_marker": "[E1]Dnmt3a[/E1] is modified by [E2]SUMO-1[/E2] in vivo and in vitro and the region of Dnmt3a responsible for interaction maps to the N-terminal regulatory domain", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "SUMO-1", "entity_2_idx": [[22, 28]], "entity_2_idx_in_text_with_entity_marker": [35, 41], "entity_2_type": "pm0108344", "entity_2_type_id": 104}], "directed": false, "reverse": false}
{"id": "HPRD50.d29.s3_HPRD50.d29.s3.p0", "text": "Functionally, sumoylation of Dnmt3a disrupts its ability to interact with histone deacetylases (HDAC1/2), but not with another interaction partner, Dnmt3b", "text_with_entity_marker": "Functionally, sumoylation of [E1]Dnmt3a[/E1] disrupts its ability to interact with histone deacetylases ([E2]HDAC1[/E2]/2), but not with another interaction partner, Dnmt3b", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dnmt3a", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "pm0106301", "entity_1_type_id": 103, "entity_2": "HDAC1", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "pm0119729", "entity_2_type_id": 108}], "directed": false, "reverse": false}
{"id": "HPRD50.d12.s0_HPRD50.d12.s0.p0", "text": "AP180 binds to the C-terminal SH2 domain of phospholipase C-gamma1 and inhibits its enzymatic activity", "text_with_entity_marker": "[E1]AP180[/E1] binds to the C-terminal SH2 domain of [E2]phospholipase C-gamma1[/E2] and inhibits its enzymatic activity", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AP180", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0106306", "entity_1_type_id": 41, "entity_2": "phospholipase C-gamma1", "entity_2_idx": [[44, 66]], "entity_2_idx_in_text_with_entity_marker": [57, 79], "entity_2_type": "pm0126499", "entity_2_type_id": 42}], "directed": false, "reverse": false}
{"id": "HPRD50.d12.s1_HPRD50.d12.s1.p0", "text": "In this report, we demonstrate the stable association of PLCgamma1 with AP180 in a clathrin-coated vesicle complex, which not only binds to the carboxyl-terminal SH2 domain of PLCgamma1, but also inhibits its enzymatic activity in a dose-dependent manner", "text_with_entity_marker": "In this report, we demonstrate the stable association of [E1]PLCgamma1[/E1] with [E2]AP180[/E2] in a clathrin-coated vesicle complex, which not only binds to the carboxyl-terminal SH2 domain of PLCgamma1, but also inhibits its enzymatic activity in a dose-dependent manner", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLCgamma1", "entity_1_idx": [[57, 66]], "entity_1_idx_in_text_with_entity_marker": [61, 70], "entity_1_type": "pm0126499", "entity_1_type_id": 42, "entity_2": "AP180", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "pm0106306", "entity_2_type_id": 41}], "directed": false, "reverse": false}
{"id": "HPRD50.d12.s1_HPRD50.d12.s1.p2", "text": "In this report, we demonstrate the stable association of PLCgamma1 with AP180 in a clathrin-coated vesicle complex, which not only binds to the carboxyl-terminal SH2 domain of PLCgamma1, but also inhibits its enzymatic activity in a dose-dependent manner", "text_with_entity_marker": "In this report, we demonstrate the stable association of PLCgamma1 with [E1]AP180[/E1] in a clathrin-coated vesicle complex, which not only binds to the carboxyl-terminal SH2 domain of [E2]PLCgamma1[/E2], but also inhibits its enzymatic activity in a dose-dependent manner", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AP180", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "pm0106306", "entity_1_type_id": 41, "entity_2": "PLCgamma1", "entity_2_idx": [[176, 185]], "entity_2_idx_in_text_with_entity_marker": [189, 198], "entity_2_type": "pm0126499", "entity_2_type_id": 42}], "directed": false, "reverse": false}
{"id": "HPRD50.d37.s0_HPRD50.d37.s0.p1", "text": "TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of TFIID", "text_with_entity_marker": "[E1]TFIID[/E1] dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to [E2]TAF(II)250[/E2], the core subunit of TFIID", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TFIID", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0109127", "entity_1_type_id": 137, "entity_2": "TAF(II)250", "entity_2_idx": [[142, 152]], "entity_2_idx_in_text_with_entity_marker": [155, 165], "entity_2_type": "pm0108292", "entity_2_type_id": 138}], "directed": false, "reverse": false}
{"id": "HPRD50.d37.s0_HPRD50.d37.s0.p5", "text": "TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to TAF(II)250, the core subunit of TFIID", "text_with_entity_marker": "TFIID dimers formed through self-association of the TATA-binding polypeptide (TBP) subunit and could be immunoprecipitated with antibodies to [E1]TAF(II)250[/E1], the core subunit of [E2]TFIID[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAF(II)250", "entity_1_idx": [[142, 152]], "entity_1_idx_in_text_with_entity_marker": [146, 156], "entity_1_type": "pm0108292", "entity_1_type_id": 138, "entity_2": "TFIID", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "pm0109127", "entity_2_type_id": 137}], "directed": false, "reverse": false}
{"id": "HPRD50.d17.s0_HPRD50.d17.s0.p0", "text": "DGKdelta (type II isozyme) contains a pleckstrin homology domain at the N terminus and a sterile alpha motif domain at the C terminus", "text_with_entity_marker": "[E1]DGKdelta[/E1] (type II isozyme) contains a [E2]pleckstrin[/E2] homology domain at the N terminus and a sterile alpha motif domain at the C terminus", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DGKdelta", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "pm0126604", "entity_1_type_id": 56, "entity_2": "pleckstrin", "entity_2_idx": [[38, 48]], "entity_2_idx_in_text_with_entity_marker": [51, 61], "entity_2_type": "pm0125262", "entity_2_type_id": 57}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s1_HPRD50.d25.s1.p0", "text": "BACKGROUND: Both androgen receptor (AR) and orphan receptor TR2 (TR2) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "text_with_entity_marker": "BACKGROUND: Both [E1]androgen receptor[/E1] (AR) and orphan receptor [E2]TR2[/E2] (TR2) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "androgen receptor", "entity_1_idx": [[17, 34]], "entity_1_idx_in_text_with_entity_marker": [21, 38], "entity_1_type": "pm0125088", "entity_1_type_id": 91, "entity_2": "TR2", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_2_type_id": 90}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s1_HPRD50.d25.s1.p1", "text": "BACKGROUND: Both androgen receptor (AR) and orphan receptor TR2 (TR2) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "text_with_entity_marker": "BACKGROUND: Both [E1]androgen receptor[/E1] (AR) and orphan receptor TR2 ([E2]TR2[/E2]) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "androgen receptor", "entity_1_idx": [[17, 34]], "entity_1_idx_in_text_with_entity_marker": [21, 38], "entity_1_type": "pm0125088", "entity_1_type_id": 91, "entity_2": "TR2", "entity_2_idx": [[65, 68]], "entity_2_idx_in_text_with_entity_marker": [78, 81], "entity_2_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_2_type_id": 90}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s1_HPRD50.d25.s1.p2", "text": "BACKGROUND: Both androgen receptor (AR) and orphan receptor TR2 (TR2) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "text_with_entity_marker": "BACKGROUND: Both androgen receptor (AR) and orphan receptor [E1]TR2[/E1] ([E2]TR2[/E2]) belong to the steroid nuclear receptor superfamily and are expressed in prostate cancer tissue and cell lines", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR2", "entity_1_idx": [[60, 63]], "entity_1_idx_in_text_with_entity_marker": [64, 67], "entity_1_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_1_type_id": 90, "entity_2": "TR2", "entity_2_idx": [[65, 68]], "entity_2_idx_in_text_with_entity_marker": [78, 81], "entity_2_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_2_type_id": 90}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s2_HPRD50.d25.s2.p0", "text": "The interaction between AR and TR2 was assessed by glutathione-S-transferase (GST) pull-down assay and mammalian two-hybrid system assay", "text_with_entity_marker": "The interaction between AR and [E1]TR2[/E1] was assessed by [E2]glutathione-S-transferase[/E2] (GST) pull-down assay and mammalian two-hybrid system assay", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR2", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_1_type_id": 90, "entity_2": "glutathione-S-transferase", "entity_2_idx": [[51, 76]], "entity_2_idx_in_text_with_entity_marker": [64, 89], "entity_2_type": "pm0116848", "entity_2_type_id": 31}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s2_HPRD50.d25.s2.p1", "text": "The interaction between AR and TR2 was assessed by glutathione-S-transferase (GST) pull-down assay and mammalian two-hybrid system assay", "text_with_entity_marker": "The interaction between AR and [E1]TR2[/E1] was assessed by glutathione-S-transferase ([E2]GST[/E2]) pull-down assay and mammalian two-hybrid system assay", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TR2", "entity_1_idx": [[31, 34]], "entity_1_idx_in_text_with_entity_marker": [35, 38], "entity_1_type": "pm0104071||pm0107975||pm0108440||pm0116348||pm0122716", "entity_1_type_id": 90, "entity_2": "GST", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "pm0116848", "entity_2_type_id": 31}], "directed": false, "reverse": false}
{"id": "HPRD50.d25.s2_HPRD50.d25.s2.p2", "text": "The interaction between AR and TR2 was assessed by glutathione-S-transferase (GST) pull-down assay and mammalian two-hybrid system assay", "text_with_entity_marker": "The interaction between AR and TR2 was assessed by [E1]glutathione-S-transferase[/E1] ([E2]GST[/E2]) pull-down assay and mammalian two-hybrid system assay", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "glutathione-S-transferase", "entity_1_idx": [[51, 76]], "entity_1_idx_in_text_with_entity_marker": [55, 80], "entity_1_type": "pm0116848", "entity_1_type_id": 31, "entity_2": "GST", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "pm0116848", "entity_2_type_id": 31}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s346_IEPA.d145.s346.p0", "text": "Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex", "text_with_entity_marker": "Aggregated beta [E1]amyloid[/E1] peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic [E2]phospholipase C[/E2] in brain cortex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[16, 23]], "entity_1_idx_in_text_with_entity_marker": [20, 27], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[156, 171]], "entity_2_idx_in_text_with_entity_marker": [169, 184], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d145.s349_IEPA.d145.s349.p0", "text": "This additionally supports the inhibitory effect of A(beta) on membrane-bound and cytosolic PLC", "text_with_entity_marker": "This additionally supports the inhibitory effect of [E1]A(beta)[/E1] on membrane-bound and cytosolic [E2]PLC[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "A(beta)", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s431_IEPA.d180.s431.p0", "text": "A loop system exists between hypothalamic neuropeptide Y (NPY) and peripheral adipose tissue leptin to maintain normal body homeostasis", "text_with_entity_marker": "A loop system exists between hypothalamic [E1]neuropeptide Y[/E1] (NPY) and peripheral adipose tissue [E2]leptin[/E2] to maintain normal body homeostasis", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuropeptide Y", "entity_1_idx": [[42, 56]], "entity_1_idx_in_text_with_entity_marker": [46, 60], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s432_IEPA.d180.s432.p0", "text": "When infused i.c.v. to normal rats to mimic its central effects, leptin decreases NPY levels, thus food intake and body weight", "text_with_entity_marker": "When infused i.c.v. to normal rats to mimic its central effects, [E1]leptin[/E1] decreases [E2]NPY[/E2] levels, thus food intake and body weight", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[65, 71]], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s434_IEPA.d180.s434.p0", "text": "Leptin increases the expression of uncoupling proteins (UCP-1, -2, -3) and thus energy dissipation", "text_with_entity_marker": "[E1]Leptin[/E1] increases the expression of [E2]uncoupling proteins[/E2] (UCP-1, -2, -3) and thus energy dissipation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[35, 54]], "entity_2_idx_in_text_with_entity_marker": [48, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d35.s86_IEPA.d35.s86.p0", "text": "Oxytocin (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F", "text_with_entity_marker": "[E1]Oxytocin[/E1] (OT) and vasopressin (AVP) stimulate [E2]insulin[/E2] and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[46, 53]], "entity_2_idx_in_text_with_entity_marker": [59, 66], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d35.s86_IEPA.d35.s86.p1", "text": "Oxytocin (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke insulin secretion from the rat insulinoma cell line, RINm5F", "text_with_entity_marker": "[E1]Oxytocin[/E1] (OT) and vasopressin (AVP) stimulate insulin and glucagon release from the pancreas, and evoke [E2]insulin[/E2] secretion from the rat insulinoma cell line, RINm5F", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d179.s430_IEPA.d179.s430.p0", "text": "Recently several significant advances have been made in this area, including the identification of the appetite regulating hormone, leptin, and a detailed understanding of its targets in the central nervous system (CNS), such as neuropeptide Y (NPY) and the melanocortin-4 receptor", "text_with_entity_marker": "Recently several significant advances have been made in this area, including the identification of the appetite regulating hormone, [E1]leptin[/E1], and a detailed understanding of its targets in the central nervous system (CNS), such as [E2]neuropeptide Y[/E2] (NPY) and the melanocortin-4 receptor", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[132, 138]], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[229, 243]], "entity_2_idx_in_text_with_entity_marker": [242, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s231_IEPA.d96.s231.p1", "text": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment", "text_with_entity_marker": "Downregulation of [E1]uncoupling protein 2[/E1] mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of [E2]leptin[/E2] treatment", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "uncoupling protein 2", "entity_1_idx": [[18, 38]], "entity_1_idx_in_text_with_entity_marker": [22, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s231_IEPA.d96.s231.p2", "text": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment", "text_with_entity_marker": "Downregulation of uncoupling protein 2 mRNA in white adipose tissue and [E1]uncoupling protein 3[/E1] mRNA in skeletal muscle during the early stages of [E2]leptin[/E2] treatment", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "uncoupling protein 3", "entity_1_idx": [[72, 92]], "entity_1_idx_in_text_with_entity_marker": [76, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s232_IEPA.d96.s232.p0", "text": "Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%)", "text_with_entity_marker": "[E1]Leptin[/E1] by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in [E2]UCP-2[/E2] mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d96.s232_IEPA.d96.s232.p1", "text": "Leptin by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and UCP-3 mRNA in SM (33-37%)", "text_with_entity_marker": "[E1]Leptin[/E1] by intravenous or intracerebroventricular infusion for 5 h was associated with a decrease in UCP-2 mRNA in WAT (47-52%) and [E2]UCP-3[/E2] mRNA in SM (33-37%)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s75_IEPA.d33.s75.p0", "text": "On Day 28 of pregnancy, OT receptors became detectable, and then OT could induce the formation of IPs", "text_with_entity_marker": "On Day 28 of pregnancy, OT receptors became detectable, and then [E1]OT[/E1] could induce the formation of [E2]IPs[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[65, 67]], "entity_1_idx_in_text_with_entity_marker": [69, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IPs", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s76_IEPA.d33.s76.p0", "text": "Thereafter, the stimulatory effects of OT on IPs formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition", "text_with_entity_marker": "Thereafter, the stimulatory effects of [E1]OT[/E1] on [E2]IPs[/E2] formation and the OT receptor levels dramatically increased toward the end of pregnancy and reduced rapidly after parturition", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OT", "entity_1_idx": [[39, 41]], "entity_1_idx_in_text_with_entity_marker": [43, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IPs", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s79_IEPA.d33.s79.p0", "text": "CONCLUSIONS: These results suggest that the formation of IPs by OT, the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition", "text_with_entity_marker": "CONCLUSIONS: These results suggest that the formation of [E1]IPs[/E1] by [E2]OT[/E2], the OT receptor levels in the myometrium, and the production of PGF2 in the decidua might play crucial roles in parturition", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IPs", "entity_1_idx": [[57, 60]], "entity_1_idx_in_text_with_entity_marker": [61, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "OT", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s215_IEPA.d91.s215.p0", "text": "Oxytocin-stimulated insulin release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways.", "text_with_entity_marker": "Oxytocin-stimulated [E1]insulin[/E1] release in a clonal beta-cell line RINm5F: involvement of [E2]phospholipase C[/E2]-dependent and -independent pathways.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[86, 101]], "entity_2_idx_in_text_with_entity_marker": [99, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s216_IEPA.d91.s216.p0", "text": "CONCLUSION: Oxy increases insulin release through both PLC and non-PLC mediated signal transduction mechanisms.", "text_with_entity_marker": "CONCLUSION: Oxy increases [E1]insulin[/E1] release through both [E2]PLC[/E2] and non-PLC mediated signal transduction mechanisms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[55, 58]], "entity_2_idx_in_text_with_entity_marker": [68, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s219_IEPA.d91.s219.p0", "text": "Oxytocin-stimulated insulin release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways", "text_with_entity_marker": "[E1]Oxytocin[/E1]-stimulated [E2]insulin[/E2] release in a clonal beta-cell line RINm5F: involvement of phospholipase C-dependent and -independent pathways", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[20, 27]], "entity_2_idx_in_text_with_entity_marker": [33, 40], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s220_IEPA.d91.s220.p0", "text": "AIM: To study the mechanisms underlying oxytocin (Oxy)-induced insulin release", "text_with_entity_marker": "AIM: To study the mechanisms underlying [E1]oxytocin[/E1] (Oxy)-induced [E2]insulin[/E2] release", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[40, 48]], "entity_1_idx_in_text_with_entity_marker": [44, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s221_IEPA.d91.s221.p0", "text": "RESULTS: Oxy increased insulin release and [Ca2+]i in a concentration-dependent manner", "text_with_entity_marker": "RESULTS: [E1]Oxy[/E1] increased [E2]insulin[/E2] release and [Ca2+]i in a concentration-dependent manner", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[23, 30]], "entity_2_idx_in_text_with_entity_marker": [36, 43], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s222_IEPA.d91.s222.p0", "text": "Oxy-induced insulin release was not altered by pretreatment with pertussis toxin (PT)", "text_with_entity_marker": "[E1]Oxy[/E1]-induced [E2]insulin[/E2] release was not altered by pretreatment with pertussis toxin (PT)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[12, 19]], "entity_2_idx_in_text_with_entity_marker": [25, 32], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s223_IEPA.d91.s223.p2", "text": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the Oxy-induced increase in insulin release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "text_with_entity_marker": "U-73122 at 8 mumol.L-1 totally abolished the Oxy-induced increases in [Ca2+]i and IP3; however it reduced the [E1]Oxy[/E1]-induced increase in [E2]insulin[/E2] release only by 36% and 63% in the monolayer and suspended cell preparations, respectively", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[110, 113]], "entity_1_idx_in_text_with_entity_marker": [114, 117], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d91.s224_IEPA.d91.s224.p0", "text": "CONCLUSION: Oxy increases insulin release through both PLC and non-PLC mediated signal transduction mechanisms", "text_with_entity_marker": "CONCLUSION: [E1]Oxy[/E1] increases [E2]insulin[/E2] release through both PLC and non-PLC mediated signal transduction mechanisms", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxy", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[26, 33]], "entity_2_idx_in_text_with_entity_marker": [39, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s365_IEPA.d151.s365.p0", "text": "Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women [see comments]", "text_with_entity_marker": "Relationship among [E1]leptin[/E1], [E2]neuropeptide Y[/E2], and galanin in young women and in postmenopausal women [see comments]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[27, 41]], "entity_2_idx_in_text_with_entity_marker": [40, 54], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s404_IEPA.d168.s404.p0", "text": "Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle", "text_with_entity_marker": "Involvement of thyroid hormones in the effect of intracerebroventricular [E1]leptin[/E1] infusion on [E2]uncoupling protein-3[/E2] expression in rat muscle", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-3", "entity_2_idx": [[92, 112]], "entity_2_idx_in_text_with_entity_marker": [105, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p0", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking [E1]leptin[/E1]-induced hyperphagia, produced a marked decrease in the expression of muscle [E2]uncoupling protein-3[/E2] (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[86, 92]], "entity_1_idx_in_text_with_entity_marker": [90, 96], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-3", "entity_2_idx": [[169, 189]], "entity_2_idx_in_text_with_entity_marker": [182, 202], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s405_IEPA.d168.s405.p5", "text": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of leptin prevented such a decrease in UCP-3", "text_with_entity_marker": "A reduction of food intake imposed on control rats (pair-feeding), aimed at mimicking leptin-induced hyperphagia, produced a marked decrease in the expression of muscle uncoupling protein-3 (UCP-3), whereas ICV infusion of [E1]leptin[/E1] prevented such a decrease in [E2]UCP-3[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[223, 229]], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[259, 264]], "entity_2_idx_in_text_with_entity_marker": [272, 277], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s406_IEPA.d168.s406.p0", "text": "To further substantiate an involvement of thyroid hormones in the effect of leptin on muscle UCP-3 expression, hypothyroid rats were ICV infused with leptin or vehicle", "text_with_entity_marker": "To further substantiate an involvement of thyroid hormones in the effect of [E1]leptin[/E1] on muscle [E2]UCP-3[/E2] expression, hypothyroid rats were ICV infused with leptin or vehicle", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[76, 82]], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s407_IEPA.d168.s407.p0", "text": "It was observed that in hypothyroid rats, ICV leptin was unable to maintain muscle UCP-3 expression at values measured in ad libitum fed controls", "text_with_entity_marker": "It was observed that in hypothyroid rats, ICV [E1]leptin[/E1] was unable to maintain muscle [E2]UCP-3[/E2] expression at values measured in ad libitum fed controls", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[46, 52]], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d168.s408_IEPA.d168.s408.p2", "text": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of leptin on muscle UCP-3 expression", "text_with_entity_marker": "These results suggest that central leptin stimulates T3 production via an activation of T4 to T3 conversion, and that this stimulation could be responsible for the effect of [E1]leptin[/E1] on muscle [E2]UCP-3[/E2] expression", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[174, 180]], "entity_1_idx_in_text_with_entity_marker": [178, 184], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-3", "entity_2_idx": [[191, 196]], "entity_2_idx_in_text_with_entity_marker": [204, 209], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d103.s242_IEPA.d103.s242.p0", "text": "The bovine ovarian granulosa cell model is a primary culture system where under stimulation by insulin or IGF-I and LH the endogenous oxytocin gene is massively upregulated", "text_with_entity_marker": "The bovine ovarian granulosa cell model is a primary culture system where under stimulation by [E1]insulin[/E1] or IGF-I and LH the endogenous [E2]oxytocin[/E2] gene is massively upregulated", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[95, 102]], "entity_1_idx_in_text_with_entity_marker": [99, 106], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[134, 142]], "entity_2_idx_in_text_with_entity_marker": [147, 155], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s290_IEPA.d122.s290.p0", "text": "Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue", "text_with_entity_marker": "Effects of intravenously infused [E1]leptin[/E1] on insulin sensitivity and on the expression of [E2]uncoupling proteins[/E2] in brown adipose tissue", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[33, 39]], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[88, 107]], "entity_2_idx_in_text_with_entity_marker": [101, 120], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s291_IEPA.d122.s291.p0", "text": "Centrally administered leptin has been shown to increase insulin-stimulated glucose utilization and to favor the expression of uncoupling proteins (UCPs)", "text_with_entity_marker": "Centrally administered [E1]leptin[/E1] has been shown to increase insulin-stimulated glucose utilization and to favor the expression of [E2]uncoupling proteins[/E2] (UCPs)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[23, 29]], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[127, 146]], "entity_2_idx_in_text_with_entity_marker": [140, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s293_IEPA.d122.s293.p0", "text": "I.v. leptin infusion also favored the expression of UCPs in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.", "text_with_entity_marker": "I.v. [E1]leptin[/E1] infusion also favored the expression of [E2]UCPs[/E2] in brown adipose tissue, either by increasing their expression or preventing the fall occurring during the pair-feeding regimen.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[5, 11]], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCPs", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s295_IEPA.d122.s295.p0", "text": "These results suggest that the overall effect of leptin on glucose utilization and on the expression of UCPs may be mediated through central mechanism", "text_with_entity_marker": "These results suggest that the overall effect of [E1]leptin[/E1] on glucose utilization and on the expression of [E2]UCPs[/E2] may be mediated through central mechanism", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCPs", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d134.s322_IEPA.d134.s322.p0", "text": "Isolation and characterization of gibbestatin B, an inhibitor of gibberellin-induced expression of alpha-amylase, and gibbestatin C from streptomycetaes", "text_with_entity_marker": "Isolation and characterization of gibbestatin B, an inhibitor of [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2], and gibbestatin C from streptomycetaes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[65, 76]], "entity_1_idx_in_text_with_entity_marker": [69, 80], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d33.s73_IEPA.d33.s73.p0", "text": "METHODS: The effects of OT on IP3 formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits", "text_with_entity_marker": "METHODS: The effects of [E1]OT[/E1] on [E2]IP3[/E2] formation and OT receptor levels were determined in the myometria of non-pregnant rabbits, Days 26, 28 and 30 of pregnancy rabbits, postpartum rabbits within 12 hours and steroid-treated ovariectomized rabbits", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[24, 26]], "entity_1_idx_in_text_with_entity_marker": [28, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s333_IEPA.d139.s333.p0", "text": "Leptin and UCP (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle", "text_with_entity_marker": "[E1]Leptin[/E1] and [E2]UCP[/E2] (1 and 2) mRNA levels were determined by reverse transcription-polymerase chain reaction (RT-PCR) methodology in adipose tissue and gastrocnemius muscle", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[11, 14]], "entity_2_idx_in_text_with_entity_marker": [24, 27], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p0", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and [E1]UCP2[/E1] expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E2]UCP2[/E2] expression, as well as for plasma leptin and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[383, 387]], "entity_2_idx_in_text_with_entity_marker": [396, 400], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p1", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and [E1]UCP2[/E1] expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma [E2]leptin[/E2] and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[422, 428]], "entity_2_idx_in_text_with_entity_marker": [435, 441], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p2", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and [E1]UCP2[/E1] expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[437, 443]], "entity_2_idx_in_text_with_entity_marker": [450, 456], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p3", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E1]UCP2[/E1] expression, as well as for plasma [E2]leptin[/E2] and WAT leptin expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[383, 387]], "entity_1_idx_in_text_with_entity_marker": [387, 391], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[422, 428]], "entity_2_idx_in_text_with_entity_marker": [435, 441], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p4", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle [E1]UCP2[/E1] expression, as well as for plasma leptin and WAT [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[383, 387]], "entity_1_idx_in_text_with_entity_marker": [387, 391], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[437, 443]], "entity_2_idx_in_text_with_entity_marker": [450, 456], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d139.s334_IEPA.d139.s334.p5", "text": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma leptin and WAT leptin expression", "text_with_entity_marker": "A negative correlation between WAT O2 consumption and UCP2 expression was found in control animals, but not in the cafeteria-fed groups, suggesting a differential response to the beta3-adrenergic compound in lean and obese animals, which is in agreement with the reported statistical interactions between obesity and Trecadrine administration found for WAT O2 consumption and muscle UCP2 expression, as well as for plasma [E1]leptin[/E1] and WAT [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[422, 428]], "entity_1_idx_in_text_with_entity_marker": [426, 432], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[437, 443]], "entity_2_idx_in_text_with_entity_marker": [450, 456], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p0", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal [E2]PIP2-PLC[/E2] activity and cytosolic PI-PLC and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p1", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal PIP2-PLC activity and cytosolic [E2]PI-PLC[/E2] and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[78, 84]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p2", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, [E1]A beta[/E1] 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A beta", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p3", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal [E1]PIP2-PLC[/E1] activity and cytosolic [E2]PI-PLC[/E2] and PIP2-PLC", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PIP2-PLC", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PI-PLC", "entity_2_idx": [[78, 84]], "entity_2_idx_in_text_with_entity_marker": [91, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p4", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal [E1]PIP2-PLC[/E1] activity and cytosolic PI-PLC and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PIP2-PLC", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d130.s314_IEPA.d130.s314.p5", "text": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic PI-PLC and PIP2-PLC", "text_with_entity_marker": "Moreover, A beta 25-35 had no effect on basal PIP2-PLC activity and cytosolic [E1]PI-PLC[/E1] and [E2]PIP2-PLC[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PI-PLC", "entity_1_idx": [[78, 84]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PIP2-PLC", "entity_2_idx": [[89, 97]], "entity_2_idx_in_text_with_entity_marker": [102, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p0", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of [E2]PLC[/E2], U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[116, 119]], "entity_2_idx_in_text_with_entity_marker": [129, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p1", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E2]PLCgamma[/E2] to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[216, 224]], "entity_2_idx_in_text_with_entity_marker": [229, 237], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p2", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of [E1]PLCgamma[/E1] and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block [E2]insulin[/E2]-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLCgamma", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[234, 241]], "entity_2_idx_in_text_with_entity_marker": [247, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p3", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of [E1]PLC[/E1], U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E2]PLCgamma[/E2] to block insulin-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[116, 119]], "entity_1_idx_in_text_with_entity_marker": [120, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCgamma", "entity_2_idx": [[216, 224]], "entity_2_idx_in_text_with_entity_marker": [229, 237], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p4", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of [E1]PLC[/E1], U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block [E2]insulin[/E2]-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[116, 119]], "entity_1_idx_in_text_with_entity_marker": [120, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[234, 241]], "entity_2_idx_in_text_with_entity_marker": [247, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s168_IEPA.d67.s168.p5", "text": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from PLCgamma to block insulin-stimulated GLUT4 translocation", "text_with_entity_marker": "To determine the functional significance of the interaction of PLCgamma and the IR, we used a specific inhibitor of PLC, U73122, or microinjection of SH2 domain glutathione S-transferase fusion proteins derived from [E1]PLCgamma[/E1] to block [E2]insulin[/E2]-stimulated GLUT4 translocation", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLCgamma", "entity_1_idx": [[216, 224]], "entity_1_idx_in_text_with_entity_marker": [220, 228], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[234, 241]], "entity_2_idx_in_text_with_entity_marker": [247, 254], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d121.s289_IEPA.d121.s289.p0", "text": "An inhibitor of PKC, Ro31-8220 (10 microM), abolished the ability of PDBu to decrease [Ca(2+)](i), without affecting the response to maximal or submaximal concentrations of AVP", "text_with_entity_marker": "An inhibitor of [E1]PKC[/E1], Ro31-8220 (10 microM), abolished the ability of PDBu to decrease [Ca(2+)](i), without affecting the response to maximal or submaximal concentrations of [E2]AVP[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[173, 176]], "entity_2_idx_in_text_with_entity_marker": [186, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s210_IEPA.d89.s210.p0", "text": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "text_with_entity_marker": "To determine the effects of food restriction and [E1]leptin[/E1] administration on several transcripts involved in energy homeostasis, we examined [E2]leptin[/E2], uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[138, 144]], "entity_2_idx_in_text_with_entity_marker": [151, 157], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s210_IEPA.d89.s210.p1", "text": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "text_with_entity_marker": "To determine the effects of food restriction and [E1]leptin[/E1] administration on several transcripts involved in energy homeostasis, we examined leptin, [E2]uncoupling proteins[/E2] (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[49, 55]], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[146, 165]], "entity_2_idx_in_text_with_entity_marker": [159, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d89.s210_IEPA.d89.s210.p2", "text": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined leptin, uncoupling proteins (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "text_with_entity_marker": "To determine the effects of food restriction and leptin administration on several transcripts involved in energy homeostasis, we examined [E1]leptin[/E1], [E2]uncoupling proteins[/E2] (UCP) 1, 2 and 3, lipoprotein lipase (LPL), beta3-adrenergic receptors (beta3AR) and hormone-sensitive lipase (HSL) mRNA levels in brown adipose tissue (BAT) and epididymal (EWAT) and perirenal (PWAT) white adipose tissue in three groups of rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[138, 144]], "entity_1_idx_in_text_with_entity_marker": [142, 148], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling proteins", "entity_2_idx": [[146, 165]], "entity_2_idx_in_text_with_entity_marker": [159, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d26.s56_IEPA.d26.s56.p0", "text": "The SGR and RGR also had different endocrine profiles with, for example, twice as high oxytocin (p < 0.01) and insulin levels (p < 0.01) in RGR compared to the SGR", "text_with_entity_marker": "The SGR and RGR also had different endocrine profiles with, for example, twice as high [E1]oxytocin[/E1] (p < 0.01) and [E2]insulin[/E2] levels (p < 0.01) in RGR compared to the SGR", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d73.s175_IEPA.d73.s175.p0", "text": "Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific PLC, and glimepiride failed completely to provoke insulin-mimetic effects", "text_with_entity_marker": "Strikingly, in adipocytes subjected to combined trypsin/salt treatment, PIG-P, PI-specific [E1]PLC[/E1], and glimepiride failed completely to provoke [E2]insulin[/E2]-mimetic effects", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[91, 94]], "entity_1_idx_in_text_with_entity_marker": [95, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[141, 148]], "entity_2_idx_in_text_with_entity_marker": [154, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p0", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on [E1]insulin[/E1] secretion, phosphoinositide-specific [E2]phospholipase Cbeta1[/E2] (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cbeta1", "entity_2_idx": [[109, 129]], "entity_2_idx_in_text_with_entity_marker": [122, 142], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p1", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on [E1]insulin[/E1] secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or [E2]PLCdelta1[/E2] was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCdelta1", "entity_2_idx": [[144, 153]], "entity_2_idx_in_text_with_entity_marker": [157, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d99.s238_IEPA.d99.s238.p2", "text": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific phospholipase Cbeta1 (PLCbeta1) or PLCdelta1 was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "text_with_entity_marker": "To study the effects of enhanced phosphoinositide hydrolysis on insulin secretion, phosphoinositide-specific [E1]phospholipase Cbeta1[/E1] (PLCbeta1) or [E2]PLCdelta1[/E2] was overexpressed in insulinoma MIN6 cells via adenoviral vectors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase Cbeta1", "entity_1_idx": [[109, 129]], "entity_1_idx_in_text_with_entity_marker": [113, 133], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLCdelta1", "entity_2_idx": [[144, 153]], "entity_2_idx_in_text_with_entity_marker": [157, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d9.s0_LLL.d9.s0.p0", "text": "Taken together, the results support the idea that sequestration of SpoIIE protein into the prespore plays an important role in the control of sigmaF activation and in coupling this activation to septation.", "text_with_entity_marker": "Taken together, the results support the idea that sequestration of [E1]SpoIIE[/E1] protein into the prespore plays an important role in the control of [E2]sigmaF[/E2] activation and in coupling this activation to septation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[67, 73]], "entity_1_idx_in_text_with_entity_marker": [71, 77], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaF", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d9.s1_LLL.d9.s1.p2", "text": "sigmaF is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "text_with_entity_marker": "[E1]sigmaF[/E1] is controlled by a regulatory cascade involving an anti-sigma factor, [E2]SpoIIAB[/E2], an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIAB", "entity_2_idx": [[77, 84]], "entity_2_idx_in_text_with_entity_marker": [90, 97], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d9.s1_LLL.d9.s1.p5", "text": "sigmaF is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "text_with_entity_marker": "[E1]sigmaF[/E1] is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, [E2]SpoIIAA[/E2], and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIAA", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d9.s1_LLL.d9.s1.p7", "text": "sigmaF is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "text_with_entity_marker": "[E1]sigmaF[/E1] is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, [E2]SpoIIE[/E2], which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaF", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIE", "entity_2_idx": [[156, 162]], "entity_2_idx_in_text_with_entity_marker": [169, 175], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d9.s1_LLL.d9.s1.p8", "text": "sigmaF is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, SpoIIE, which converts the inactive, phosphorylated form of SpoIIAA back to the active form.", "text_with_entity_marker": "sigmaF is controlled by a regulatory cascade involving an anti-sigma factor, SpoIIAB, an anti-anti-sigma factor, SpoIIAA, and a membrane-bound phosphatase, [E1]SpoIIE[/E1], which converts the inactive, phosphorylated form of [E2]SpoIIAA[/E2] back to the active form.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[156, 162]], "entity_1_idx_in_text_with_entity_marker": [160, 166], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "SpoIIAA", "entity_2_idx": [[216, 223]], "entity_2_idx_in_text_with_entity_marker": [229, 236], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d26.s0_LLL.d26.s0.p0", "text": "From these results we conclude that ComK negatively regulates degR expression by preventing sigmaD-driven transcription of degR, possibly through interaction with the control region.", "text_with_entity_marker": "From these results we conclude that [E1]ComK[/E1] negatively regulates degR expression by preventing [E2]sigmaD[/E2]-driven transcription of degR, possibly through interaction with the control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaD", "entity_2_idx": [[92, 98]], "entity_2_idx_in_text_with_entity_marker": [105, 111], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d26.s0_LLL.d26.s0.p1", "text": "From these results we conclude that ComK negatively regulates degR expression by preventing sigmaD-driven transcription of degR, possibly through interaction with the control region.", "text_with_entity_marker": "From these results we conclude that [E1]ComK[/E1] negatively regulates [E2]degR[/E2] expression by preventing sigmaD-driven transcription of degR, possibly through interaction with the control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "degR", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d26.s0_LLL.d26.s0.p2", "text": "From these results we conclude that ComK negatively regulates degR expression by preventing sigmaD-driven transcription of degR, possibly through interaction with the control region.", "text_with_entity_marker": "From these results we conclude that [E1]ComK[/E1] negatively regulates degR expression by preventing sigmaD-driven transcription of [E2]degR[/E2], possibly through interaction with the control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "degR", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d26.s0_LLL.d26.s0.p4", "text": "From these results we conclude that ComK negatively regulates degR expression by preventing sigmaD-driven transcription of degR, possibly through interaction with the control region.", "text_with_entity_marker": "From these results we conclude that ComK negatively regulates degR expression by preventing [E1]sigmaD[/E1]-driven transcription of [E2]degR[/E2], possibly through interaction with the control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaD", "entity_1_idx": [[92, 98]], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "degR", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d26.s1_LLL.d26.s1.p0", "text": "We have shown previously that the transcription of degR is driven by an alternative sigma factor, sigmaD.", "text_with_entity_marker": "We have shown previously that the transcription of [E1]degR[/E1] is driven by an alternative sigma factor, [E2]sigmaD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "degR", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaD", "entity_2_idx": [[98, 104]], "entity_2_idx_in_text_with_entity_marker": [111, 117], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d4.s0_LLL.d4.s0.p0", "text": "Secondly, SpoIIE is essential for the activation of the first compartment-specific transcription factor sigma(F) in the prespore.", "text_with_entity_marker": "Secondly, [E1]SpoIIE[/E1] is essential for the activation of the first compartment-specific transcription factor [E2]sigma(F)[/E2] in the prespore.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIE", "entity_1_idx": [[10, 16]], "entity_1_idx_in_text_with_entity_marker": [14, 20], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigma(F)", "entity_2_idx": [[104, 112]], "entity_2_idx_in_text_with_entity_marker": [117, 125], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d13.s0_LLL.d13.s0.p0", "text": "Production of sigmaK about 1 h earlier than normal does affect Spo0A, which when phosphorylated is an activator of sigE transcription.", "text_with_entity_marker": "Production of [E1]sigmaK[/E1] about 1 h earlier than normal does affect [E2]Spo0A[/E2], which when phosphorylated is an activator of sigE transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaK", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "Spo0A", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d13.s0_LLL.d13.s0.p2", "text": "Production of sigmaK about 1 h earlier than normal does affect Spo0A, which when phosphorylated is an activator of sigE transcription.", "text_with_entity_marker": "Production of sigmaK about 1 h earlier than normal does affect [E1]Spo0A[/E1], which when phosphorylated is an activator of [E2]sigE[/E2] transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Spo0A", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigE", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d13.s1_LLL.d13.s1.p1", "text": "The ald promoter, like the sigE promoter, is believed to be recognized by sigmaA RNA polymerase, suggesting that sigmaK may inhibit sigmaA activity late in sporulation.", "text_with_entity_marker": "The [E1]ald[/E1] promoter, like the sigE promoter, is believed to be recognized by [E2]sigmaA[/E2] RNA polymerase, suggesting that sigmaK may inhibit sigmaA activity late in sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ald", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaA", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d13.s1_LLL.d13.s1.p2", "text": "The ald promoter, like the sigE promoter, is believed to be recognized by sigmaA RNA polymerase, suggesting that sigmaK may inhibit sigmaA activity late in sporulation.", "text_with_entity_marker": "The ald promoter, like the [E1]sigE[/E1] promoter, is believed to be recognized by [E2]sigmaA[/E2] RNA polymerase, suggesting that sigmaK may inhibit sigmaA activity late in sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigE", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaA", "entity_2_idx": [[74, 80]], "entity_2_idx_in_text_with_entity_marker": [87, 93], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d13.s1_LLL.d13.s1.p6", "text": "The ald promoter, like the sigE promoter, is believed to be recognized by sigmaA RNA polymerase, suggesting that sigmaK may inhibit sigmaA activity late in sporulation.", "text_with_entity_marker": "The ald promoter, like the sigE promoter, is believed to be recognized by sigmaA RNA polymerase, suggesting that [E1]sigmaK[/E1] may inhibit [E2]sigmaA[/E2] activity late in sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaK", "entity_1_idx": [[113, 119]], "entity_1_idx_in_text_with_entity_marker": [117, 123], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaA", "entity_2_idx": [[132, 138]], "entity_2_idx_in_text_with_entity_marker": [145, 151], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d13.s2_LLL.d13.s2.p0", "text": "In the mother cell compartment of sporulating cells, expression of the sigE gene, encoding the earlier-acting sigma factor, sigmaE, is negatively regulated by the later-acting sigma factor, sigmaK.", "text_with_entity_marker": "In the mother cell compartment of sporulating cells, expression of the [E1]sigE[/E1] gene, encoding the earlier-acting sigma factor, sigmaE, is negatively regulated by the later-acting sigma factor, [E2]sigmaK[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigE", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaK", "entity_2_idx": [[190, 196]], "entity_2_idx_in_text_with_entity_marker": [203, 209], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
